<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004251.pub4" GROUP_ID="BACK" ID="552702031408130236" MERGED_FROM="" MODIFIED="2013-08-23 14:55:45 +0100" MODIFIED_BY="Teresa Marin" NOTES="&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-08-23 00:01:06 +0200" NOTES_MODIFIED_BY="Peter Kroeling" REVIEW_NO="" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.10">
<COVER_SHEET MODIFIED="2013-08-23 14:55:45 +0100" MODIFIED_BY="Teresa Marin">
<TITLE MODIFIED="2009-05-07 21:19:45 +0200" MODIFIED_BY="[Empty name]">Electrotherapy for neck pain</TITLE>
<CONTACT MODIFIED="2013-08-23 14:55:45 +0100" MODIFIED_BY="Teresa Marin"><PERSON ID="12707" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><LAST_NAME>Kroeling</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Associate Professor</POSITION><EMAIL_1>kroeling@med.uni-muenchen.de</EMAIL_1><ADDRESS><DEPARTMENT>Dept. of Physical Medicine and Rehabilitation</DEPARTMENT><ORGANISATION>Ludwig-Maximilians-University of Munich</ORGANISATION><ADDRESS_1>Marchionini-Str. 17</ADDRESS_1><CITY>D-81377 München</CITY><ZIP>D-80801</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49-89-2180-78219</PHONE_1><FAX_1>+49-89-7095-78230</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-08-23 14:55:45 +0100" MODIFIED_BY="Teresa Marin"><PERSON ID="12707" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><LAST_NAME>Kroeling</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Associate Professor</POSITION><EMAIL_1>kroeling@med.uni-muenchen.de</EMAIL_1><ADDRESS><DEPARTMENT>Dept. of Physical Medicine and Rehabilitation</DEPARTMENT><ORGANISATION>Ludwig-Maximilians-University of Munich</ORGANISATION><ADDRESS_1>Marchionini-Str. 17</ADDRESS_1><CITY>D-81377 München</CITY><ZIP>D-80801</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49-89-2180-78219</PHONE_1><FAX_1>+49-89-7095-78230</FAX_1></ADDRESS></PERSON><PERSON ID="5293" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Anita</FIRST_NAME><LAST_NAME>Gross</LAST_NAME><SUFFIX>MSc</SUFFIX><POSITION>Associate Clinical Professor</POSITION><EMAIL_1>grossa@mcmaster.ca</EMAIL_1><EMAIL_2>grossa@sympatico.ca</EMAIL_2><ADDRESS><DEPARTMENT>School of Rehabilitation Science &amp; Department of Clinical Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>McMaster University</ORGANISATION><ADDRESS_1>1400 Main Street West</ADDRESS_1><CITY>Hamilton</CITY><ZIP>L8S 1C7</ZIP><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 905 525 1256</PHONE_1><PHONE_2>+1 905 577 0098</PHONE_2><FAX_1>+1 905 5770603</FAX_1></ADDRESS></PERSON><PERSON ID="17420" ROLE="AUTHOR"><FIRST_NAME>Nadine</FIRST_NAME><LAST_NAME>Graham</LAST_NAME><SUFFIX>BA BHScPT</SUFFIX><POSITION>Assistant Clinical Professor</POSITION><EMAIL_1>nadinelino@sympatico.ca</EMAIL_1><ADDRESS><DEPARTMENT>School of Rehabilitation Science</DEPARTMENT><ORGANISATION>McMaster University</ORGANISATION><ADDRESS_1>1200 Main Street West</ADDRESS_1><CITY>Hamilton</CITY><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 (905) 304-4430</PHONE_1><FAX_1>+1 (905) 304-4431</FAX_1></ADDRESS></PERSON><PERSON ID="4E09F97182E26AA201BA4B54471EA324" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Stephen</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Burnie</LAST_NAME><EMAIL_1>sburnie@cmcc.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Clinical Education</DEPARTMENT><ORGANISATION>Canadian Memorial Chiropractic College</ORGANISATION><ADDRESS_1>6100 Leslie Street</ADDRESS_1><CITY>Toronto</CITY><ZIP>M2H 3J1</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="z1301181445227177561403861413274" ROLE="AUTHOR"><FIRST_NAME>Grace</FIRST_NAME><LAST_NAME>Szeto</LAST_NAME><EMAIL_1>grace.szeto@polyu.edu.hk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Rehabilitation Sciences</DEPARTMENT><ORGANISATION>The Hong Kong Polytechnic University</ORGANISATION><CITY>Hung Hom</CITY><REGION>Kowloon</REGION><COUNTRY CODE="HK">Hong Kong</COUNTRY></ADDRESS></PERSON><PERSON ID="15632" ROLE="AUTHOR"><FIRST_NAME>Charles</FIRST_NAME><MIDDLE_INITIALS>H</MIDDLE_INITIALS><LAST_NAME>Goldsmith</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Professor of Biostatistics</POSITION><EMAIL_1>charles_goldsmith@sfu.ca</EMAIL_1><EMAIL_2>cgoldsmith@arthritisresearch.ca</EMAIL_2><ADDRESS><DEPARTMENT>Faculty of Health Sciences</DEPARTMENT><ORGANISATION>Simon Fraser University</ORGANISATION><ADDRESS_1>Blossom Hall, Room 9510</ADDRESS_1><ADDRESS_2>8888 University Drive</ADDRESS_2><CITY>Burnaby</CITY><ZIP>V5A 1S6</ZIP><REGION>BC</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 778 782 9060</PHONE_1><FAX_1>+1 778 782 5927</FAX_1></ADDRESS></PERSON><PERSON ID="5300" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ted</FIRST_NAME><LAST_NAME>Haines</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>hainest@mcmaster.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Clinical Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>McMaster University</ORGANISATION><ADDRESS_1>1200 Main Street West</ADDRESS_1><ADDRESS_2>HSC 3H54</ADDRESS_2><CITY>Hamilton</CITY><ZIP>L8N 3Z5</ZIP><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 905 525 9140 Ext: 22333</PHONE_1></ADDRESS></PERSON><PERSON ID="89057916562913028126110819175540" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Mario</FIRST_NAME><LAST_NAME>Forget</LAST_NAME><SUFFIX>PT</SUFFIX><EMAIL_1>mario.forget@forces.gc.ca</EMAIL_1><EMAIL_2>mforget2@cogeco.ca</EMAIL_2><ADDRESS><DEPARTMENT>Department of Physiotherapy</DEPARTMENT><ORGANISATION>Department of National Defense (DND)</ORGANISATION><ADDRESS_1>PO Box 17000, Stn. Forces</ADDRESS_1><CITY>Kingston</CITY><ZIP>K7K 7B4</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 613 541-5010 #5456</PHONE_1><FAX_1>+1 613 540-8031</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-07-04 20:26:08 +0200" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="17" MONTH="1" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="8" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="1" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2009"/>
</DATES>
<WHATS_NEW MODIFIED="2013-08-22 23:12:12 +0200" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Updated literature search from 2009 to August 2012, 2 new publications were included, 7 publications were excluded.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-08-22 23:12:12 +0200" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>20 studies (21 publications) included in qualitative synthesis:<BR/>galvanic current versus placebo (n = 1);<BR/>iontophoresis versus no treatment (n = 1), versus comparison (n = 1);<BR/>TENS versus placebo (n = 3), + another treatment versus that same treatment (n = 3), versus comparison (n = 3), versus other dosage (n = 1);<BR/>EMS versus placebo (n = 1), versus no treatment (n = 1), + another intervention versus that same intervention (n = 1), versus comparison (n = 1); Static magnetic field versus placebo (n = 1); PEMF versus placebo (n = 1), versus comparison (n = 1);</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-07-04 20:22:55 +0200" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-07-04 20:22:55 +0200" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Inclusion criteria modified and contracted to clearly isolate the unique effect of electrotherapy, resulting in four publications excluded from the 2005 version of the review. An additional kind of electrotherapy was also identified (repetitive magnetic stimulation, rMS).</P>
<P>However, there were no essential changes in conclusions - the evidence neither supports nor refutes the efficacy of electrotherapy for the management of neck pain. Further research is very likely to change both the estimate of effect and our confidence in the results.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-01-23 19:18:41 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="14" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-06-17 21:43:40 +0200" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2008-06-17 21:43:40 +0200" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>McMaster University</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Ludwig Maximilians University of Munich</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Western Ontario</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-06-17 21:43:40 +0200" MODIFIED_BY="[Empty name]">
<NAME>St. Josephs's Healthcare</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Consortial Centre for Chiropractic Research - Nat. Institute of Health, Bethseda, MD</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Hamilton Hospital Association, Ontario</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-08-22 23:22:41 +0200" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-05-07 16:59:17 +0200" MODIFIED_BY="[Empty name]">Electrotherapy for neck pain</TITLE>
<SUMMARY_BODY MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>Neck pain is common, disabling and costly. Electrotherapy is an umbrella term that covers a number of therapies using electric current that aim to reduce pain and improve muscle tension and function.</P>
<P>
<B>Study characteristics</B>
</P>
<P>This updated review included 20 small trials (N = 1239). We included adults (&gt; 18 years old) with acute whiplash or non-specific neck pain as well as chronic neck pain including degenerative changes, myofascial pain or headaches that stem from the neck. No index for severity of the disorders could be specified. The evidence was current to August 2012. The results of the trials could not be pooled because they examined different populations, types and doses of electrotherapy and comparison treatments, and measured slightly different outcomes.  </P>
<P>
<B>Key results</B>
</P>
<P>We cannot make any definitive statements about the efficacy of electrotherapy for neck pain because of the low or very low quality of the evidence for each outcome, which in most cases was based on the results of only one trial. </P>
<P>For patients with acute neck pain, TENS possibly relieved pain better than electrical muscle stimulation, not as well as exercise and infrared light, and as well as manual therapy and ultrasound. There was no additional benefit when added to infrared light, hot packs and exercise, physiotherapy, or a combination of a neck collar, exercise and pain medication. For patients with acute whiplash, iontophoresis was no more effective than no treatment, interferential current, or a combination of traction, exercise and massage for relieving neck pain with headache.</P>
<P>For patients with chronic neck pain, TENS possibly relieved pain better than placebo and electrical muscle stimulation, not as well as exercise and infrared light, and possibly as well as manual therapy and ultrasound. Magnetic necklaces were no more effective than placebo for relieving pain; and there was no additional benefit when electrical muscle stimulation was added to either mobilisation or manipulation.</P>
<P>For patients with myofascial neck pain, TENS, FREMS (<U>FRE</U>quency <U>M</U>odulated <U>N</U>eural <U>S</U>timulation, a variation of TENS) and repetitive magnetic stimulation seemed to relieve pain better than placebo.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>About 70% of the trials were poorly conducted studies. The trials were very small, with a range of 16 to 336 participants. The data were sparse and imprecise, which suggests that results cannot be generalized to the broader population and contributes to the reduction in the quality of the evidence. Therefore, further research is very likely to change the results and our confidence in the results.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-02-21 17:16:55 +0100" MODIFIED_BY="[Empty name]">
<P>Neck pain is common, disabling and costly. The effectiveness of electrotherapy as a physiotherapeutic option remains unclear. This is an update of a Cochrane review first published in 2005 and previously updated in 2009.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-08-16 14:52:28 +0200" MODIFIED_BY="[Empty name]">
<P>This systematic review assessed the short, intermediate and long-term effects of electrotherapy on pain, function, disability, patient satisfaction, global perceived effect, and quality of life in adults with neck pain with and without radiculopathy or cervicogenic headache.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-08-16 14:52:48 +0200" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL, MEDLINE, EMBASE, MANTIS, CINAHL, and ICL, without language restrictions, from their beginning to August 2012; handsearched relevant conference proceedings; and consulted content experts.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-08-16 14:52:48 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs), in any language, investigating the effects of electrotherapy used primarily as unimodal treatment for neck pain. Quasi-RCTs and controlled clinical trials were excluded.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-08-16 14:52:48 +0200" MODIFIED_BY="[Empty name]">
<P>We used standard methodological procedures expected by The Cochrane Collaboration. We were unable to statistically pool any of the results, but we assessed the quality of the evidence using an adapted GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-08-16 14:52:48 +0200" MODIFIED_BY="[Empty name]">
<P>Twenty small trials (1239 people with neck pain) containing 38 comparisons were included. Analysis was limited by trials of varied quality, heterogeneous treatment subtypes and conflicting results. The main findings for reduction of neck pain by treatment with electrotherapeutic modalities were as follows.</P>
<P>Very low quality evidence determined that pulsed electromagnetic field therapy (PEMF) and repetitive magnetic stimulation (rMS) were more effective than placebo, while transcutaneous electrical nerve stimulation (TENS) showed inconsistent results.</P>
<P>Very low quality evidence determined that PEMF, rMS and TENS were more effective than placebo.</P>
<P>Low quality evidence (1 trial, 52 participants)<B>
<I> </I>
</B>determined that permanent magnets (necklace) were no more effective than placebo (standardized mean difference (SMD) 0.27, 95% CI -0.27 to 0.82, random-effects model).</P>
<P>Very low quality evidence<B>
<I> </I>
</B>showed that modulated galvanic current, iontophoresis and electric muscle stimulation (EMS) were not more effective than placebo.</P>
<P>There were four trials that reported on other outcomes such as function and global perceived effects, but none of the effects were of clinical importance. When TENS, iontophoresis and PEMF were compared to another treatment, very low quality evidence prevented us from suggesting any recommendations. No adverse side effects were reported in any of the included studies.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="VEP  ">
<P>We cannot make any definite statements on the efficacy and clinical usefulness of electrotherapy modalities for neck pain. Since the evidence is of low or very low quality, we are uncertain about the estimate of the effect. Further research is very likely to change both the estimate of effect and our confidence in the results. Current evidence for PEMF, rMS, and TENS shows that these modalities might be more effective than placebo. When compared to other interventions the quality of evidence was very low thus preventing further recommendations.</P>
<P>Funding bias should be considered, especially in PEMF studies. Galvanic current, iontophoresis, EMS, and a static magnetic field did not reduce pain or disability. Future trials on these interventions should have larger patient samples, include more precise standardization, and detail treatment characteristics.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-08-22 23:22:41 +0200" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-08-22 23:22:41 +0200" MODIFIED_BY="[Empty name]">
<P>For many years, electrotherapy has been commonly used as one of the physiotherapeutic options to treat neck pain. In contrast, little is known about its efficacy and efficiency. In our first review, published in 2005 (<LINK REF="REF-Kroeling-2005" TYPE="REFERENCE">Kroeling 2005</LINK>) and evaluating 11 publications, we found the evidence for all described modalities of electrotherapy either lacking, limited or conflicting. Our first update (<LINK REF="REF-Kroeling-2009" TYPE="REFERENCE">Kroeling 2009</LINK>) replaced the 2005 review and added seven recent publications, including studies on a new modality. Four studies (<LINK REF="STD-Ammer-1990" TYPE="STUDY">Ammer 1990</LINK>; <LINK REF="STD-Chee--1986" TYPE="STUDY">Chee 1986</LINK>; <LINK REF="STD-Persson-2001" TYPE="STUDY">Persson 2001</LINK>; <LINK REF="STD-Provinciali-1996" TYPE="STUDY">Provinciali 1996</LINK>) that were included in the first review were excluded in the 2009 update, because studies of multimodal treatment were excluded; the unique contribution of the electrotherapy could not be identified. In our 2009 update (<LINK REF="REF-Kroeling-2009" TYPE="REFERENCE">Kroeling 2009</LINK>)18 small trials (1093 people with neck pain) were included. Analysis was limited by trials of varied quality, heterogeneous treatment subtypes and conflicting results.<BR/>
</P>
<CONDITION MODIFIED="2013-08-22 23:14:36 +0200" MODIFIED_BY="[Empty name]">
<P>We studied neck pain that could be classified as either:</P>
<UL>
<LI>non-specific mechanical neck pain, including whiplash associated disorders (WAD) category I and II (<LINK REF="REF-Spitzer-1987" TYPE="REFERENCE">Spitzer 1987</LINK>; <LINK REF="REF-Spitzer-1995" TYPE="REFERENCE">Spitzer 1995</LINK>), myofascial neck pain, and degenerative changes including osteoarthritis and cervical spondylosis (<LINK REF="REF-Schumacher-1993" TYPE="REFERENCE">Schumacher 1993</LINK>);</LI>
<LI>cervicogenic headache (<LINK REF="REF-Olesen-1988" TYPE="REFERENCE">Olesen 1988</LINK>; <LINK REF="REF-Olesen-1997" TYPE="REFERENCE">Olesen 1997</LINK>; <LINK REF="REF-Sjaastad-1990" TYPE="REFERENCE">Sjaastad 1990</LINK>; or</LI>
<LI>neck disorders with radicular findings (<LINK REF="REF-Spitzer-1987" TYPE="REFERENCE">Spitzer 1987</LINK>; <LINK REF="REF-Spitzer-1995" TYPE="REFERENCE">Spitzer 1995</LINK>).</LI>
</UL>
<P>It can be classified as acute (less than 30 days), subacute (30 to 90 days) or chronic duration (longer than 90 days). Neck pain is typically provoked by neck movements and by physical examination provocation tests, and is located between the occiput to upper thoracic spine with the associated musculature.</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-08-16 14:53:37 +0200" MODIFIED_BY="[Empty name]">
<P>Electrotherapy is a treatment category and may include: direct current, iontophoresis, electrical nerve stimulation, electrical muscle stimulation, pulsed electromagnetic fields, repetitive magnetic stimulation, and permanent magnets. Their underpinning mechanisms vary and are described in the following section.</P>
</INTERVENTION>
<THEORY MODIFIED="2013-08-16 15:08:37 +0200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="6">1) Galvanic current for pain control</HEADING>
<P>Treatment by direct current (DC), so-called Galvanic current, reduces pain by inhibiting nociceptor activity (<LINK REF="REF-Cameron-1999" TYPE="REFERENCE">Cameron 1999</LINK>). This effect is restricted to the area of current flow through the painful region. The main indication for Galvanic current is the treatment of acute radicular pain and inflammation of periarticular structures such as tendons and ligaments. Because DC enhances the transport of ionised substances through the skin, it can also be used to promote resorption of topical treatments, especially anti-inflammatory drugs (iontophoresis).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2) Electrical nerve stimulation (ENS) or transcutaneous electrical nerve stimulation (TENS) for pain control</HEADING>
<P>Alternating electrical current (AC) or modulated DC (so-called Galvanic stimulation), mostly in the form of rectangular impulses, may inhibit pain-related potentials at the spinal and supraspinal level, known as 'gate control'. This underpins all classical forms of stimulating electrotherapy (for example diadynamic current), as well as a modern form called TENS (including Ultra-Reiz). While Galvanic current efficacy is restricted to the area of current flow, analgesic effects of ENS can be observed in the whole segmental region, both ipsilateral and contralateral (<LINK REF="REF-Cameron-1999" TYPE="REFERENCE">Cameron 1999</LINK>; <LINK REF="REF-Kroeling-1998" TYPE="REFERENCE">Kroeling 1998</LINK>; <LINK REF="REF-Stucki-2000" TYPE="REFERENCE">Stucki 2000</LINK>; <LINK REF="REF-Stucki-2007" TYPE="REFERENCE">Stucki 2007</LINK>; <LINK REF="REF-Walsh-1997" TYPE="REFERENCE">Walsh 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3) Electrical muscle stimulation</HEADING>
<P>Most characteristics of EMS are comparable to TENS. The critical difference is in the intensity, which leads to additional muscle contractions. Primary pain relief via gate control can be obtained by EMS, TENS or other forms of ENS (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>). Rhythmic muscle stimulation by modulated DC, AC or interferential current probably increases joint range of motion (ROM), re-educates muscles, retards muscle atrophy, and increases muscle strength. The circulation can be increased and muscle hypertension decreased, which may lead to secondary pain relief (<LINK REF="REF-Tan-1998" TYPE="REFERENCE">Tan 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">4) Pulsed electromagnetic fields (PEMF) and permanent magnets</HEADING>
<P>Electricity is always connected with both electrical and magnetic forces. Alternating or pulsed electromagnetic fields induce electric current within the tissue. Even though these currents are extremely small, we recognize PEMF and the application of permanent magnets as forms of electrotherapy. Their main therapeutic purpose is for enhancement of bone or tissue healing and pain reduction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">5) Repetitive magnetic stimulation</HEADING>
<P>Repetitive magnetic stimulation (rMS), in contrast to PEMF therapy, is a rather new (mid-1980s) neurophysiologic technique that allows the transcutaneous induction of nerve stimulating electric currents. This technique requires extremely strong and sharp magnetic impulses (for example 15,000 amperes peak current; 2.5 T field strength; &lt; 1 msec) applied by specially designed coils (&lt; 10 cm) over the target area. Modern devices allow the repetition of up to 60 impulses per second. Mainly developed to study and influence brain functions, rMS also stimulates spinal chord fibres and peripheral nerves. Initial studies used peripheral rMS for therapeutic reasons, such as in myofascial pain syndrome (<LINK REF="REF-Pujol-1998" TYPE="REFERENCE">Pujol 1998</LINK>; <LINK REF="STD-Smania-2003" TYPE="STUDY">Smania 2003</LINK>; <LINK REF="STD-Smania-2005" TYPE="STUDY">Smania 2005</LINK>). Since the resulting small electric impulses are the nerve stimulating factor, rMS effects may be similar to TENS and EMS. </P>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2013-08-16 14:54:06 +0200" MODIFIED_BY="[Empty name]">
<P>Neck disorders with episodic pain and functional limitation (<LINK REF="REF-Hogg_x002d_Johnson-2008" TYPE="REFERENCE">Hogg-Johnson 2008</LINK>) are common in the general population (<LINK REF="REF-Carroll-2008a" TYPE="REFERENCE">Carroll 2008a</LINK>; <LINK REF="REF-US-Census-Bureau-2012" TYPE="REFERENCE">US Census Bureau 2012</LINK>), in workers (<LINK REF="REF-C_x00f4_t_x00e9_-2008" TYPE="REFERENCE">Côté 2008</LINK>) and in whiplash associated disorders (WAD) (<LINK REF="REF-Carroll-2008b" TYPE="REFERENCE">Carroll 2008b</LINK>). In a Canadian study, about 5% of cases revealed a clinically important disability (<LINK REF="REF-C_x00f4_t_x00e9_-1998" TYPE="REFERENCE">Côté 1998</LINK>). There is a great impact on the work force; and 3% to 11% of claimants are off work each year (<LINK REF="REF-C_x00f4_t_x00e9_-2008" TYPE="REFERENCE">Côté 2008</LINK>). Direct and indirect costs are substantive (<LINK REF="REF-Hogg_x002d_Johnson-2008" TYPE="REFERENCE">Hogg-Johnson 2008</LINK>). Chronic pain accounts for about USD 150 to USD 215 billion each year in economic loss (that is lost workdays, therapy, disability) (<LINK REF="REF-NRC-2001" TYPE="REFERENCE">NRC 2001</LINK>; <LINK REF="REF-US-Census-Bureau-1996" TYPE="REFERENCE">US Census Bureau 1996</LINK>). The annual expenditure on medical care for back and neck conditions adjusted for inflation per patient increased by 95%, from USD 487 in 1999 to USD 950 in 2008 (<LINK REF="REF-Davis-2012" TYPE="REFERENCE">Davis 2012</LINK>). Yet very little is known about the effectiveness of most of the numerous available treatments still. Two systematic reviews have been published subsequent to ours. <LINK REF="REF-Teasell-2010" TYPE="REFERENCE">Teasell 2010</LINK> investigated acute whiplash while <LINK REF="REF-Leaver-2010" TYPE="REFERENCE">Leaver 2010</LINK> reviewed non-specific neck pain. Neither review revealed any new data and agreed with our former update. There continues to be very little information on this topic. Therefore ongoing updates of this review are necessary.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>This systematic review assessed the short, intermediate and long-term effects of electrotherapy on pain, function, disability, patient satisfaction, global perceived effect, and quality of life in adults with neck pain with and without radiculopathy or cervicogenic headache.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-08-22 23:15:10 +0200" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-08-22 23:15:10 +0200" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-08-16 14:54:23 +0200" MODIFIED_BY="[Empty name]">
<P>We included published randomized controlled trials (RCTs) in any language. Quasi-RCTs and controlled clinical trials (CCTs) were excluded.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-08-22 23:15:10 +0200" MODIFIED_BY="VEP  ">
<P>The participants were adults, 18 years or older, who suffered from acute (less than 6 weeks), subacute (6 to 12 weeks) or chronic (longer than 12 weeks) neck pain categorized as:</P>
<UL>
<LI>non-specific mechanical neck pain, including WAD category I and II (<LINK REF="REF-Spitzer-1987" TYPE="REFERENCE">Spitzer 1987</LINK>; <LINK REF="REF-Spitzer-1995" TYPE="REFERENCE">Spitzer 1995</LINK>), myofascial neck pain, and degenerative changes including osteoarthritis and cervical spondylosis (<LINK REF="REF-Schumacher-1993" TYPE="REFERENCE">Schumacher 1993</LINK>);</LI>
<LI>cervicogenic headache (<LINK REF="REF-Olesen-1988" TYPE="REFERENCE">Olesen 1988</LINK>; <LINK REF="REF-Olesen-1997" TYPE="REFERENCE">Olesen 1997</LINK>; <LINK REF="REF-Sjaastad-1990" TYPE="REFERENCE">Sjaastad 1990</LINK>; and</LI>
<LI>neck disorders with radicular findings (<LINK REF="REF-Spitzer-1987" TYPE="REFERENCE">Spitzer 1987</LINK>; <LINK REF="REF-Spitzer-1995" TYPE="REFERENCE">Spitzer 1995</LINK>).</LI>
</UL>
<P>Studies were excluded if they investigated neck pain with definite or possible long tract signs, neck pain caused by other pathological entities (<LINK REF="REF-Schumacher-1993" TYPE="REFERENCE">Schumacher 1993</LINK>), headache that was not of cervical origin but was associated with the neck, co-existing headache when either the neck pain was not dominant or the headache was not provoked by neck movements or sustained neck postures, or 'mixed' headaches.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>All studies used at least one type of electrotherapy: direct current, iontophoresis, electrical nerve stimulation; electrical muscle stimulation; pulsed electromagnetic fields (PEMF), repetitive magnetic stimulation (rMS) and permanent magnets.</P>
<P>Interventions were contrasted against the following comparisons:</P>
<UL>
<LI>electrotherapy versus sham or placebo (e.g. TENS versus sham TENS or sham ultrasound);</LI>
<LI>electrotherapy plus another intervention versus that same intervention (e.g. TENS + exercise versus exercise);</LI>
<LI>electrotherapy versus another intervention (e.g. TENS versus exercise);</LI>
<LI>one type of electrotherapy versus another type (e.g. modulated versus continuous TENS).</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="5">Exclusion criteria</HEADING>
<P>Other forms of high frequency electromagnetic fields, such as short wave diathermy, microwave, ultrasound and infrared light, were not considered in this review because their primary purpose is to cause therapeutic heat. Since electro-acupuncture is a special form of acupuncture, it was also excluded. Multimodal treatment approaches that included electrotherapy were excluded if the unique contribution of electrotherapy could not be determined.</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>The outcomes of interest were pain relief (for example a Numerical Rating Scale), disability (for example Neck Disability Index), function (for example activities of daily living) including work-related outcomes (for example return to work, sick leave), patient satisfaction, global perceived effect and quality of life. Adverse events as well as costs of care were reported if available. The duration of follow-up was defined as:</P>
<UL>
<LI>immediate post-treatment (within one day);</LI>
<LI>short-term follow-up (closest to four weeks);</LI>
<LI>intermediate-term follow-up (closest to six months); and</LI>
<LI>long-term follow-up (closest to12 months).</LI>
</UL>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>The outcomes of interest were pain relief, disability, and function including work-related outcomes.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-02-04 18:27:48 +0100" MODIFIED_BY="[Empty name]">
<P>Patient satisfaction, global perceived effect and quality of life.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-08-16 14:54:54 +0200" MODIFIED_BY="[Empty name]">
<P>References of retrieved articles were independently screened by two review authors. Note that our systematic review methodological design is consistent with the Cochrane Back Group methods.</P>
<ELECTRONIC_SEARCHES MODIFIED="2013-08-16 14:54:41 +0200" MODIFIED_BY="[Empty name]">
<P>A research librarian searched computerized bibliographic databases without language restrictions for medical, chiropractic, and allied health literature. The search for this review was part of a comprehensive search on physical medicine modalities. These databases were searched for this update from December 2008 to August 2012.</P>
<P>We searched the following databases: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), EMBASE (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Manual Alternative and Natural Therapy (MANTIS). Subject headings (MeSH) and key words included anatomical terms (neck, neck muscles, cervical plexus, cervical vertebrae, atlanto-axial joint, atlanto-occipital joint, spinal nerve roots, brachial plexus); disorder and syndrome terms (arthritis, myofascial pain syndromes, fibromyalgia, spondylitis, spondylosis, spinal osteophytosis, spondylolisthesis, headache, whiplash injuries, cervical rib syndrome, torticollis, cervico-brachial neuralgia, radiculitis, polyradiculitis, polyradiculoneuritis, thoracic outlet syndrome); treatment terms (multimodal treatment, electric stimulation therapy, transcutaneous electric nerve stimulation, rehabilitation, ultrasonic therapy, phototherapy, lasers, physical therapy, acupuncture, biofeedback, chiropractic, electric stimulation therapy); and methodological terms. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for the full MEDLINE search strategy. We also searched trial registers such as ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-08-16 14:54:54 +0200" MODIFIED_BY="[Empty name]">
<P>We communicated with identified content experts, searched conference proceedings of the World Confederation for Physical Therapy 2011 and International Federation of Orthopaedic and Manipulative Therapists 2008. In addition, we searched our own personal files for grey literature.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-08-16 14:55:12 +0200" MODIFIED_BY="[Empty name]">
<P>Two review authors independently conducted citation identification and study selection. All forms were pre-piloted. Each pair of review authors met for consensus and consulted a third author when there was persisting disagreement. Agreement (yes, unclear, no) was assessed for study selection using the quadratic weighted Kappa statistic, Cicchetti weights (<LINK REF="REF-Landis-1977" TYPE="REFERENCE">Landis 1977</LINK>).  </P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-08-16 14:55:12 +0200" MODIFIED_BY="[Empty name]">
<P>Two review authors independently conducted data abstraction. Forms used were pre-piloted. Data were extracted on the methods (RCT type, number analysed, number randomized, intention-to-treat analysis), participants (disorder subtype, duration of disorder), interventions (treatment characteristics for the treatment and comparison groups, dosage and treatment parameters, co-intervention, treatment schedule), outcomes (baseline mean, reported results, point estimate with 95% confidence intervals (CI), power, side effects, costs of care) and notes (if authors were contacted or points of consideration related to the RCT). These factors are detailed in the 'Characteristics of included studies'<I> </I>table.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-08-16 14:55:12 +0200" MODIFIED_BY="[Empty name]">
<P>We conducted the 'Risk of bias' assessment for RCTs using the criteria recommended by The Cochrane Collaboration (<A HREF="http://archie.cochrane.org/sections/documents/view?document=31198806159047039474111110230213&amp;format=REVMAN#REF-Higgins-2011">Higgins 2011</A>) and the Cochrane Back Review Group (<A HREF="http://archie.cochrane.org/sections/documents/view?document=31198806159047039474111110230213&amp;format=REVMAN#REF-Furlan-2009">Furlan 2009</A>) (see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>). At least two review authors independently assessed the risk of bias. A consensus team met to reach a final assessment. The following characteristics were assessed for risk of bias: randomisation; concealment of treatment allocation; blinding of patient, provider, and outcome assessor; incomplete data: withdrawals, dropout rate and intention-to-treat analysis; selective outcome reporting; other including similar at baseline, similar co-interventions, acceptable compliance, similar timing of assessment. A study with a low risk of bias was defined as having low risk of bias on six or more of these items and no fatal flaws.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-08-16 14:56:21 +0200" MODIFIED_BY="[Empty name]">
<P>Standardized mean differences (SMD) with 95% confidence intervals (95% CI) were calculated for continuous data while relative risks (RR) were calculated for dichotomous outcomes. We selected SMD over weighted mean difference (WMD) because we were looking across different interventions and most interventions used different outcome measures with different scales. For outcomes reported as medians, effect sizes were calculated using the formula by <LINK REF="REF-Kendal-1963" TYPE="REFERENCE">Kendal 1963</LINK> (p 237). When neither continuous nor dichotomous data were available, we extracted the findings and the statistical significance as reported by the author(s) in the original study.</P>
<P>In the absence of clear guidelines on the size of a clinically important effect, a commonly applied system by <LINK REF="REF-Cohen-1988" TYPE="REFERENCE">Cohen 1988</LINK> was used: small (0.20), medium (0.50) and large (0.80). A minimal clinically important difference between treatments for the purpose of the review was 10 points on a 100-point pain intensity scale (small: WMD &lt; 10%; moderate: 10% &#8804; WMD &lt; 20%; large: 20% &#8804; WMD of the visual analogue scale (VAS)). For the neck disability index, we used a minimum clinically important difference of 7/50 neck disability index units. It is noted that the minimal detectable change varies from 5/50 for non-complicated neck pain to 10/50 for cervical radiculopathy (<LINK REF="REF-MacDermid-2009" TYPE="REFERENCE">MacDermid 2009</LINK>). To translate effect measures into clinically meaningful terms and give the clinician a sense of the magnitude of the treatment effect, we calculated the number needed to treat (NNT) when the effect size was statistically significant (NNT: the number of patients a clinician needs to treat in order to achieve a clinically important improvement in one) (<LINK REF="REF-Gross-2002" TYPE="REFERENCE">Gross 2002</LINK>).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-08-16 14:56:42 +0200" MODIFIED_BY="[Empty name]">
<P>We performed one multiple treatment meta-analysis for the <LINK REF="STD-Hurwitz-2002" TYPE="STUDY">Hurwitz 2002</LINK> trial that used a factorial design. We used a random-effects model to allow for heterogeneity within each subgroup. An I<SUP>2</SUP> statistic was also computed for subgroup differences. The data in the subgroups were independent.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-08-16 14:56:42 +0200" MODIFIED_BY="[Empty name]">
<P>Where data were not extractable primary authors were contacted. See the 'Characteristics of included studies' table, 'Notes' for details. Missing data from <LINK REF="STD-Hurwitz-2002" TYPE="STUDY">Hurwitz 2002</LINK> and <LINK REF="STD-Chiu-2005" TYPE="STUDY">Chiu 2005</LINK> were obtained in this manner. No other data were requested. Missing data that were greater than 10 years old were not requested.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-08-16 14:56:42 +0200" MODIFIED_BY="[Empty name]">
<P>Prior to calculation of a pooled effect measure, we assessed the reasonableness of pooling on clinical grounds. The possible sources of heterogeneity considered were: symptom duration (acute versus chronic); subtype of neck pain (for example WAD); intervention type (for example DC versus pulsed); characteristics of treatment (for example dosage, technique); and outcomes (pain relief, measures of function and disability, patient satisfaction, quality of life). We were unable to perform any of these calculations because the data were incompatible. </P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-08-16 14:56:54 +0200" MODIFIED_BY="[Empty name]">
<P>Occurrences of reporting biases were noted in the text and 'Characteristics of included studies' tables, 'Notes' column. Our review search methods addressed language bias; no additional languages were selected for this review. Funding bias was possible in three trials (<LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK>; <LINK REF="STD-Thuile-2002" TYPE="STUDY">Thuile 2002</LINK>; <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK>). One trial from Spain was judged to have serious flaws and high risks of bias which may represent reporting bias (<LINK REF="STD-Escortell_x002d_Mayor-2011" TYPE="STUDY">Escortell-Mayor 2011</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-08-16 14:56:54 +0200" MODIFIED_BY="[Empty name]">
<P>We assessed the quality of the body of the evidence using the GRADE approach, as recommended in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) and adapted in the updated Cochrane Back Review Group (CBRG) method guidelines (<LINK REF="REF-Furlan-2009" TYPE="REFERENCE">Furlan 2009</LINK>). Domains that may decrease the quality of the evidence are: 1) study design, 2) risk of bias, 3) inconsistency of results, 4) indirectness (not to generalize), 5) imprecision (insufficient data), and 6) other factors (for example reporting bias). The quality of the evidence was reduced by a level based on the performance of the studies against these five domains (see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> for definitions of these domains). All plausible confounding factors were considered as were their potential effects on the demonstrated treatment responses and the treatment dose-response gradient (<LINK REF="REF-Atkins-2004" TYPE="REFERENCE">Atkins 2004</LINK>). Levels of quality of evidence were defined as the following.</P>
<UL>
<LI>High quality evidence: there are consistent findings among at least 75% of RCTs with low risk of bias; consistent, direct and precise data; and no known or suspected publication biases. Further research is unlikely to change either the estimate or our confidence in the results.</LI>
<LI>Moderate quality evidence: one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</LI>
<LI>Low quality evidence: two of the domains are not met. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</LI>
<LI>Very low quality evidence: three of the domains are not met. We are very uncertain about the results.</LI>
<LI>No evidence: no RCTs were identified that addressed this outcome.</LI>
</UL>
<P>We also considered a number of factors to place the results into a larger clinical context: temporality, plausibility, strength of association, dose response, adverse events, and cost. Clinical relevance was addressed for individual trials and reported either in the 'Characteristics of included studies' table or in the text.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>We had also planned to assess the influence of risk of bias (concealment of allocation, blinding of outcome assessor), duration (acute, subacute, chronic), and subtypes of the disorder (non-specific, WAD, degenerative change-related, radicular findings, cervicogenic headache), but again data were too sparse. Since a meta-analysis was not possible, sources of heterogeneity were not explored.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-08-16 14:57:00 +0200" MODIFIED_BY="[Empty name]">
<P>Sensitivity analysis or meta-regression for (1) symptom duration, (2) methodological quality, and (3) subtype of neck disorder were planned but were not carried out because we did not have enough data in any one category.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-08-22 23:16:46 +0200" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-08-21 23:28:23 +0200" MODIFIED_BY="[Empty name]">
<P>Twenty trials (1239 participants) were selected (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). The duration of the disorder, disorder subtypes and electrotherapy subtypes were as follows.</P>
<UL>
<LI>Acute whiplash associated disorders (WAD) with or without cervicogenic headache  (n = 4):<B> </B>
<LINK REF="STD-Fialka-1989" TYPE="STUDY">Fialka 1989</LINK>, electrical muscle stimulation (EMS) and iontophoresis; <LINK REF="STD-Hendriks-1996" TYPE="STUDY">Hendriks 1996</LINK>, transcutaneous electric nerve stimulation (TENS); <LINK REF="STD-Foley_x002d_Nolan-1992" TYPE="STUDY">Foley-Nolan 1992</LINK>, pulsed electromagnetic field (PEMF); <LINK REF="STD-Thuile-2002" TYPE="STUDY">Thuile 2002</LINK>, PEMF.</LI>
</UL>
<UL>
<LI>Acute non-specific neck pain (n = 1): <LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>, TENS.</LI>
</UL>
<UL>
<LI>Chronic myofascial neck pain (n = 5): <LINK REF="STD-Farina-2004" TYPE="STUDY">Farina 2004</LINK>, TENS; <LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>, TENS; <LINK REF="STD-Hou-2002" TYPE="STUDY">Hou 2002</LINK>, TENS;  <LINK REF="STD-Smania-2003" TYPE="STUDY">Smania 2003</LINK>, repetitive magnetic stimulation (rMS); <LINK REF="STD-Smania-2005" TYPE="STUDY">Smania 2005</LINK>, rMS.</LI>
</UL>
<UL>
<LI>Chronic neck pain due to osteoarthritic cervical degenerative changes (n = 2):<B> </B>
<LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK>, PEMF;  <LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK>, PEMF.</LI>
</UL>
<UL>
<LI>Chronic non-specific neck pain (n = 5): <LINK REF="STD-Chiu-2005" TYPE="STUDY">Chiu 2005</LINK>, TENS; <LINK REF="STD-Flynn-1987" TYPE="STUDY">Flynn 1987</LINK>, TENS; <LINK REF="STD-Foley_x002d_Nolan-1990" TYPE="STUDY">Foley-Nolan 1990</LINK>, PEMF; <LINK REF="STD-Hong-1982" TYPE="STUDY">Hong 1982</LINK>, static magnetic field; <LINK REF="STD-Philipson-1983" TYPE="STUDY">Philipson 1983</LINK>, modulated galvanic current.          </LI>
</UL>
<UL>
<LI>Subacute or chronic neck pain with or without cervicogenic headache and radicular findings (n = 1): <LINK REF="STD-Hurwitz-2002" TYPE="STUDY">Hurwitz 2002</LINK>, EMS.</LI>
</UL>
<UL>
<LI>Subacute or chronic non-specific neck pain (n = 1): <LINK REF="STD-Escortell_x002d_Mayor-2011" TYPE="STUDY">Escortell-Mayor 2011</LINK>.</LI>
</UL>
<P>One trial was translated from Danish (<LINK REF="STD-Philipson-1983" TYPE="STUDY">Philipson 1983</LINK>). Three further non-English trials (two French, one Italian) were subsequently excluded because they did not meet our criteria.</P>
<P>Six ongoing trials have been registered but not published (<LINK REF="STD-Triano-2009" TYPE="STUDY">Triano 2009</LINK>; Escortell 2011; <LINK REF="STD-Guayasam_x00ed_n-2013" TYPE="STUDY">Guayasamín 2013</LINK>; <LINK REF="STD-Taniguchi-2010" TYPE="STUDY">Taniguchi 2010</LINK>; <LINK REF="STD-Weintraub-2007" TYPE="STUDY">Weintraub 2007</LINK>).</P>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-08-16 14:57:08 +0200" MODIFIED_BY="[Empty name]">
<P>Twenty-five studies were excluded (n = 7 in 2011). The reasons were: the intervention (n = 9) (<LINK REF="STD-Ammer-1990" TYPE="STUDY">Ammer 1990</LINK>; <LINK REF="STD-Fernadez_x002d_de_x002d_las-Penas2004" TYPE="STUDY">Fernadez-de-las Penas2004</LINK>; <LINK REF="STD-Forestier-2007a" TYPE="STUDY">Forestier 2007a</LINK>; <LINK REF="STD-Forestier-2007b" TYPE="STUDY">Forestier 2007b</LINK>; <LINK REF="STD-Klaber_x002d_Moffett-2005" TYPE="STUDY">Klaber-Moffett 2005</LINK>; <LINK REF="STD-Persson-2001" TYPE="STUDY">Persson 2001</LINK>; <LINK REF="STD-Provinciali-1996" TYPE="STUDY">Provinciali 1996</LINK>; <LINK REF="STD-Vas-2006" TYPE="STUDY">Vas 2006</LINK>; <LINK REF="STD-Vikne-2007" TYPE="STUDY">Vikne 2007</LINK>); population (n = 9)<B> </B>(<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coletta-1988" TYPE="STUDY">Coletta 1988</LINK>; <LINK REF="STD-Gabis-2003" TYPE="STUDY">Gabis 2003</LINK>; <LINK REF="STD-Hansson-1983" TYPE="STUDY">Hansson 1983</LINK>; <LINK REF="STD-Jahanshahi-1991" TYPE="STUDY">Jahanshahi 1991</LINK>; <LINK REF="STD-Porzio-2000" TYPE="STUDY">Porzio 2000</LINK>; <LINK REF="STD-Rigato-2002" TYPE="STUDY">Rigato 2002</LINK>; <LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>; <LINK REF="STD-Wilson-1974" TYPE="STUDY">Wilson 1974</LINK>); design (n = 5) (<LINK REF="STD-Chee--1986" TYPE="STUDY">Chee 1986</LINK>; <LINK REF="STD-Gonzales_x002d_Iglesias-2009" TYPE="STUDY">Gonzales-Iglesias 2009</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Vitiello-2007" TYPE="STUDY">Vitiello 2007</LINK>; <LINK REF="STD-Yip-2007" TYPE="STUDY">Yip 2007</LINK>); comparison (n = 1) (<LINK REF="STD-Dusunceli-2009" TYPE="STUDY">Dusunceli 2009</LINK>); outcome (n = 1) (<LINK REF="STD-Garrido_x002d_Elustondo-2010" TYPE="STUDY">Garrido-Elustondo 2010</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-08-16 14:57:24 +0200" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<ALLOCATION MODIFIED="2013-08-16 14:57:14 +0200" MODIFIED_BY="[Empty name]">
<P>The allocation of concealment and reports on adequate randomisation were unclear in 60% of the trials (see also <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-01-03 18:41:09 +0100" MODIFIED_BY="[Empty name]">
<P>There was no clear reporting of blinding of patients (50%), providers (60%) or observers (60%).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-08-16 14:57:14 +0200" MODIFIED_BY="[Empty name]">
<P>In 50% of the trials there was attrition bias, when considering both dropouts (30%) and intention-to-treat (ITT) analysis (50%).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-01-03 18:46:19 +0100" MODIFIED_BY="[Empty name]">
<P>Selective reporting was present or unclear in 80% of the trials.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-08-16 14:57:24 +0200" MODIFIED_BY="[Empty name]">
<P>In <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK> their research support was listed as Bio-Magnetic Systems, Inc. (co-author Markoll was the principle shareholder of Bio-Magnetic Sytems; Markoll and Trock were sentenced in 2001 for billing unapproved electromagnetic therapy (see FDA report: <A HREF="http://www.fda.gov/ora/about/enf_story/archive/2001/ch6/oci6.htm">http://www.fda.gov/ora/about/enf_story/archive/2001/ch6/oci6.htm</A>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-08-22 23:16:46 +0200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Galvanic current</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Modulated Galvanic current versus placebo</HEADING>
<P>One study with a high risk of bias (<LINK REF="STD-Philipson-1983" TYPE="STUDY">Philipson 1983</LINK>) assessed the effects of 'diadynamic' modulated Galvanic current (50 or 100 Hz) against placebo for patients with chronic pain in trigger points of the neck and shoulders.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No difference (RR 0.69, 95% CI 0.39 to 1.24, random-effects model) between the groups was found after a one-week treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Global perceived effect</I>
</HEADING>
<P>No difference between the groups was noted immediately post-treatment.</P>
<P>
<B>Conclusion</B>: there was very low quality evidence of no difference in pain or global perceived effect when diadynamic modulated Galvanic current was evaluated at immediate post-treatment.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Iontophoresis</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Iontophoresis versus no treatment</HEADING>
<P>One study with a high risk of bias (<LINK REF="STD-Fialka-1989" TYPE="STUDY">Fialka 1989</LINK>) assessed the effects of iontophoresis (DC combined with diclofenac gel) compared to no treatment for patients with acute WAD pain with or without cervicogenic headache.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief:</I>
</HEADING>
<P>No difference between the groups was determined after a five-week treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Cervicogenic headache</I>
</HEADING>
<P>No difference (RR 0.66, 95% CI 0.28 to 1.57, random-effects model) between the groups was reported after a five-week treatment.</P>
<P>
<B>Conclusion</B>: very low quality evidence suggested that iontophoresis when compared to no treatment improved pain and headache for patients with acute WAD with or without cervicogenic headache.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Iontophoresis versus comparison</HEADING>
<P>One study with a high risk of bias (<LINK REF="STD-Fialka-1989" TYPE="STUDY">Fialka 1989</LINK>) assessed the effects of iontophoresis (DC combined with diclofenac gel, same as above) against two other treatments: a) interferential current, and b) multimodal treatment (traction + therapeutic exercise + massage) for patients with acute WAD.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No difference between the groups was determined after a five-week treatment period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Cervicogenic headache</I>
</HEADING>
<P>No difference between the groups was reported after five weeks of treatment.</P>
<P>
<B>Conclusion</B>: there was very low quality evidence that iontophoresis improved pain or headache when contrasted against either interferential or a multimodal approach for acute WAD or cervicogenic headache.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Transcutaneous electrical nerve stimulation (TENS) </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. TENS versus placebo (sham control)</HEADING>
<P>Two studies with low risk of bias (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>; <LINK REF="STD-Smania-2005" TYPE="STUDY">Smania 2005</LINK>) and two with high risk of bias (<LINK REF="STD-Flynn-1987" TYPE="STUDY">Flynn 1987</LINK>; <LINK REF="STD-Sahin-2011" TYPE="STUDY">Sahin 2011</LINK>) compared TENS to sham controls for patients with chronic neck pain.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>All four trials reported immediate post-treatment pain relief favouring TENS. The results varied and they could not be combined since they assessed outcomes of very different treatment schedules. One trial also reported short-term pain relief, but our calculations did not support that (SMD -0.52, 95% CI -1.24 to 0.20, random-effects model) (<LINK REF="STD-Smania-2005" TYPE="STUDY">Smania 2005</LINK>).</P>
<P>
<B>Conclusion</B>: there was very low quality evidence (four trials with sparse and non-generalizable data; group sizes between 7 and 22 participants) showing varied results for TENS therapy, with different frequencies and treatment schedules, immediately post-treatment for patients with chronic neck pain.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. TENS plus another treatment versus that same treatment</HEADING>
<P>Three studies with high risk of bias utilized TENS (80 to 100 Hz) for individuals with chronic neck pain (<LINK REF="STD-Chiu-2005" TYPE="STUDY">Chiu 2005</LINK>), myofascial neck pain (<LINK REF="STD-Hou-2002" TYPE="STUDY">Hou 2002</LINK>), and acute neck pain (<LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>). Another trial assessed TENS (Ultra-Reiz, 143 Hz) for patients with acute WAD (<LINK REF="STD-Hendriks-1996" TYPE="STUDY">Hendriks 1996</LINK>). In these trials, TENS was added to other interventions received by both comparison groups (<LINK REF="STD-Chiu-2005" TYPE="STUDY">Chiu 2005</LINK>: Infrared; <LINK REF="STD-Hou-2002" TYPE="STUDY">Hou 2002</LINK>: hot pack, exercises; <LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>: neck collar, exercises, analgesic; <LINK REF="STD-Hendriks-1996" TYPE="STUDY">Hendriks 1996</LINK>: standard physiotherapy).</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>Three trials reported no benefit of TENS at post-treatment (<LINK REF="STD-Hou-2002" TYPE="STUDY">Hou 2002</LINK>), short (<LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>) and intermediate-term (<LINK REF="STD-Chiu-2005" TYPE="STUDY">Chiu 2005</LINK>) follow-up. One trial (<LINK REF="STD-Hendriks-1996" TYPE="STUDY">Hendriks 1996</LINK>) favoured Ultra-Reiz for pain relief in the short term. Due to different dosage parameters, data were not pooled.</P>
<P>
<B>Conclusion</B>: there was very low quality evidence (two trials with group sizes between 10 and 13, one with no blinding and different treatment regimens) that the addition of TENS had no additional significant effect on pain relief in patients with acute to chronic neck pain, and that Ultra-Reiz reduced pain for patients with acute WAD (one trial, 2 X 8 participants).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. TENS versus comparison</HEADING>
<P>Three studies with high risk of bias compared TENS to EMS (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>), ultrasound (<LINK REF="STD-Flynn-1987" TYPE="STUDY">Flynn 1987</LINK>) and manual therapy (<LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>) for treatment of acute and chronic neck pain. One study with high risk of bias (<LINK REF="STD-Escortell_x002d_Mayor-2011" TYPE="STUDY">Escortell-Mayor 2011</LINK>)<B> </B>compared TENS to manual therapy for subacute and chronic neck pain.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>TENS seemed superior to EMS (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>), but there was little or no difference between TENS and manual therapy (<LINK REF="STD-Nordemar-1981" TYPE="STUDY">Nordemar 1981</LINK>; <LINK REF="STD-Escortell_x002d_Mayor-2011" TYPE="STUDY">Escortell-Mayor 2011</LINK>) or ultrasound (<LINK REF="STD-Flynn-1987" TYPE="STUDY">Flynn 1987</LINK>).</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (trials with group sizes between 7 and 43 participants, sparse and non-generalizable data) that TENS may relieve pain better than EMS, but there was little or no difference between the effects of TENS and manual therapy (low quality evidence) or ultrasound (very low quality evidence) for patients with acute or chronic neck pain.<B> </B>Due to different comparative treatments, the results of the trials could not be pooled.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. TENS versus TENS (with different parameters)</HEADING>
<P>One study with a low risk of bias (<LINK REF="STD-Farina-2004" TYPE="STUDY">Farina 2004</LINK>) examined the effects of TENS (100 Hz)  against FREMS (a frequency and intensity varying TENS modification, 1 to 40 Hz) for chronic myofascial pain. Another study with high risk of bias (<LINK REF="STD-Sahin-2011" TYPE="STUDY">Sahin 2011</LINK>) compared conventional TENS (100 Hz) with both acupuncture like (AL)-TENS (4 Hz) and burst-mode (Burst)-TENS (100 Hz, 2 Hz) for chronic myofascial pain.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>TENS and FREMS were both reported to be significantly effective for pain relief (VAS) after one week of treatment, and at one and three-month follow-up (<LINK REF="STD-Farina-2004" TYPE="STUDY">Farina 2004</LINK>). Conventional TENS showed no significant difference over AL-TENS or Burst-TENS after three weeks of treatment (<LINK REF="STD-Sahin-2011" TYPE="STUDY">Sahin 2011</LINK>).</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (one trial, 19 + 21 participants; insufficient data reported) that FREMS and TENS were similarly effective for the treatment of chronic myofascial neck pain. There was very low quality evidence (one trial, two comparisons with 37 participants) that conventional TENS was similar to Burst-TENS or AL-TENS for chronic myofascial pain immediately post-treatment.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Electrical Muscle Stimulation (EMS)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. EMS versus placebo (sham control)</HEADING>
<P>One trial with a low risk of bias (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>) studied the effects of a single EMS treatment (20 minutes,10 Hz) for chronic neck pain with cervical trigger points compared to sham control.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No difference for pain intensity and pressure threshold was found.</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (one trial, 22 + 18 participants) that a single treatment of EMS had no effect on trigger point tenderness compared to placebo treatment in patients with chronic neck pain.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. EMS (interferential current) versus no treatment</HEADING>
<P>One study with a high risk of bias described the effect of EMS (stereodynamic 50 Hz interferential current) (<LINK REF="STD-Fialka-1989" TYPE="STUDY">Fialka 1989</LINK>) for acute WAD versus no treatment.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No difference between treated and untreated control patients was found for neck pain relief and headache.</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (one trial, 2 x 15 participants) that EMS neither reduced neck pain nor cervicogenic headache in patients with acute WAD, compared to no treatment.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. EMS plus another treatment versus the same treatment</HEADING>
<P>One 2 x 2 x 2 factorial design study with a low risk of bias (<LINK REF="STD-Hurwitz-2002" TYPE="STUDY">Hurwitz 2002</LINK>) compared the effects of additional EMS on two independent groups with mobilisation and two independent groups with manipulation (each arm with or without moist heat) for patients with subacute to chronic neck pain with and without cervicogenic headache or radicular symptoms. </P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No differences between the groups were found at post-treatment, short-term and intermediate-term follow-up (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). A multiple treatment meta-analysis from one factorial design of independent groups was pooled (SMD 0.09, 95% CI -0.15 to 0.33, random-effects model) with an I<SUP>2</SUP> of 0% at intermediate-term follow-up (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Function</I>
</HEADING>
<P>No differences between the groups were found (pooled SMD 0.09, 95% CI -0.15 to 0.33, random-effects model; I<SUP>2</SUP> = 0%) at post-treatment, short-term and intermediate-term follow-up (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Patient satisfaction</I>
</HEADING>
<P>No differences between the groups were found (pooled SMD 0.02, 95% CI -0.22 to 0.26, random-effects model; I<SUP>2</SUP> = 0%) at post-treatment, short-term and intermediate-term follow-up (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
<P>
<B>Conclusion</B>: there was low quality evidence (1 factorial designed trial, N = 336; three EMS groups, N = ~ 40; no EMS settings or treatment schedules reported) that EMS had no significant impact on pain relief, disability and patient satisfaction when used as an adjunct to cervical mobilisation and manipulation, at post-treatment, short-term and intermediate-term follow-up.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. EMS versus comparison</HEADING>
<P>One study with a low risk of bias compared the effect of EMS to TENS for chronic myofascial pain (<LINK REF="STD-Hsueh-1997" TYPE="STUDY">Hsueh 1997</LINK>), and one study with a high risk of bias to treatment with iontophoresis for patients with acute WAD (<LINK REF="STD-Fialka-1989" TYPE="STUDY">Fialka 1989</LINK>; see above).</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>EMS was found to be inferior to TENS for pain relief immediately following treatment. No difference was found between EMS and Iontophoresis at post-treatment and short-term follow-up.</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (one trial, 20 + 18 participants; one treatment only; poor clinical relevance) that EMS was inferior to TENS for pain relief of chronic neck pain. There was very low quality evidence (one trial, 2 x 15 participants) that there was no significant difference between EMS and iontophoresis for pain relief in acute WAD.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pulsed electromagnetic field (PEMF) </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. PEMF versus placebo or sham control</HEADING>
<P>Two studies with a low risk of bias examined the efficacy of non-thermal, high frequency PEMF (miniaturized high frequency (HF) generator, 27 MHz, 1.5 mW/cm²) treatment on<B> </B>patients with chronic neck pain (<LINK REF="STD-Foley_x002d_Nolan-1990" TYPE="STUDY">Foley-Nolan 1990</LINK>) and acute WAD (<LINK REF="STD-Foley_x002d_Nolan-1992" TYPE="STUDY">Foley-Nolan 1992</LINK>). Two other trials with a low risk of bias studied the efficacy of low frequency PEMF therapy (&lt; 100 Hz) for participants with chronic cervical osteoarthritis pain (<LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK>; <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK>). All four studies were sham-controlled by inactive devices.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>In their first trial, the authors (<LINK REF="STD-Foley_x002d_Nolan-1990" TYPE="STUDY">Foley-Nolan 1990</LINK>) found that pain intensity (VAS) was reduced post-treatment. In their second trial (<LINK REF="STD-Foley_x002d_Nolan-1992" TYPE="STUDY">Foley-Nolan 1992</LINK>) no relevant effects were found. <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK> reported significant pain relief after four to six weeks of treatment, but not at the one-month follow-up. <LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK> reported significant pain relief, favouring the active PEMF group, after three weeks of treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Function</I>
</HEADING>
<P>
<LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK> reported no differences in improvement in function.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Global perceived effects</I>
</HEADING>
<P>
<LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK> and <LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK> reported no differences in effects.</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence that non-thermal high frequency PEMF (27 MHz) reduced acute or chronic neck pain, and that low frequency PEMF (&lt; 100 Hz) may have reduced pain from cervical spine osteoarthritis after some weeks of treatment. Even though these trials were rated as having a low risk of bias by our validity assessment team, they were imprecise, inconsistent and may have been influenced by other biases. The evidence rating was therefore reduced from moderate quality to very low for the following reasons: funding bias may have been present in <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK> and <LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK>; the PEMF application (in a cervical collar worn 24 hours per day) in <LINK REF="STD-Foley_x002d_Nolan-1990" TYPE="STUDY">Foley-Nolan 1990</LINK> and <LINK REF="STD-Foley_x002d_Nolan-1992" TYPE="STUDY">Foley-Nolan 1992</LINK> was a very uncommon PEMF method using diathermy-like HF-pulses but with intensities far below the thermal threshold. The biological rationale for the chosen treatment was based on literature from 1940 and remains unclear.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> 2. PEMF versus comparison</HEADING>
<P>One study with a high risk of bias (<LINK REF="STD-Thuile-2002" TYPE="STUDY">Thuile 2002</LINK>) compared low frequency PEMF (&lt; 100 Hz) treatment versus a standard therapy for WAD patients.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>Reported results favoured PEMF therapy for neck pain relief and headache reduction in patients with WAD.</P>
<P>
<B>Conclusion</B>:<B> </B>there was very low quality evidence (one trial, 44 + 48 participants; no placebo control; funding bias unclear) that PEMF may have reduced WAD-related neck pain and headache compared to a standard therapy.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Repetitive magnetic stimulation (rMS) </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. rMS versus placebo</HEADING>
<P>Two similar studies with a low risk of bias (<LINK REF="STD-Smania-2003" TYPE="STUDY">Smania 2003</LINK>; <LINK REF="STD-Smania-2005" TYPE="STUDY">Smania 2005</LINK>) evaluated rMS therapy (400 mT, 4000 pulses per session) for patients with myofascial neck pain against placebo ultrasound.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief and function</I>
</HEADING>
<P>Pain and disability (VAS, Neck Pain Disability (NPD)) reduction by rMS was more effective than placebo for the treatment of myofascial neck pain at two weeks, one month (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>) (pooled SMD -1.35, 95% CI -1.96 to -0.74, random-effects model), and three months follow-up.</P>
<P>
<B>Conclusion</B>:<B> </B>we found very low quality evidence (two trials from the same research group, with sparse and non-generalizable data, 9 to 16 participants in either group) that rMS was effective for a short-term reduction of chronic neck pain and disability compared to placebo. However, although the NNT = 3 and treatment advantage was 46% to 56%, because of the low quality of the evidence one should treat the results with caution. Publication bias may be considered. Funding was not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Static magnetic field</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Static magnetic field (permanent magnets, necklace) versus sham control</HEADING>
<P>One study with a low risk of bias (<LINK REF="STD-Hong-1982" TYPE="STUDY">Hong 1982</LINK>) investigated the efficacy of a magnetic necklace (120 mT) on patients with chronic neck and shoulder pain compared to a sham control group with identical but non-magnetic necklaces.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Pain relief</I>
</HEADING>
<P>No differences (SMD 0.27, 95% CI -0.27 to 0.82, random-effects model) were found between the groups (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
<P>
<B>Conclusion</B>:<B> </B>there was low quality evidence (one trial, 27 + 25 participants) that permanent magnets were not effective for chronic neck and shoulder pain relief.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Side effects</HEADING>
<P>No adverse side effects were reported in any of the included studies evaluated above. However, studies were too small for a valid evaluation of adverse effects.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Costs</HEADING>
<P>No costs were reported in any of the included studies evaluated above.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>Electrotherapy has been developed during the last two centuries. The systematic use of electric currents for therapeutic reasons began shortly after Luigi Galvani's observations (1780) that electric currents cause muscle contractions if stimulating efferent nerves. Since then, a growing variety of methods, including electromagnetic and magnetic agents, have been developed for a manifold of therapeutic reasons. Only a small selection of these methods have been investigated by the trials described above, direct or modulated Galvanic currents, iontophoresis, transcutaneous electrical nerve stimulation (TENS), electrical muscle stimulation (EMS), low or high frequency pulsed electromagnetic fields (PEMF), repetitive magnetic stimulation (rMS) and permanent magnets. A great deal of research in these fields has been published in the past 25 years (<LINK REF="REF-Cameron-1999" TYPE="REFERENCE">Cameron 1999</LINK>), however only 20 trials examining the treatment of neck pain met our review criteria. Therefore, evidence for any of the modalities was found to be of low or very low quality, due to the size of the trials and the heterogeneity of the populations, interventions and outcomes. This precluded meta-analysis and resulted in sparse data. The average sample size over all treatment groups was about 20 participants.<BR/>
</P>
<SUMMARY_OF_RESULTS MODIFIED="2013-08-16 14:59:21 +0200" MODIFIED_BY="[Empty name]">
<P>For this review, there were 20 trials with 38 comparisons that met our inclusion criteria. No outcomes had high or moderate strength of evidence. The evidence for all electrotherapy interventions for neck pain is of low or very low quality, which means that we are very uncertain about the estimate of effect. Further research is very likely to have an important impact on this and our confidence in the results. Therefore, no conclusions can be drawn regarding the effectiveness of electrotherapy for neck pain based on the available small trials. Large randomized controlled trials are needed to get a valid and precise estimate of the effect of electrotherapy for neck pain.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>In general, convincing, high or moderate quality evidence for any of the described modalities was lacking. Thirty-eight comparisons in 20 studies<B> </B>examined seven different forms, and their modifications, of electrotherapy. Of the few studies that examined the same modalities, conclusions were limited by the heterogeneity of the treatment parameters or population. For example, the frequency for TENS ranged from 60 Hz to 143 Hz, with disorders from acute WAD to chronic myofascial pain. This heterogeneity made it impossible to pool the data and difficult to interpret the applicability of the results. More research needs to be done in order to confirm the positive findings, and to determine which treatment parameters are the most applicable and for which disorders. <B>
<I> </I>
</B>
</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-08-16 15:09:52 +0200" MODIFIED_BY="[Empty name]">
<P>Performance and detection bias are the two dominant biases influencing our systematic review findings. Specifically, blinding of the patients and providers are essential considerations for future trials. Co-interventions need to be avoided to establish clearer results.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-08-16 15:00:23 +0200" MODIFIED_BY="[Empty name]">
<P>Language bias was avoided by including all languages during study selection, however non-English databases were not searched (that is Chinese databases).</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-08-16 15:00:23 +0200" MODIFIED_BY="[Empty name]">
<P>The evidence presented in this review needs to be compared to the evidence described in other reviews. The limited number of reviews on the subject makes it difficult to carry out that comparison. There was conflicting evidence in the results on PEMF (<LINK REF="STD-Sutbeyaz--2006" TYPE="STUDY">Sutbeyaz 2006</LINK>; <LINK REF="STD-Thuile-2002" TYPE="STUDY">Thuile 2002</LINK>; <LINK REF="STD-Trock-1994" TYPE="STUDY">Trock 1994</LINK>), such that the positive findings for PEMF were strongly doubted in other reviews (<LINK REF="REF-Hulme-2002" TYPE="REFERENCE">Hulme 2002</LINK>; <LINK REF="REF-Schmidt_x002d_Rohlfing-2000" TYPE="REFERENCE">Schmidt-Rohlfing 2000</LINK>). We also have these concerns and caution the reader that funding bias may be present. In particular, research support was declared as being provided by Bio-Magnetic Systems, Inc. Co-author Markoll was principle shareholder of Bio-Magnetic Sytems; Markoll and Trock were sentenced in 2001 for billing unapproved electromagnetic therapy (see FDA report:http://www.fda.gov/ora/about/enf_story/archive/2001/ch6/oci6.htm).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-08-16 15:00:33 +0200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-08-16 15:00:33 +0200" MODIFIED_BY="[Empty name]">
<P>We cannot make any definitive statements on the efficacy and clinical usefulness of electrotherapy modalities for neck pain. Since the quality of the evidence is low or very low, we are uncertain about the estimates of the effect. Further research is very likely to change both the estimate of effect and our confidence in the results. Current evidence for rMS, TENS and PEMF shows that these modalities might be more effective than placebo but not other interventions, and funding bias has to be considered, especially in PEMF studies. Galvanic current, iontophoresis, electric muscle stimulation (EMS) and a static magnetic field did not reduce pain or disability.  </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-08-16 15:00:33 +0200" MODIFIED_BY="[Empty name]">
<P>Due to a lack of consensus on parameters, and the restricted quality of most of the publications, additional studies need to be done to confirm the results described in this review.<B>
<I> </I>
</B>Possible new trials examining these specific interventions should include more participants and correct the internal validity and reporting shortcomings found in earlier randomized controlled trials. They should include more precise standardization and description of treatment characteristics.<B>
<BR/>
</B>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-01-10 18:18:24 +0100" MODIFIED_BY="[Empty name]">
<P>We thank our volunteer translators and the Cochrane Back Review Group editors. </P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-08-16 15:00:43 +0200" MODIFIED_BY="[Empty name]">
<P>No conflicts of interest known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-08-16 15:00:43 +0200" MODIFIED_BY="[Empty name]">
<P>This review is one of a series of reviews being conducted by the Cervical Overview Group (COG): Burnarski D, Burnie S, Eddy A, Ezzo J, Goldsmith C, Graham N, Gross A, Haines T, Haraldsson B, Hoving J, Kay T, Kroeling P, Linge L, Peloso P, Miller J, Morien A, Perry L, Radylovick Z, Santaguida P, Szeto G,Trinh K, Wang E, White R.</P>
<P>The primary review authors for this review and their contributions are listed below.</P>
<P>Kroeling P: manuscript preparation, data extraction, synthesis, conclusion, recommendations, public presentation, publication, public responsibility</P>
<P>Gross A: grant submission, citation identification and selection, data entry, synthesis, conclusions, manuscript preparation and review, public presentation, project coordination</P>
<P>Graham N: electronic study searches, author communication, validity assessment, organisation</P>
<P>Burnie S: validity assessment, synthesis, manuscript review</P>
<P>Szeto G: risk of bias assessment; synthesis, final publication</P>
<P>Goldsmith CH: statistical analysis, grant submission, validity assessment, manuscript review</P>
<P>Haines T: identification and selection, synthesis, conclusions, manuscript review</P>
<P>Forget M: validity assessment, synthesis, conclusions, manuscript review</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-08-16 15:00:43 +0200" MODIFIED_BY="[Empty name]">
<P>Assessment of risk of bias, GRADE method application, inclusion criteria</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-08-22 23:21:03 +0200" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-08-21 23:45:18 +0200" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-08-21 23:27:43 +0200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Chiu-2005" MODIFIED="2009-08-04 23:49:53 +0200" MODIFIED_BY="VEP  " NAME="Chiu 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-08-04 23:49:53 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chiu TW, Hui-Chan C, Cheing G</AU>
<TI>A randomized clinical trial of TENS and exercise for patients with chronic neck pain</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2005</YR>
<VL>19</VL>
<PG>850-60</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:49:32 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Escortell_x002d_Mayor-2011" MODIFIED="2013-08-21 23:27:43 +0200" MODIFIED_BY="[Empty name]" NAME="Escortell-Mayor 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-08-21 23:27:43 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Escortell E</AU>
<TI>Manual therapy effectiveness in comparison with electric nerve stimulation (TENS) in patients with neck pain</TI>
<SO>ClinicalTrials.gov identifier: NCT01153737</SO>
<YR>Feb 2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-08-16 15:07:40 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Escortell-Major E, Lebrijo-Perez G, Perez-Martin Y, Asunsolo-del Barco, Riesgo-Fuertes R, Saa-Requejo C, por el Gruppo TEMA-TENS</AU>
<TI>Randomized clinical trial for primary care patients with neck pain: manual therapy versus electrical stimulation</TI>
<TO>Ensayo clinico aleatorizado en pacientes con cervicalgia mecanica en atencion primaria: terapia manual frente a electroestimulacion nerviosa transcutanea</TO>
<SO>Atención Primaria</SO>
<YR>2008</YR>
<VL>40</VL>
<NO>7</NO>
<PG>337-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-08-16 11:49:19 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Escortell-Mayor E, Riesgo-Fuertes R, Garrido-Elustondo S, Asunsolo-del Barco A, Diaz-Pulido B, Blanco-Diaz M, Bejerano-Alvarez E and TEMA-TENS Group</AU>
<TI>Primary care randomized clinical trial: Manual therapy effectiveness in comparison with TENS in patients with neck pain</TI>
<SO>Manual Therapy</SO>
<YR>2011</YR>
<VL>16</VL>
<PG>66-73</PG>
<IDENTIFIERS MODIFIED="2013-08-14 17:45:00 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farina-2004" MODIFIED="2013-08-14 17:47:39 +0200" MODIFIED_BY="VEP  " NAME="Farina 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-08-14 17:47:39 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farina S, Casarotto M, Benelle M, Tinassi M, Fiaschi A, Goldoni M, et al</AU>
<TI>A randomized controlled study on the effect of two different treatments in myofascial pain syndrome</TI>
<SO>Europa Medicophysica</SO>
<YR>2004</YR>
<VL>40</VL>
<PG>293-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fialka-1989" MODIFIED="2013-08-16 11:59:22 +0200" MODIFIED_BY="VEP  " NAME="Fialka 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-08-16 11:59:22 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fialka V, Preisinger E, Bohler A</AU>
<TI>Zur physikalischen diagnostik und physikalischen therapie der distorsio columnae vertebralis cervicalis</TI>
<SO>Zeitschrift fur physikalische Medizin, Balneologie, medizinische Klimatologie</SO>
<YR>1989</YR>
<VL>18</VL>
<PG>390-7</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:50:32 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flynn-1987" MODIFIED="2009-07-30 21:15:56 +0200" MODIFIED_BY="VEP  " NAME="Flynn 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-07-30 21:15:56 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flynn T</AU>
<TI>A comparative study between UltraReiz and Ultrasound in the treatment for relief of pain in whiplash injuries</TI>
<SO>Physiotherapy Ireland</SO>
<YR>1987</YR>
<VL>8</VL>
<NO>1</NO>
<PG>11-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foley_x002d_Nolan-1990" NAME="Foley-Nolan 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foley-Nolan D, Barry C, Coughlan RJ, O'Connor P, Roden D</AU>
<TI>Pulsed high frequency (27MHz) electromagnetic therapy for persistent neck pain: A double blind, placebo-controlled study of 20 patients</TI>
<SO>Orthopaedics</SO>
<YR>1990</YR>
<VL>13</VL>
<PG>445-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foley_x002d_Nolan-1992" MODIFIED="2013-08-14 17:52:01 +0200" MODIFIED_BY="[Empty name]" NAME="Foley-Nolan 1992" YEAR="1992">
<REFERENCE MODIFIED="2013-08-14 17:52:01 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foley-Nolan D, Moore K, Codd M, Barry C, O'Connaor P, Coughlan RJ</AU>
<TI>Low energy high frequency pulsed electromagnetic therapy for acute whiplash injuries. A double blind randomized controlled study</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1992</YR>
<VL>24</VL>
<NO>1</NO>
<PG>51-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hendriks-1996" MODIFIED="2009-08-04 23:51:15 +0200" MODIFIED_BY="VEP  " NAME="Hendriks 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-08-04 23:51:15 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hendriks O, Horgan A</AU>
<TI>Ultra-reiz current as an adjunct to standard physiotherapy treatment of the acute whiplash patient</TI>
<SO>Physiotherapy Ireland</SO>
<YR>1996</YR>
<VL>17</VL>
<NO>1</NO>
<PG>13-7</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:51:15 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong-1982" MODIFIED="2013-08-14 17:52:24 +0200" MODIFIED_BY="VEP  " NAME="Hong 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-08-14 17:52:24 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hong CZ, Lin JC, Bender LF, Schaeffer JN, Meltzer RJ, Causin P</AU>
<TI>Magnetic necklace: Its therapeutic effectiveness on neck and shoulder pain</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1982</YR>
<VL>63</VL>
<PG>462-6</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:51:36 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hou-2002" MODIFIED="2013-08-14 17:52:47 +0200" MODIFIED_BY="[Empty name]" NAME="Hou 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-08-14 17:52:47 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hou CR, Tsai LC, Cheng KF, Chung KC, Hong CZ</AU>
<TI>Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger point sensitivity</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2002</YR>
<VL>83</VL>
<PG>1406-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsueh-1997" MODIFIED="2013-08-14 17:53:12 +0200" MODIFIED_BY="[Empty name]" NAME="Hsueh 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-08-14 17:53:12 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsueh TC, Cheng PT, Kuan TS, Hong CZ</AU>
<TI>The immediate effectiveness of electrical nerve stimulation and electrical muscle stimulation on myofascial trigger points</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>1997</YR>
<VL>76</VL>
<PG>471-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hurwitz-2002" MODIFIED="2013-08-14 17:53:29 +0200" MODIFIED_BY="[Empty name]" NAME="Hurwitz 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-08-14 17:53:29 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hurwitz EL, Morgenstern H, Harber P, Kominski GF, Yu F, Adams AH</AU>
<TI>A randomized trial of chiropractic manipulation and mobilization for patients with neck pain: clinical outcomes from the UCLA Neck Pain Study</TI>
<SO>American Journal of Public Health</SO>
<YR>2002</YR>
<VL>92</VL>
<NO>10</NO>
<PG>1634-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nordemar-1981" MODIFIED="2013-08-16 12:00:26 +0200" MODIFIED_BY="[Empty name]" NAME="Nordemar 1981" YEAR="1981">
<REFERENCE MODIFIED="2013-08-16 12:00:26 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nordemar R, Thorner C</AU>
<TI>Treatment of acute cervical pain - A comparative group study</TI>
<SO>Pain</SO>
<YR>1981</YR>
<VL>10</VL>
<PG>93-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philipson-1983" MODIFIED="2013-08-16 12:01:33 +0200" MODIFIED_BY="VEP  " NAME="Philipson 1983" YEAR="1983">
<REFERENCE MODIFIED="2013-08-16 12:01:33 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philipson T, Haagensen N, Laumann V, Nies M, Thorup K, Hansen TI</AU>
<TI>The effect of diadynamic current on chronic soft-tissue pain in the neck and shoulder girdle</TI>
<TO>Effekten af diadynamisk stroem pa kroniske bloeddelsmerter i nakke-skulderaget</TO>
<SO>Ugeskrift for Laeger</SO>
<YR>1983</YR>
<VL>145</VL>
<PG>479-81</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:52:07 +0200" MODIFIED_BY="VEP  ">
<IDENTIFIER MODIFIED="2009-08-04 23:52:07 +0200" MODIFIED_BY="VEP  " TYPE="OTHER" VALUE="(Danish, translated)"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sahin-2011" MODIFIED="2013-08-16 12:02:32 +0200" MODIFIED_BY="[Empty name]" NAME="Sahin 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-08-16 12:02:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lidia L, Shklar B, Kesner Baruch Y, Raz R, Gabis E, Geva D</AU>
<TI>Effect of different transcutaneous electrical stimulation modalities on cervical myofascial pain syndrome</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2011</YR>
<VL>41</VL>
<PG>256&#8211;61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smania-2003" MODIFIED="2009-07-28 20:40:08 +0200" MODIFIED_BY="VEP  " NAME="Smania 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-07-28 20:40:08 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smania N, Corato E, Fiaschi A, Pietropoli P, Aglioti S, Tinazzi M</AU>
<TI>Therapeutic effects of peripheral repetitive magnetic stimulation on myofascial pain syndrome</TI>
<SO>Clinical Neurophysiology</SO>
<YR>2003</YR>
<VL>114</VL>
<PG>350-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smania-2005" MODIFIED="2013-08-16 12:03:05 +0200" MODIFIED_BY="[Empty name]" NAME="Smania 2005" YEAR="">
<REFERENCE MODIFIED="2013-08-16 12:03:05 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smania N, Corato E, Fiaschi A, Pietropoli P, Aglioti SM, Tinazzi M</AU>
<TI>Repetetive magnetic stimulation: a novel therapeutic approach for myofascial pain syndrome</TI>
<SO>Journal of Neurology</SO>
<YR>2005</YR>
<VL>252</VL>
<PG>307-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sutbeyaz--2006" MODIFIED="2013-08-14 17:55:21 +0200" MODIFIED_BY="VEP  " NAME="Sutbeyaz  2006" YEAR="2006">
<REFERENCE MODIFIED="2013-08-14 17:55:21 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sutbeyaz ST, Sezer N, Kuseoglu BF</AU>
<TI>The effect of pulsed electromagnetic fields in the treatment of cervical osteoarthritis: a randomized, double-blind, sham controlled study</TI>
<SO>Rheumatology International</SO>
<YR>2006</YR>
<VL>26</VL>
<PG>320-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thuile-2002" MODIFIED="2009-08-04 23:52:49 +0200" MODIFIED_BY="VEP  " NAME="Thuile 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-08-04 23:52:49 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thuile CH, Walzi M</AU>
<TI>Evaluation of electromagnetic fields in the treatment of pain in patients with lumbar radiculopathy or the whiplash syndrome</TI>
<SO>NeuroRehabilitation</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>63-7</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:52:49 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trock-1994" MODIFIED="2013-08-14 17:55:58 +0200" MODIFIED_BY="VEP  " NAME="Trock 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-08-14 17:55:58 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trock DH, Bollet AJ, Markoll R</AU>
<TI>The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and the cervical spine. Report of randomized, double blind, placebo controlled trials</TI>
<SO>Journal of Rheumatology</SO>
<YR>1994</YR>
<VL>21</VL>
<NO>10</NO>
<PG>1903-11</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:52:56 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-08-16 12:12:31 +0200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ammer-1990" MODIFIED="2009-08-04 23:53:10 +0200" MODIFIED_BY="VEP  " NAME="Ammer 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-08-04 23:53:10 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ammer K, Rathkolb O</AU>
<TI>Physical therapy in occipital headaches</TI>
<TO>Physikalische Therapie bei Hinterhauptschmerzen</TO>
<SO>Manual Medizin</SO>
<YR>1990</YR>
<VL>28</VL>
<PG>65-8</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:53:10 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-11-24 11:38:26 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chee--1986" MODIFIED="2009-08-04 23:53:20 +0200" MODIFIED_BY="VEP  " NAME="Chee  1986" YEAR="1986">
<REFERENCE MODIFIED="2009-08-04 23:53:20 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chee E, Walter H</AU>
<TI>Treatment of trigger point with microamperage transcutaneous electrical nerve stimulation (TENS) - (The electro-acuscope 80)</TI>
<SO>Journal Manipulative and Physiological Therapeutics</SO>
<YR>1986</YR>
<VL>9</VL>
<NO>2</NO>
<PG>131-4</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:53:20 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2007" MODIFIED="2013-08-16 12:04:19 +0200" MODIFIED_BY="[Empty name]" NAME="Chen 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-08-16 12:04:19 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen L, Zhang X, Ding H, Tao Y, Zhan H</AU>
<TI>Comparative study on effects of manipulation treatment and TENS on patients with cervicogenic headache</TI>
<TO>Chinese language</TO>
<SO>Journal of Chinese Integrative Medicine</SO>
<YR>2007</YR>
<VL>5</VL>
<NO>4</NO>
<PG>403-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coletta-1988" MODIFIED="2013-08-16 12:04:57 +0200" MODIFIED_BY="[Empty name]" NAME="Coletta 1988" YEAR="1988">
<REFERENCE MODIFIED="2013-08-16 12:04:57 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coletta R, Maggiolo F, Di Tizio S</AU>
<TI>Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes</TI>
<SO>International Journal of Clinical Pharmacology Research</SO>
<YR>1988</YR>
<VL>8</VL>
<NO>4</NO>
<PG>295-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dusunceli-2009" MODIFIED="2013-08-14 17:56:35 +0200" MODIFIED_BY="[Empty name]" NAME="Dusunceli 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-08-14 17:56:35 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dusunceli Y, Ozturk C, Atamaz F, Hepguler S, Durmaz B</AU>
<TI>Efficacy of neck stabilisation exercises for neck pain: a randomized controlled study</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2009</YR>
<VL>41</VL>
<PG>626-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernadez_x002d_de_x002d_las-Penas2004" MODIFIED="2013-08-16 12:05:57 +0200" MODIFIED_BY="VEP  " NAME="Fernadez-de-las Penas2004" YEAR="2004">
<REFERENCE MODIFIED="2013-08-16 12:05:57 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez-de-las-Penas C, Fernandez-Carnero J, Palomque del Cerro L, Miangolarra-Page JC</AU>
<TI>Manipulative treatment vs. conventional physiotherapy treatment in whiplash injury: a randomized controlled trial</TI>
<SO>Journal of Whiplash &amp; Related Disorders</SO>
<YR>2004</YR>
<VL>3</VL>
<NO>2</NO>
<PG>73-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Forestier-2007a" MODIFIED="2013-08-16 12:06:21 +0200" MODIFIED_BY="VEP  " NAME="Forestier 2007a" YEAR="2007">
<REFERENCE MODIFIED="2013-08-16 12:06:21 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forestier R, Francon A, Saint-Arromand F, Bertolino C, Guillemot A, Graber-Duvernay B, et al</AU>
<TI>Are SPA therapy and pulsed electromagnetic field therapy effective for chronic neck pain? Randomized clinical trial. First part: clinical evaluation</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>2007</YR>
<VL>50</VL>
<PG>140-7</PG>
<IDENTIFIERS MODIFIED="2009-08-04 23:56:33 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Forestier-2007b" MODIFIED="2013-02-20 20:54:55 +0100" MODIFIED_BY="VEP  " NAME="Forestier 2007b" YEAR="2007">
<REFERENCE MODIFIED="2013-02-20 20:54:55 +0100" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forestier R, Francon A, Saint AF, Bertolino C, Graber-Duvernay B, Guillemot A, et al</AU>
<TI>Are spa therapy and pulsed electromagnetic field therapy effective for chronic neck pain? Randomized clinical trial. Second part: medicoeconomic approach</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>2007</YR>
<VL>50</VL>
<PG>148-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="CO2007"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gabis-2003" MODIFIED="2013-08-16 12:06:52 +0200" MODIFIED_BY="[Empty name]" NAME="Gabis 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-08-16 12:06:52 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gabis L, Shklar B, Geva D</AU>
<TI>Immediate influence of transcranial electrostimulation on pain and beta-endorphin blood levels. An active placebo controlled study</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>2003</YR>
<VL>82</VL>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gabis-2009" MODIFIED="2013-08-14 17:57:21 +0200" MODIFIED_BY="[Empty name]" NAME="Gabis 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-08-14 17:57:21 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gabis L, Shklar B, Kesner Baruch Y, Raz R, Gabis E, Geva D</AU>
<TI>Pain reduction using transcranial electrostimulation: a double blind, active placebo controlled trial</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2009</YR>
<VL>41</VL>
<PG>256&#8211;61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garrido_x002d_Elustondo-2010" MODIFIED="2013-08-14 17:58:04 +0200" MODIFIED_BY="[Empty name]" NAME="Garrido-Elustondo 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-08-14 17:58:04 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garrido-Elustondo S, Riesgo-Fuertes R, Escortell-Mayor E, Asunsolo del Barco A, Perez-Martin Y, Martin-Castro B</AU>
<TI>Satisfaction of patients with mechanical neck disorders attended to by primary care physical therapists</TI>
<SO>Journal of Evaluation in Clinical Practice</SO>
<YR>2010</YR>
<VL>16</VL>
<PG>445-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gemmell-2011" MODIFIED="2013-08-16 12:07:24 +0200" MODIFIED_BY="[Empty name]" NAME="Gemmell 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-08-16 12:07:24 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gemmell H, Hilland A</AU>
<TI>Immediate effect of electric point stimulation (TENS) in treating latent upper trapezius trigger points: a double blind randomized placebo-controlled trial</TI>
<SO>Journal of Bodywork and Movement Therapies</SO>
<YR>2011</YR>
<VL>15</VL>
<PG>348-54</PG>
<IDENTIFIERS MODIFIED="2013-08-14 17:57:36 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzales_x002d_Iglesias-2009" MODIFIED="2012-01-26 22:37:41 +0100" MODIFIED_BY="[Empty name]" NAME="Gonzales-Iglesias 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-06-09 17:01:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzales-Iglesias J, Fernandez de-Las -Penas C, Cleland J, Albuquerque-Sendin F, Palomeque-del-Cerro L, Mendez-Sanchez R</AU>
<TI>Inclusion of thoracic spine thrust manipulation into an electrotherapy/thermal program for the management of patients with acute mechanical neck pain: A randomized clinical trial</TI>
<SO>Manual Therapy</SO>
<YR>2009</YR>
<VL>14</VL>
<PG>306-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-06-09 16:54:45 +0200" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansson-1983" NAME="Hansson 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansson P, Ekblom A</AU>
<TI>TENS as compared to placebo TENS for relief of acute oro-facial pain</TI>
<SO>Pain</SO>
<YR>1983</YR>
<VL>15</VL>
<PG>157-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jahanshahi-1991" MODIFIED="2013-08-16 12:08:01 +0200" MODIFIED_BY="[Empty name]" NAME="Jahanshahi 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-08-16 12:08:01 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jahanshahi M, Sartory G, Marsden CD</AU>
<TI>EMG biofeedback treatment of torticollis: a controlled outcome study</TI>
<SO>Biofeedback and Self-Regulation</SO>
<YR>1991</YR>
<VL>16</VL>
<NO>4</NO>
<PG>413-48</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="CO97:359"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klaber_x002d_Moffett-2005" MODIFIED="2013-08-16 12:08:51 +0200" MODIFIED_BY="VEP  " NAME="Klaber-Moffett 2005" YEAR="">
<REFERENCE MODIFIED="2013-08-16 12:08:51 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klaber-Moffett JA, Jackson DA, Richmond S, Hahn S, Coulton S, Farrin A, et al</AU>
<TI>Randomized trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: outcomes and patients preference</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>75-</VL>
<PG>1-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="doi: 10.1136/bmj.38268.82 (published 7 December 2004)"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-1997" MODIFIED="2013-08-16 12:09:12 +0200" MODIFIED_BY="[Empty name]" NAME="Lee 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-08-16 12:09:12 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee JC, Lin DT, Hong CZ</AU>
<TI>The effectiveness of simultaneous thermotherapy with ultrasound and electrotherapy with combined AC and DC current on the immediate pain relief of myofascial trigger points</TI>
<SO>Journal of Musculoskeletal Pain</SO>
<YR>1997</YR>
<VL>5</VL>
<NO>1</NO>
<PG>81-90</PG>
<IDENTIFIERS MODIFIED="2011-06-09 14:48:52 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Persson-2001" MODIFIED="2013-08-14 17:58:27 +0200" MODIFIED_BY="[Empty name]" NAME="Persson 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-06-18 20:07:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson LCG, Carlsson CA, Carlsson JY</AU>
<TI>Long-lasting cervical radicular pain managed with surgery, physiotherapy or a cervical collar</TI>
<SO>Spine</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>7</NO>
<PG>751-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-06-18 20:07:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson LCG, Lilja A</AU>
<TI>Pain, coping, emotional state and physical function in patients with chronic radicular neck pain. A comparison between patients treated with surgery, physiotherapy or neck collar. A blinded, prospective randomized study</TI>
<SO>Disability and Rehabilitation</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>8</NO>
<PG>325-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-08-14 17:58:27 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson LCG, Moritz U, Brandt L, Carlsson CA</AU>
<TI>Cervical radiculopathy: pain, muscle weakness and sensory loss in patients with cervical radiculopathy treated with surgery physiotherapy or cervical collar</TI>
<SO>European Spine Journal</SO>
<YR>1997</YR>
<VL>6</VL>
<NO>4</NO>
<PG>265-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porzio-2000" MODIFIED="2013-08-16 12:10:36 +0200" MODIFIED_BY="[Empty name]" NAME="Porzio 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-08-16 12:10:36 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porzio F</AU>
<TI>Use of thermomagnetic bandages and belts in cervical and lumbar pain syndromes. Experimental study with double blind method versus placebo</TI>
<TO>Impiege di fasce e cinture termomagnetice nelle sindromi dolorose cervicali e lombari. Studio sperimentale con il metodo della doppia cecita vs. placebo</TO>
<SO>La Clinica Terapeutica</SO>
<YR>2000</YR>
<VL>151</VL>
<PG>140-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Provinciali-1996" MODIFIED="2013-08-16 12:11:40 +0200" MODIFIED_BY="[Empty name]" NAME="Provinciali 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-08-16 12:11:40 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Provinciali L, Baroni M, Illuminati L, Ceravolo MG</AU>
<TI>Multimodal treatment to prevent the late whiplash syndrome</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1996</YR>
<VL>28</VL>
<PG>105-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigato-2002" MODIFIED="2009-08-05 00:02:39 +0200" MODIFIED_BY="VEP  " NAME="Rigato 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-08-05 00:02:39 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rigato M, Battisti E, Fortunato M, Giordano N</AU>
<TI>Comparison between the analgesic and therapeutic effects of a musically modulated electromagnetic field (TAMMEF) and those of a 100 Hz electromagnetic field: blind experiment on patients suffering from cervical spondylosis or shoulder periarthritis</TI>
<SO>Journal of Medical Engineering and Technology</SO>
<YR>2002</YR>
<VL>26</VL>
<NO>6</NO>
<PG>253-8</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:02:39 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vas-2006" MODIFIED="2013-02-20 21:01:15 +0100" MODIFIED_BY="VEP  " NAME="Vas 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-02-20 21:01:15 +0100" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vas J, Perea-Milla E, Mendez C, et al</AU>
<TI>Efficacy and safety of acupuncture for chronic uncomplicated neck pain: A randomized controlled study</TI>
<SO>Pain</SO>
<YR>2006</YR>
<VL>126</VL>
<PG>245-55</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:02:51 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vikne-2007" MODIFIED="2009-08-05 00:03:01 +0200" MODIFIED_BY="VEP  " NAME="Vikne 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-08-05 00:03:01 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vikne J, Oedegaard A,, Laerum E, Ihlebaek C, Kirkesola G</AU>
<TI>A randomized study of new sling exercise treatment vs traditional physiotherapy for patients with chronic whiplash-associated disorders with unsettled compensation claims</TI>
<SO>Journal Rehabilitation Medicine</SO>
<YR>2007</YR>
<VL>39</VL>
<PG>252-9</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:03:01 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Vitiello-2007" MODIFIED="2009-08-05 00:03:11 +0200" MODIFIED_BY="VEP  " NAME="Vitiello 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-08-05 00:03:11 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vitiello AL, Bonello RP, Pollard HP</AU>
<TI>The effectiveness of ENAR(R) for the treatment of chronic neck pain in Australian adults: A preliminary single blind, randomized controlled trial</TI>
<SO>Chiropractic &amp; Osteopathy</SO>
<YR>2007</YR>
<VL>15</VL>
<NO>9</NO>
<PG>1-11</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:03:11 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007" MODIFIED="2013-08-16 12:12:31 +0200" MODIFIED_BY="[Empty name]" NAME="Wang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-08-16 12:12:31 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang Z, Chen L, Zhu W</AU>
<TI>Observation on the transient analgesic effect of abdominal acupuncture TENS on neck pain, shoulder, loin and legs</TI>
<SO>Chinese Acupuncture and Moxibustion</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>9</NO>
<PG>657-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1974" MODIFIED="2009-07-28 20:45:08 +0200" MODIFIED_BY="VEP  " NAME="Wilson 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-07-28 20:45:08 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson DH</AU>
<TI>Comparison of short wave diathermy and pulsed electromagnetic energy in treatment of soft tissue injuries</TI>
<SO>Physiotherapy</SO>
<YR>1974</YR>
<VL>60</VL>
<NO>10</NO>
<PG>309-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yip-2007" MODIFIED="2009-08-05 00:03:25 +0200" MODIFIED_BY="VEP  " NAME="Yip 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-08-05 00:03:25 +0200" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yip YB, Tse HS, Wu KK</AU>
<TI>An experimental study comparing the effects of combined transcutaneous acupoint electrical stimulation and electromagnetic millimeter waves for spinal pain in Hong Kong</TI>
<SO>Complementary Therapies in Clinical Practice</SO>
<YR>2007</YR>
<VL>13</VL>
<PG>4-14</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:03:25 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-12-20 17:50:54 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2013-08-21 23:45:18 +0200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Guayasam_x00ed_n-2013" MODIFIED="2013-08-21 23:44:30 +0200" MODIFIED_BY="[Empty name]" NAME="Guayasamín 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-08-21 23:44:30 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Guayasamín I</AU>
<TI>Study of clinical documentation, controlled, double-blind, randomized, multicenter, designed to evaluate the effectiveness and tolerance of fixed combination of thiocolchicoside plus diclofenac potassium in reduction of acute painful muscle contracture</TI>
<SO>http://rpcec.sld.cu/trials/RPCEC00000162-En</SO>
<YR>(accessed 21 August 2013)</YR>
<IDENTIFIERS MODIFIED="2013-08-21 17:54:12 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-08-21 23:42:43 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-08-21 23:42:43 +0200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Rigistro Publico Cubano de Ensayos Clinicos RPCEC00000162"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Taniguchi-2010" MODIFIED="2013-08-21 23:45:18 +0200" MODIFIED_BY="[Empty name]" NAME="Taniguchi 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-08-21 23:45:18 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Taniguchi N, Kanai S</AU>
<TI>Effect of neck-type magnetotherapeutic device (magneloop) for neck and shoulder pain</TI>
<SO>International Journal of Rheumatic Diseases. Proceedings of the 14th Congress of Asia Pacific League of Associations for Rheumatology; 2010 July 11-15, Hong Kong</SO>
<YR>2010</YR>
<VL>13</VL>
<PG>230</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-08-21 23:39:20 +0200" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Triano-2009" MODIFIED="2013-08-21 23:43:01 +0200" MODIFIED_BY="[Empty name]" NAME="Triano 2009" YEAR="2007">
<REFERENCE MODIFIED="2013-08-21 23:40:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Triano JJ</AU>
<TI>Efficacy of the InterX 5000 in the Treatment of Chronic Neck Pain</TI>
<SO>http://ClinicalTrials.gov/show/NCT01382537</SO>
<YR>(accessed 21 August 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-08-21 23:30:06 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Woodhouse L, Triano J</AU>
<TI>Proposal to evaluate the efficacy of the InterX5000 in the treatment of chronic neck and shoulder pain</TI>
<TO>Industry Partner Grant: $100,000</TO>
<SO>Neuro Group Inc</SO>
<YR>2007-06/2009-05</YR>
<VL>McMaster University, Canadian Memorial Chiropractic College</VL>
<NO>Hamilton, Ontario, Canada</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-08-21 23:43:01 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-08-21 23:43:01 +0200" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01382537"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Weintraub-2007" MODIFIED="2013-08-21 23:41:23 +0200" MODIFIED_BY="[Empty name]" NAME="Weintraub 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-08-21 23:41:23 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Weintraub MI</AU>
<TI>Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain (SLEEP/MAG)</TI>
<SO>http://ClinicalTrials.gov/show/NCT00445133.</SO>
<YR>(accessed 21 August 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-08-21 23:41:11 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-08-21 23:41:11 +0200" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00445133"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-08-22 23:21:03 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-08-16 12:29:30 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Atkins-2004" MODIFIED="2012-01-05 17:13:51 +0100" MODIFIED_BY="[Empty name]" NAME="Atkins 2004" TYPE="JOURNAL_ARTICLE">
<AU>Atkins D, Best D, Briss PA, et al; GRADE working group</AU>
<TI>Grading quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>328</VL>
<NO>7454</NO>
<PG>1490</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boutron-2005" MODIFIED="2013-01-17 21:30:11 +0100" MODIFIED_BY="[Empty name]" NAME="Boutron 2005" TYPE="JOURNAL_ARTICLE">
<AU>Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, et al</AU>
<TI>A checklist to evaluate a report of a non pharmacological trial (CLEAR NPT) was developed using consensus</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2005</YR>
<VL>58</VL>
<PG>1233-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cameron-1999" MODIFIED="2013-08-16 12:13:59 +0200" MODIFIED_BY="[Empty name]" NAME="Cameron 1999" TYPE="BOOK">
<AU>Cameron MH (editor)</AU>
<SO>Physical agents in rehabilitation. From research to practice</SO>
<YR>1999</YR>
<EN>1st</EN>
<PB>WB Saunders Company</PB>
<CY>Philadelphia, New York, London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carroll-2008a" MODIFIED="2013-08-16 12:14:26 +0200" MODIFIED_BY="VEP  " NAME="Carroll 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Carroll LJ, Hogg-Johnson S, van der Velde G, Haldeman S, Holm LW, Carragee EJ, et al</AU>
<TI>Course and prognostic factors for neck pain in the general population: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>4S</NO>
<PG>S75-S82</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:03:40 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<REFERENCE ID="REF-Carroll-2008b" MODIFIED="2009-08-05 00:18:08 +0200" MODIFIED_BY="VEP  " NAME="Carroll 2008b" TYPE="OTHER">
<AU>Carroll LJ, Holm LW, Hogg-Johnson S, Côté P, Cassidy JD, Haldeman S, et al</AU>
<TI>Course and prognostic factors for neck pain in whiplash-associated disorders (WAD); results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>4S</NO>
<PG>S83-92</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:03:48 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1988" MODIFIED="2008-06-17 21:42:18 +0200" MODIFIED_BY="[Empty name]" NAME="Cohen 1988" TYPE="BOOK">
<AU>Cohen J</AU>
<SO>Statistical power analysis for the behavioural sciences</SO>
<YR>1988</YR>
<EN>2nd</EN>
<PB>Lawrence Erlbaum Associates</PB>
<CY>Hilldale, NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-C_x00f4_t_x00e9_-1998" MODIFIED="2009-07-28 20:34:39 +0200" MODIFIED_BY="VEP  " NAME="Côté 1998" TYPE="JOURNAL_ARTICLE">
<AU>Côté P, Cassidy D, Corroll L</AU>
<TI>The Saskatchewan health and back pain survey. The prevalence of neck pain and related disability in Saskatchewan adults</TI>
<SO>Spine</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>15</NO>
<PG>1689-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-C_x00f4_t_x00e9_-2008" MODIFIED="2009-08-05 00:21:01 +0200" MODIFIED_BY="VEP  " NAME="Côté 2008" TYPE="JOURNAL_ARTICLE">
<AU>Côté P, Kristman V, Vidmar M, Van Eerd D, Hogg-Johnson S, Beaton D, et al</AU>
<TI>The prevalence and incidence of work absenteeism involving neck pain. A cohort of Ontario lost-time claimants</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>4S</NO>
<PG>S192-8</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:19:25 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<REFERENCE ID="REF-Davis-2012" MODIFIED="2013-08-16 12:15:47 +0200" MODIFIED_BY="[Empty name]" NAME="Davis 2012" TYPE="JOURNAL_ARTICLE">
<AU>Davis MA, Onega T, Weeks WB, Lurie JD</AU>
<TI>Where the United States spends Its spine dollars expenditures on different ambulatory services for the management of back and neck conditions</TI>
<SO>Spine</SO>
<YR>2012</YR>
<VL>37</VL>
<NO>19</NO>
<PG>1693-701</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furlan-2009" MODIFIED="2009-07-28 20:37:13 +0200" MODIFIED_BY="VEP  " NAME="Furlan 2009" TYPE="UNPUBLISHED">
<AU>Furlan AD, Pennick V, Bombardier C, van Tulder MW on behalf of the Cochrane Back Review Group Editorial Board</AU>
<TI>Updated method guidelines for systematic reviews in the Cochrane Back Review Group</TI>
<SO>Spine</SO>
<YR>2009 in press</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gross-2002" MODIFIED="2013-01-11 23:58:35 +0100" MODIFIED_BY="[Empty name]" NAME="Gross 2002" TYPE="JOURNAL_ARTICLE">
<AU>Gross A, Kay T, Kennedy C, Gasner D, Hurley L, Yardley K, Hendry L</AU>
<TI>Clinical practice guideline on the use of manipulation or mobilization in the treatment of adults with mechanical neck disorder</TI>
<SO>Manual Therapy</SO>
<YR>2002</YR>
<VL>7</VL>
<NO>4</NO>
<PG>193-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-08-16 12:17:10 +0200" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>March 2011 (updated)</YR>
<EN>Version 5.1.0 www.cochrane-handbook.org</EN>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hogg_x002d_Johnson-2008" MODIFIED="2009-08-05 00:26:26 +0200" MODIFIED_BY="VEP  " NAME="Hogg-Johnson 2008" TYPE="JOURNAL_ARTICLE">
<AU>Hogg-Johnson S, van der Velde G, Carroll LJ, Holm LW, Cassidy JD, Guzman J, et al</AU>
<TI>The burden and determinants of neck pain in the general population: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>4S</NO>
<PG>S39-S51</PG>
<IDENTIFIERS MODIFIED="2009-08-05 00:25:00 +0200" MODIFIED_BY="VEP  "/>
</REFERENCE>
<REFERENCE ID="REF-Hulme-2002" MODIFIED="2013-01-17 17:48:48 +0100" MODIFIED_BY="[Empty name]" NAME="Hulme 2002" TYPE="COCHRANE_REVIEW">
<AU>Hulme J, Robinson V, DeBie R, Wells G, Judd M, Tugwell P</AU>
<TI>Electromagnetic fields for treatment of osteoarthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<PG>Art. No.: CD003523</PG>
<IDENTIFIERS MODIFIED="2013-01-17 17:48:48 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-01-17 17:48:48 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003523"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kendal-1963" NAME="Kendal 1963" TYPE="BOOK">
<AU>Kendal MG, Stuart A</AU>
<SO>The advanced theory of statistics: Distribution theory</SO>
<YR>1963</YR>
<VL>1</VL>
<PG>237</PG>
<EN>2nd</EN>
<PB>Hofner Publishing Co.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kroeling-1998" MODIFIED="2013-08-16 12:17:49 +0200" MODIFIED_BY="[Empty name]" NAME="Kroeling 1998" TYPE="BOOK_SECTION">
<AU>Kroeling P, Gottschild S, Kosarev A, Pfeiffer R</AU>
<TI>TENS increases the pressure pain threshold in a tibia model</TI>
<SO>Kepplinger B (editor): Pain: clinical aspects and therapeutical issues</SO>
<YR>1998</YR>
<PB>Edition Selva</PB>
<CY>Linz</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landis-1977" MODIFIED="2013-08-16 12:18:04 +0200" MODIFIED_BY="[Empty name]" NAME="Landis 1977" TYPE="JOURNAL_ARTICLE">
<AU>Landis RJ, Koch GG</AU>
<TI>The measure of observer agreement for categorical data</TI>
<SO>Biometrics</SO>
<YR>1977</YR>
<VL>33</VL>
<PG>159-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leaver-2010" MODIFIED="2011-10-27 16:07:24 +0200" MODIFIED_BY="[Empty name]" NAME="Leaver 2010" TYPE="JOURNAL_ARTICLE">
<AU>Leaver AM, Refshauge KM, Maher CG, McAuley JH</AU>
<TI>Conservative interventions provide short-term relief for non-specific neck pain: a systematic review</TI>
<SO>Journal of Physiotherapy</SO>
<YR>2010</YR>
<VL>56</VL>
<NO>2</NO>
<PG>73-85</PG>
<IDENTIFIERS MODIFIED="2011-10-27 15:13:43 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-10-27 15:13:43 +0200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-MacDermid-2009" MODIFIED="2011-11-24 20:29:05 +0100" MODIFIED_BY="[Empty name]" NAME="MacDermid 2009" TYPE="JOURNAL_ARTICLE">
<AU>MacDermid JC, Walton DM, Avery S, Blanchard A, Etruw E, McAlpine C</AU>
<TI>Measurement properties of the neck disability index: a systematic review</TI>
<SO>Journal of Orthopaedic &amp; Sports Physical Therapy</SO>
<YR>2009</YR>
<VL>39</VL>
<NO>5</NO>
<PG>400-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NRC-2001" MODIFIED="2008-12-02 23:53:24 +0100" MODIFIED_BY="[Empty name]" NAME="NRC 2001" TYPE="CONFERENCE_PROC">
<AU>National Research Council</AU>
<SO>National Academy Press</SO>
<YR>2001</YR>
<CY>Washington DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olesen-1988" NAME="Olesen 1988" TYPE="JOURNAL_ARTICLE">
<AU>Olesen J</AU>
<TI>Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain</TI>
<SO>Cephalgia</SO>
<YR>1988</YR>
<VL>8</VL>
<NO>7</NO>
<PG>61-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olesen-1997" MODIFIED="2013-08-16 12:18:48 +0200" MODIFIED_BY="[Empty name]" NAME="Olesen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Olesen J, Gobel H</AU>
<TI>ICD-10 Guide for Headaches. Guide to the classification, diagnosis and assessment of headaches in accordance with the tenth revision of the international classification of diseases and related health problems and its application to neurology</TI>
<SO>Cephalgia</SO>
<YR>1997</YR>
<VL>17 Suppl 19</VL>
<PG>29-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pujol-1998" MODIFIED="2013-08-16 12:21:48 +0200" MODIFIED_BY="[Empty name]" NAME="Pujol 1998" TYPE="JOURNAL_ARTICLE">
<AU>Pujol J, Pascual-Leone A, Dolz C, Delgado E, Dolz JL, Aldomà J</AU>
<TI>The effect of repetitive magnetic stimulation on localized musculoskeletal pain</TI>
<SO>Neuroreport</SO>
<YR>1998</YR>
<VL>9</VL>
<NO>8</NO>
<PG>1745-8</PG>
<PB>Lippincott-Raven Publishers</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt_x002d_Rohlfing-2000" MODIFIED="2013-08-16 12:24:38 +0200" MODIFIED_BY="[Empty name]" NAME="Schmidt-Rohlfing 2000" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt-Rohlfing B, Silny J, Niethard FU</AU>
<TI>Pulsating electromagnetic fields in the treatment of orthopaedic diseases: a review and meta-analysis</TI>
<TO>Pulsierende elektromagnetische Felder in der Behandlung von Verletzungen und Erkrankungen der Bewegungsorgane - eine Übersicht und Metaanalyse</TO>
<SO>Zeitschrift fur Orthopadie und ihre Grenzgebiete</SO>
<YR>2000</YR>
<VL>138</VL>
<PG>379-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schumacher-1993" NAME="Schumacher 1993" TYPE="BOOK">
<AU>Schumacher HR, Klippel JH, Koopman WJ (eds)</AU>
<SO>Primer on the Rheumatic Diseases</SO>
<YR>1993</YR>
<EN>10th</EN>
<PB>Arthritis Foundation</PB>
<CY>Atlanta</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sjaastad-1990" NAME="Sjaastad 1990" TYPE="JOURNAL_ARTICLE">
<AU>Sjaastad O, Fredriksen TA, Pfaffenrath V</AU>
<TI>Cervicogenic Headache: Diagnostic criteria</TI>
<SO>Headache</SO>
<YR>1990</YR>
<VL>30</VL>
<PG>725-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spitzer-1987" MODIFIED="2013-08-16 12:25:04 +0200" MODIFIED_BY="[Empty name]" NAME="Spitzer 1987" TYPE="JOURNAL_ARTICLE">
<AU>Spitzer WO, Leblanc FE, Dupuis M</AU>
<TI>Scientific approach to the assessment and management of activity related spinal disorders</TI>
<SO>Spine</SO>
<YR>1987</YR>
<VL>Suppl 7</VL>
<PG>S1-S59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spitzer-1995" NAME="Spitzer 1995" TYPE="JOURNAL_ARTICLE">
<AU>Spitzer WO, Skovron ML, Salmi LR, Cassidy JD, Duranceau J, Suissa S, et al</AU>
<TI>Scientific monograph of the Quebeck Task Force on Whiplash-Associated Disorders: Redefining "whiplash" and its management</TI>
<SO>Spine</SO>
<YR>1995</YR>
<VL>Suppl</VL>
<PG>1S-73S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stucki-2000" NAME="Stucki 2000" TYPE="JOURNAL_ARTICLE">
<AU>Stucki G, Kroeling P</AU>
<TI>Physical therapy and rehabilitation in the management of rheumatic disorders</TI>
<SO>Baillieres Best Practice and Research. Clinical Rheumatology</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>4</NO>
<PG>751-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stucki-2007" MODIFIED="2008-08-20 10:31:35 +0200" MODIFIED_BY="[Empty name]" NAME="Stucki 2007" TYPE="BOOK">
<AU>Stucki G, Kroeling P</AU>
<SO>Rheumatology</SO>
<YR>2007</YR>
<VL>1</VL>
<PG>557-568</PG>
<EN>4th</EN>
<ED>Hochberg M, Silman A, Smolen J, Weinblatt ME, Weisman MH</ED>
<PB>Mosby</PB>
<CY>Edinburgh</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tan-1998" NAME="Tan 1998" TYPE="BOOK">
<AU>Tan JC</AU>
<SO>Practical manual of physical medicine and rehabilitation</SO>
<YR>1998</YR>
<PB>Mosby</PB>
<CY>St. Louis, Missouri</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Teasell-2010" MODIFIED="2013-08-16 12:27:44 +0200" MODIFIED_BY="[Empty name]" NAME="Teasell 2010" TYPE="JOURNAL_ARTICLE">
<AU>Teasell RW, McClure JA, Walton D, Pretty J, Salter K, Meyer M, et al</AU>
<TI>A research synthesis of therapeutic interventions for whiplash-associated disorder: Part 2 - interventions for acute WAD</TI>
<SO>Pain Research and Management (Canadian Pain Society)</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>5</NO>
<PG>295-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US-Census-Bureau-1996" MODIFIED="2013-01-17 16:57:21 +0100" MODIFIED_BY="[Empty name]" NAME="US Census Bureau 1996" TYPE="BOOK">
<AU>United States Census Bureau</AU>
<TI>Statistical Abstract of the United States 1996</TI>
<SO>US Bureau of Census</SO>
<YR>1996</YR>
<EN>116</EN>
<PB>US Bureau of Census</PB>
<CY>Washington DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US-Census-Bureau-2012" MODIFIED="2013-08-16 12:29:30 +0200" MODIFIED_BY="[Empty name]" NAME="US Census Bureau 2012" TYPE="JOURNAL_ARTICLE">
<AU>US Census Bureau</AU>
<TI>The 2012 Statistical Abstract of U.S</TI>
<SO>The National Data Book</SO>
<YR>&lt;www.census.gov/prod/www/abs/statab.html&gt;</YR>
<VL>Section 3: Health and Nutrician</VL>
<PG>132 (retrieved 2013-01-16)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Tulder-2003" MODIFIED="2013-01-17 21:30:57 +0100" MODIFIED_BY="[Empty name]" NAME="van Tulder 2003" TYPE="JOURNAL_ARTICLE">
<AU>van Tulder M, Furlan A, Bombardier C, Bouter L</AU>
<TI>Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<NO>12</NO>
<PG>1290-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walsh-1997" NAME="Walsh 1997" TYPE="BOOK">
<AU>Walsh DM</AU>
<SO>TENS: Clinical applications and related theory</SO>
<YR>1997</YR>
<PB>Churchill Livingston</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-08-22 23:21:03 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Kroeling-2005" MODIFIED="2013-08-16 12:30:38 +0200" MODIFIED_BY="[Empty name]" NAME="Kroeling 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kroeling P, Gross AR, Goldsmith CH and the Cervical Overview Group</AU>
<TI>A Cochrane review of electrotherapy for mechanical neck disorders</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>21</NO>
<PG>E641-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kroeling-2009" MODIFIED="2013-08-21 17:52:21 +0200" MODIFIED_BY="[Empty name]" NAME="Kroeling 2009" TYPE="COCHRANE_REVIEW">
<AU>Kroeling P, Gross A, Goldsmith CH, Burnie SJ, Haines T, Graham N, Brant A </AU>
<TI>Electrotherapy for neck pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<PG>Art. No.: CD004251.pub4</PG>
<IDENTIFIERS MODIFIED="2013-01-17 21:46:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-01-17 21:46:46 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004251.pub4"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-08-23 00:01:05 +0200" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-08-23 00:01:05 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="VEP  " STUDY_ID="STD-Chiu-2005">
<CHAR_METHODS MODIFIED="2013-08-16 09:36:23 +0200" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Number Analysed/Randomized: 109/145<BR/>Intension-to-treat Analysis: calculated<BR/>Power Analysis: 90% power</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-16 15:00:51 +0200" MODIFIED_BY="VEP  ">
<P>Chronic neck pain (not specified)<BR/>Duration of Complaint for Cases at baseline: Subacute (&gt;3 months)<BR/>Duration of Complaint for Control at baseline: Subacute (&gt;3 months)</P>
<P>G1: N = 73<BR/>G2: N = 67<BR/>G3: N = 78</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:00:51 +0200" MODIFIED_BY="[Empty name]">
<P>G1: TENS (TENS)<BR/>a. 30 minutes of dual channel portable TENS unit (ITO model 1302). Continuous trains of 150ms square pulse at 80 Hz. 4 Electrodes (4x4cm); b) infrared irradiation, 20 min; c) education on neck care</P>
<P>G2: Exercise Program (Ex) + IR<BR/>a. deep neck flexor-using pressure sensor @20mmHg x10 min (10 sec on/15 sec off)<BR/>b.Strengthening using a Multi Cervical Rehabilitation Unit (MCRU). 15 reps of flexion, extension at 20% of Peak Isometric Strength (PIS) as warm up Then Dynamic flexion and extension with variable resistance x 0-12 reps<BR/>c. Infrared irradiation<BR/>d. 35 minutes of exercise per session</P>
<P>G3: a) Infrared Irradiation, 20 min; b) education on neck care<BR/>
</P>
<P>Duration of Treatment: 6 weeks, 2 sessions/week<BR/>Duration of Follow-up: 6 months</P>
<P>CO-INTERVENTION: Infrared Irradiation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:01:22 +0200" MODIFIED_BY="VEP  ">
<P>PAIN (VAS, 0 to 10)<BR/>Baseline Median: G1 4.69, G2 4.61, G3 4.26<BR/>Reported Results: NS (between the three groups)<BR/>SMD(Ex+IR versus TENS): -0.13 (95% CI:-0.51 to 0.26)<BR/>
</P>
<P>FUNCTION (Chinese version of Northwick Park Questionnaire, 0 to 4)<BR/>Baseline Median: G1 1.39, G2 1.55, G3 1.36<BR/>Reported Results: Ex + IR was favoured over TENS (P=0.02)<BR/>SMD(Ex+IR versus TENS): -1.10(95% CI:-1.51 to -0.69)<BR/>
</P>
<P>REASON FOR DROPOUTS: Reported<BR/>SIDE EFFECT: No complications occurred<BR/>COST OF CARE: NR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Different treatment times for TENS+IR and  IR control group. Pathology of  patients completely unknown (only selection criteria: neck pain &gt; 3 months)</P>
<P>
<U>MISSING DATA:</U> A request was made to clarify data that differed slightly in two reports. Dr Chui responded to a request for clarification. "Please be informed that the subjects were the same groups (exercise and control) of patients as reported in spine but the TENS group was introduced in the Clinical Rehab article and different methods of calculation/ analysis of the neck muscle strength were used in the Clinical Rehab. article."</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<CHAR_METHODS MODIFIED="2013-02-20 20:42:29 +0100" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Number Analysed/Randomized: 71/90<BR/>Intension-to-treat Analysis: calculated<BR/>Power Analysis: 47.5% power</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>subacute or chronic neck pain (grade I and II)<BR/>Duration of Complaint for Cases at baseline: chronic (mean 20 weeks)<BR/>Duration of Complaint for Control at baseline: chronic (mean 22 weeks)</P>
<P>G1 TENS: N = 43<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>G1: TENS (+ exercise)<BR/>a. TENS electrode placement in the painful area in the metamere or in the nerve's pathway (Adel and Luykey 1996) portable digital TENS unit (Manufacturer: Enraf-Nonius; model TENSMED911). 150 microsecond pulse duration, 80Hz, adjustable amplitude, 30 minutes duration, 10 sessions on alternate days for about 1 month</P>
<P>b. Exercise: isometric exercise, neck exercise and postural skills in the form of a handout and explained individually over two sessions to perform at home.</P>
<P>G2: Manual Therapy (MT) + exercise<BR/>a. Neuromuscular technique, post isometric stretching , spray and stretch, Jones technique (Chaitow 1991, Girardin 2004), 30 minute duration, 10 sessions on alternate days for about 1 month<BR/>b. Exercise: isometric exercise, neck exercise and postural skills in the form of a handout and explained individually over two sessions to perform at home</P>
<P>Duration of Treatment: 3 to 4 weeks, 10 sessions<BR/>Duration of Follow-up: 6 months</P>
<P>CO-INTERVENTION: medication consumption of anti-inflammatory, analgesics, and muscle relaxants; no significant difference between groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:01:32 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN Intensity (VAS, 0 to 100 mm, high score indicates worse)</P>
<P>Baseline mean: TENS (+exercise) 56.4; MT (+exercise) 54.9<BR/>Reported results: Comparison between TENS and MT group: P = 0.9 (NS)</P>
<P>SMD TENS versus MT : 0.11 [-0.35, 0.58]</P>
<P>FUNCTION (NDI, 0 to 50, high score indicates worse)<BR/>Baseline Mean: TENS (+exercise) 34.4; MT (+exercise) 31.63</P>
<P>Reported results: Comparison between TENS and MT group: P = 0.67 (NS)</P>
<P>SMD TENS versus MT: -0.07 [-0.53, 0.40]</P>
<P>PCS (SF-12 Physical component SF 12 summary, 0 to 50, high score indicates better)<BR/>Baseline Mean: TENS (+exercise) 42.7; MT (+exercise) 43.3<BR/>Reported results: Comparison between TENS and MT group: P = 0.45 (NS)</P>
<P>SMD TENS versus MT: 0.19 [-0.23, 0.61]</P>
<P>REASON FOR DROPOUTS: Reported<BR/>
</P>
<P>SIDE EFFECTS: no important side effects in either group</P>
<P>COST OF CARE: NR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-05 18:13:12 +0100" MODIFIED_BY="[Empty name]">
<P>Location of Study: Madrid Region, Spain; the paper was judged to have serious flaws and high risks of bias </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:01:54 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farina-2004">
<CHAR_METHODS MODIFIED="2013-08-16 15:01:49 +0200" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Analysed/randomized: 40/40<BR/>blinding:<BR/>patients<BR/>evaluation examiner regarding treatment<BR/>therapist regarding clinical status<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-28 22:30:59 +0200" MODIFIED_BY="VEP  ">
<P>Myofascial pain syndrome (upper m. trapezius)<BR/>
</P>
<P>G1: N = 21<BR/>G2: N = 19</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:01:49 +0200" MODIFIED_BY="[Empty name]">
<P>G1: TENS (Phyacton 787, Uniphy, Netherlands) 100 Hz, 0.25 ms pulse width; placement: negative electrode on most painful trigger point; intensity: below muscular contraction (&lt; 39mA), at patient's comfort</P>
<P>G2: FREMS; a variation of TENS: <U>FRE</U>quency <U>M</U>odulated <U>N</U>eural <U>S</U>timulation (ETS 501-Physioflog, Lorenz Biotech, Italy); high voltage (&gt;300V) low intensity (&lt; 0.01 mA) and short duration impulses (0.01 msec); programmed frequency variations 1-40 Hz; placement: positive electrode at most painful trigger point</P>
<P>Co-interventions: all patients were instructed to avoid PT for 2 months and analgesic medication for 2 weeks</P>
<P>Treatment schedule: 10 treatment sessions, 5 days a week, for 2 consecutive weeks; duration 20 minutes each</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:01:54 +0200" MODIFIED_BY="VEP  ">
<P>NECK PAIN AND DISABILITY (NPDVAS; 0 to 10)<BR/>(means only; SD not reported!)</P>
<P>Baseline mean: G1 5.29; G2 4.81<BR/>At 1week treatment: G1 2.81; G2 2.46<BR/>Follow up 1 month: G1 3.24; G2 1.29<BR/>Follow up 3 months: G1 4.09; G2 2.73</P>
<P>Reported statistical analysis results: baseline versus 1 week/ 1 month/ 3 months: all P &lt; 0,001 (except P &lt; 0.05 for TENS 3 at months)</P>
<P>Further outcome parameters: Algometry; Cervical ROM; Triggerpoint characteristics; similar results</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-30 21:04:35 +0200" MODIFIED_BY="VEP  ">
<P>Conclusion of authors: Both TENS and FREMS have positive short-term effects on MPS, but medium-term effects were achieved only with FREMS. However, no statistical significant differences between TENS and FREMS have been observed in most outcome parameters. Means and statistical results are reported, but SD values are missing (though announced).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:02:17 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fialka-1989">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:11 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: not patient, not observer</P>
<P>Analysed/randomized:<BR/>60/60 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:04:55 +0200" MODIFIED_BY="VEP  ">
<P>acute whiplash (&gt;5 &lt;10 days), cervicogenic headache</P>
<P>G1: N = 15<BR/>G2: N = 15<BR/>G3: N = 15<BR/>G4: N = 15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:11 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Stereodynamic 50 Hz interferential current (Stereodynator, Siemens), treatment duration 15 minutes, 2 triple electrodes on neck and dorsal spine; intensity not reported</P>
<P>G2: Iontophoresis: DC, duration 20 minutes, diclofenac-gel on a filter paper, placed under the electrodes on the neck, intensity 0.1 mA/cm<SUP>2</SUP>
</P>
<P>G3: Multimodal treatment : Traction, therapeutic exercise, massage (THGM)</P>
<P>G4: Control group; no therapy</P>
<P>Treatment schedule:<BR/>start of treatment after first investigation (5-10 days after car accident); number of treatments and end of treatment not reported. Second investigation after 35 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:17 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN (neck; headache; patient's report)</P>
<P>Baseline Mean: not reported<BR/>Reported Results: improvement, significance not specified<BR/>RR (G1 versus G4 for neck pain): 0.76 (95% CI Random: 0.18, 3.24)<BR/>RR (G1 versus G4 for headache): 1.37 (95% CI Random: 0.29, 6.53)<BR/>RR (G2 versus G4 for neck pain): 1.00 (95% CI Random: 0.42, 2.40)<BR/>RR (G2 versus G4 for headache): 0.66 (95% CI Random: 0.28, 1.57)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:02:17 +0200" MODIFIED_BY="[Empty name]">
<P>No number of treatments reported<BR/>No adequate statistical evaluation<BR/>No use of VAS for neck pain or headache</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:02:24 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flynn-1987">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:24 +0200" MODIFIED_BY="[Empty name]">
<P>RCT (pilot study)</P>
<P>Blinding: not reported</P>
<P>Analysed/randomized: 21/21 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:10:40 +0200" MODIFIED_BY="VEP  ">
<P>whiplash associated pain (duration not reported)</P>
<P>G1: N = 7<BR/>G2: N = 7<BR/>G3: N = 7</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:24 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Ultra-Reiz 143 Hz (Endomed 404) intensity as tolerated, &lt; 35mA; electrodes with viscose sponge at painful area; duration: 14 minutes</P>
<P>G2: ultrasound (Multiphon unit) 3 MHZ, pulsed 1:1, intensity 0.5 W/ cm<SUP>2</SUP>; duration 6 minutes</P>
<P>G3: same treatment as in G2, but intensity 0.0 W/cm<SUP>2</SUP> (placebo)</P>
<P>Co-interventions for all groups: posture advices and neck care including collar. Home exercises twice a day; continuing any medication as before, but not starting with new medication</P>
<P>Treatment schedule:<BR/>G1:8 times in 2 weeks<BR/>G2 and G3: 8 times in 3 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:24 +0200" MODIFIED_BY="VEP  ">
<P>NECK PAIN (VAS 0 to 10cm)</P>
<P>reported pre / post results (SD):<BR/>G1: 7.42 (1.30) / 2.32 (1,51) (P &lt; 0.05)<BR/>G2: 5.1 (2.72) / 4.07 ( 2.73) (n.s.)<BR/>G3: 4.43 (1.49) / 2.31 (2.31) (n.s.)</P>
<P>reported baseline group differences:<BR/>G1 versus G2: P &lt; 0,05<BR/>G1 versus G3: P &lt; 0,002</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:02:24 +0200" MODIFIED_BY="[Empty name]">
<P>Different treatment times for G1 (2 weeks) and G2/G3 (3 weeks)<BR/>The author characterized the investigation as a "pilot study" (small and uneven groups).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:02:38 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:38 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 20/20 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:05:15 +0200" MODIFIED_BY="VEP  ">
<P>Chronic non-specific neck pain</P>
<P>G1: N = 10<BR/>G2: N = 10</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:38 +0200" MODIFIED_BY="[Empty name]">
<P>G1: HF-PEMF therapy by a collar, fitted with a miniaturized short wave (HF-) generator; frequency: 27 MHz; pulse width: 0.06 ms; repetition frequency: 450/ second; mean power: 1.5 mW/cm<SUP>2</SUP>
</P>
<P>G2: placebo HF-PEMF</P>
<P>Co-interventions G1and G2: anti-inflammatory analgesics, depending on pain intensity</P>
<P>Treatment schedule:<BR/>G1: 3 times in 3 weeks active<BR/>G2: 3 weeks placebo and 3 weeks active; 8 hours daily<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:38 +0200" MODIFIED_BY="VEP  ">
<P>PAIN INTENSITY (VAS 10 cm):<BR/>Baseline Mean: not reported<BR/>Reported Results: significant at 3 weeks of treatment<BR/>P &lt; 0.05</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>This therapy is an uncommon PEMF method, using diathermy-like HF-pulses, but with intensities far below the thermal threshold. The reason for the chosen treatment is only based on a literature remark in 1940 and remains unclear.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:02:45 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:44 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 40/40 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:05:25 +0200" MODIFIED_BY="VEP  ">
<P>Acute whiplash injury (&lt;3 days)</P>
<P>G1: N = 20<BR/>G2: N = 20</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:45 +0200" MODIFIED_BY="[Empty name]">
<P>G1: HF-PEMF therapy (see: Foley-Nolan 1990)</P>
<P>G2: placebo HF-PEMF</P>
<P>Co-interventions G1+G2: optional anti-inflammatory analgesics; optional physiotherapy treatment after 4 weeks, if progress not satisfying</P>
<P>Treatment schedule:<BR/>12 weeks; 8 hours daily</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:45 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS 10 cm):<BR/>Baseline Mean: not reported<BR/>Reported Results: not significant</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:02:44 +0200" MODIFIED_BY="[Empty name]">
<P>This therapy is an uncommon PEMF method, using diathermy-like HF pulses, but with intensities far below the thermal threshold. The reason for the chosen treatment is only based on a literature remark in 1940 and remains unclear.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hendriks-1996">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:51 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: none</P>
<P>Analysed/randomized: 16/16</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-23 17:01:16 +0100" MODIFIED_BY="[Empty name]">
<P>Acute whiplash (&lt; 3 days)</P>
<P>G1: n = 8<BR/>G2: n = 8</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:51 +0200" MODIFIED_BY="[Empty name]">
<P>G1: group 2 treatment, plus Ultra-Reiz current 143 Hz, intensity individually graduated, 2 6x8 cm electrodes with viscose sponge placed paravertebral (C4 to T3), duration 15 minutes</P>
<P>G2: standard physiotherapy: ice 15 minutes in clinic and 1 time per day at home; ROM exercises at home; advice on neck care, posture, use of collar</P>
<P>Co-interventions: prescribed drugs were continued as instructed by medical staff</P>
<P>Treatment schedule: 5 sessions within 1 week<BR/>measurements: immediately after 5th session<BR/>Follow-up: 6 weeks after final treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:51 +0200" MODIFIED_BY="VEP  ">
<P>PAIN INTENSITY (VAS 100mm)<BR/>Baseline Mean: not reported<BR/>Reported Results: significant difference (P &lt; 0.05) favouring Group 1 immediately post-treatment (N = 16) and at 6 weeks (N=14) follow-up (P &lt; 0.005)</P>
<P>SIDE EFFECT: not reported<BR/>COST OF CARE: not reported<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Only unrelated t-test values for A/B comparison, but no specific VAS data reported. Single group sizes not clearly specified</P>
<P>No numbers of patients were given in tables for each group; authors failed to present information for a large number of criteria</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:02:59 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hong-1982">
<CHAR_METHODS MODIFIED="2013-08-16 15:02:59 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 52/52 patients</P>
<P>(2 of 4 groups evaluated)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:06:12 +0200" MODIFIED_BY="VEP  ">
<P>Chronic non-specific neck and shoulder pain</P>
<P>G1: N = 27<BR/>G2: N = 25</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:02:59 +0200" MODIFIED_BY="[Empty name]">
<P>G1: necklace with magnetic samarium cobalt elements; field strength: 1200 Gauss (120 mT) flux density at surface</P>
<P>G2: placebo necklace</P>
<P>Treatment schedule: 3 weeks; 24 hours daily<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:02:59 +0200" MODIFIED_BY="VEP  ">
<P>PAIN INTENSITY (4-point rating scale):<BR/>Baseline Mean: magnetic 2.84, non-magnetic 3.10<BR/>End of Study Mean: magnetic 2.56, non-magnetic 2.74<BR/>Absolute Benefit: magnetic 0.10, non-magnetic 0.37<BR/>Reported Results: not significant, SMD: 0.27 (95% CI Random: -0.27, 0.82)<BR/>Power: 82%</P>
<P>PATIENT PERCEIVED IMPROVEMENT:<BR/>Baseline Mean: NR,<BR/>Reported Results: magnetic 52% improved, non-magnetic 44% improved<BR/>RR: 0.86 (95% CI Random: 0.51, 1.45)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Two ignored groups had no pain (controls with active and placebo necklace)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:03:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hou-2002">
<CHAR_METHODS MODIFIED="2013-08-16 15:03:10 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: none</P>
<P>Analysed/randomized: 71/71</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:06:22 +0200" MODIFIED_BY="VEP  ">
<P>Myofascial neck pain; duration of disorder not specified</P>
<P>G1: N = 9<BR/>G2: N = 9<BR/>G3: N = 9<BR/>G4: N = 21<BR/>G5: N = 13<BR/>G6: N = 10</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:03:10 +0200" MODIFIED_BY="[Empty name]">
<P>G1: TENS 100 Hz/ 0.25 ms, ischemic compression, hot pack 20 minutes, Active ROM exercise</P>
<P>G2: TENS 100 Hz/ 0.25 ms, spray and stretch, hot pack for 20 minutes, Active ROM exercises</P>
<P>G3: interferential current (100 Hz interfering wave for 20 minutes), myofascial release technique, hot pack for 20 minutes, Active ROM exercises</P>
<P>G4: hot pack 20 minutes, Active ROM exercise</P>
<P>G5: ischemic compression, hot pack 20 minutes, Active ROM exercise</P>
<P>G6: spray and stretch by Simon et al, hot pack for 20 minutes, Active ROM exercise</P>
<P>Treatment schedule: 1 session</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:03:10 +0200" MODIFIED_BY="VEP  ">
<P>PAIN INTENSITY (VAS)</P>
<P>reported results: all groupsG1-G6 have significantly improved concerning pre/post treatment (P &lt; 0.05)</P>
<P>G4 versus G3: RR: -1,20 ( 95% CI Random: -2.50, -0.36) = hot pack versus interference (P &lt; 0.05)<BR/>G4 versus G2: RR: -1,17 ( 95% CI Random: -2.02, - 0.33 = hot pack versus TENS (P &lt; 0.05)</P>
<P>Reported Results: G1 versus G2 not significant,G2 versus G6 not significant, G3 versus G4 significant favouring G3, G1 versus G5 not significant</P>
<P>SMD (G1 versus G5): 0.56 (95% CI Random: -1.43, 0.31)<BR/>SMD (G2 versus G6): -0.72 (95% CI Random: -1.65, 0.22)<BR/>SMD (G3 versus G4): -1.20 (95% CI Random: -2.05, -0.36)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-02-20 22:16:19 +0100" MODIFIED_BY="[Empty name]">
<P>20 minutes TENS treatment time appears to be extremely short designed, compared to usual recommendations (at least 30 minutes for TENS)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:03:19 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hsueh-1997">
<CHAR_METHODS MODIFIED="2013-08-16 15:03:19 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 60/60 patients<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-20 22:17:02 +0100" MODIFIED_BY="VEP  ">
<P>Chronic myofascial neck pain with trigger points at trapezius muscle</P>
<P>G1: N = 22<BR/>G2: N = 20<BR/>G3: N = 18</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-05-13 12:22:57 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Group A or TENS (60 Hz) at trapezius muscle; feel strong stimulation without muscle contraction</P>
<P>G2: Group B or EMS (electrical muscle stimulation); 10 Hz; visible trapezius muscle stimulation</P>
<P>G3: Group C or sham electrotherapy at trapezius muscle</P>
<P>Treatment schedule: 1 session, 20 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:03:19 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS):<BR/>Baseline Mean: not reported<BR/>Reported Results: significant improvement favouring group B versus C; not significant group A versus C<BR/>SMD (A versus C): -0.36 (95% CI Random: -0.99, -0.27)<BR/>SMD (B versus C): -2.60 (95% CI Random: -3.48, -1.71)<BR/>Power: 6%</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:03:19 +0200" MODIFIED_BY="[Empty name]">
<P>20 minutes TENS treatment time appears to be extremely short, compared to usual recommendations (at least 30 minutes for TENS)<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="VEP  " STUDY_ID="STD-Hurwitz-2002">
<CHAR_METHODS>
<P>RCT (2x2x2 factorial design)</P>
<P>Analysed/Randomized: 269/336</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:12:43 +0200" MODIFIED_BY="VEP  ">
<P>Subacute and chronic neck pain with or without radicular symptoms and cervicogenic headache</P>
<P>Manipulaton groups<BR/>G1/G2/G5 /G6<BR/>total N = 171</P>
<P>Mobilisation groups<BR/>G3/ G4/ G7/ G8<BR/>total N = 165</P>
<P>Single groups:<BR/>N = NR</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:03:29 +0200" MODIFIED_BY="VEP  ">
<P>G1: Manipulation with electrical muscle stimulation (Manip/EMS): 10-minute application of EMS before manipulation; EMS parameters not reported</P>
<P>G2: Manipulation with electrical muscle stimulation (Manip/EMS) and heat: 10-minute moist heat application and EMS simultaneously before mobilisation</P>
<P>G3: Mobilisation with EMS (Mob/EMS): 10-minute application of this modality before mobilisation; parameters NR</P>
<P>G4: Mobilisation with heat and electrical muscle stimulation (Manip/EMS)</P>
<P>G5: Manipulation (Manip): at least 1 controlled, dynamic thrust applied with high velocity low amplitude force, directed at 1 or more restricted upper thoracic or cervical spine joint segments</P>
<P>G6: Manipulation with heat (Manip/Heat): 10-minute moist heat application before manipulation</P>
<P>G7: Mobilisation (Mob): 1 or more low velocity, variable amplitude movements directed to 1 or more restricted upper thoracic or cervical spine joint segments</P>
<P>G8: Mobilisation with heat (Mob/Heat): 10-minute moist heat application before mobilisation</P>
<P>Co-intervention: All participants received information on posture and body mechanics and one or more of the following: stretching, flexibility, or strengthening exercises and advice about ergonomic and workplace modifications</P>
<P>Treatment schedule: unclear: "...at least 1 treatment..." (manip / mob)<BR/>No maximum, no average number of treatments reported</P>
<P>Measurements / follow up: 2 weeks; 6 weeks; 3 months; 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:03:29 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (most severe pain, NRS 0 to10)<BR/>Baseline Mean: Not reported for each subgroup<BR/>Reported Results: no significant differences</P>
<P>e.g.: at 6 months<BR/>SMD (EMS + manip versus manip): 0.07 (95% CI -0.40 to 0.55)</P>
<P>DISABILITY (NDI 0 to 50)<BR/>Reported Results: no significant difference<BR/>at 6 months<BR/>SMD (EMS + manip versus manip): 0.08 (95% CI: -0.39 to 0.55)</P>
<P>PATIENT SATISFACTION<BR/>Reported Results: no significant difference<BR/>at 4 weeks<BR/>SMD (EMS + manip versus manip): -0.13 (95% CI: -0.60 to 0.35)</P>
<P>SIDE EFFECTS: interviewed at 4 weeks of care, no known study-related adverse events<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Factorial design. No relevant differences between EMS (G3, G4, G7, G8) v no EMS (G1, G2, G5, G6)</P>
<P>"At least 1 treatment", but no maximum, no average number of treatments by mob/ manip or modalities reported</P>
<P>10 minutes modalities treatment time appears extremely short design, compared to usual recommendations (at least 30 minutes). No setting parameters for EMS were reported</P>
<P>
<U>Missing Data</U>: a request to clarify the specific treatment parameters was sent but no response received. However, a request for data (end of study mean and SD for each outcome) was sent and response received from Hurwitz 2002.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:04:05 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nordemar-1981">
<CHAR_METHODS MODIFIED="2013-08-16 15:04:05 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: none</P>
<P>Analysed/randomized: 30/30 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:13:03 +0200" MODIFIED_BY="VEP  ">
<P>Acute non-specific neck pain (&lt; 3 days; without radiation)</P>
<P>G1: N = 10<BR/>G2: N = 10<BR/>G3: N = 10</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-27 14:36:05 +0200" MODIFIED_BY="[Empty name]">
<P>G1: TENS: 80 Hz; intensity just below pain threshold; neck collar, rest, exercise, analgesic</P>
<P>G2: Manual Therapy (MT): soft tissue treatment, manual traction, neuromuscular mobilization, collar, rest, exercise, analgesic</P>
<P>G3: Neck collar, rest, exercise, analgesic</P>
<P>Treatment schedule:<BR/>G1: 3 times per week; 15 minutes<BR/>G2: 3 times per week; 30 minutes<BR/>G3: intermittent collar use over 2 weeks<BR/>Follow-up: after 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:04:05 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS 100 mm):<BR/>Baseline Mean: TENS 83, MT 97, collar 90<BR/>End of Study Mean: TENS 0, MT 0, collar 0<BR/>Absolute Benefit: TENS 83, MT 97, collar 90<BR/>Reported Results: no significant difference<BR/>SMD (TENS versus collar): -0.50 (-1.39, 0.39)<BR/>SMD (TENS versus MT): -0.04 (-0.92, 0.83)<BR/>Power: 8%</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-04-27 17:37:45 +0200" MODIFIED_BY="[Empty name]">
<P>Most patients had no need of treatment after first week in all groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="VEP  " STUDY_ID="STD-Philipson-1983">
<CHAR_METHODS MODIFIED="2013-08-16 15:04:11 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients</P>
<P>Analysed/Randomized: 40/40 patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:13:14 +0200" MODIFIED_BY="VEP  ">
<P>Chronic non-specific neck and shoulder pain</P>
<P>G1: N = 20<BR/>G2: N = 20</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-17 21:00:30 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Diadynamic Current (LP)</P>
<P>G2: Placebo group: current turned up until patient felt sensation in neck, then turned off<BR/>Treatment schedule: 4 minutes each at 3 trigger points; 5 consecutive days<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS):<BR/>Baseline Mean: not reported<BR/>Reported Results: not significant difference<BR/>RR: 0.69 (95% CI Random: 0.39, 1.24)<BR/>Power: 13%</P>
<P>PATIENT RATED IMPROVEMENT (5-point scale):<BR/>Baseline Mean: not reported<BR/>Reported Results: no significant difference;<BR/>RR: 0.07 (95% CI Random: 0.33, 1.47)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:04:18 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sahin-2011">
<CHAR_METHODS MODIFIED="2013-01-10 13:27:02 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-16 15:04:18 +0200" MODIFIED_BY="[Empty name]">
<P>Forty patients with cervical myofascial pain syndrome [MPS] &gt; 3 months</P>
<P>Groups, randomized / analysed</P>
<P>G1 n = 20 / 19</P>
<P>G2 n = 20 / 18</P>
<P>G3 n = 20 / 19</P>
<P>G4 n = 20 / 19</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:04:18 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Conventional TENS with a frequency of 100 Hz, 40 &#956;s duration, low amplitude</P>
<P>G2: Acupuncture-like TENS (AL-TENS) with a frequency of 4 Hz, 250 &#956;s duration, high amplitude</P>
<P>G3: Burst TENS with high [100 Hz] and low [2 Hz] frequency, 40 &#956;s, high amplitude</P>
<P>G4: Placebo TENS: electrical stimulation until patients sensation, then turned down to zero</P>
<P>Treatment schedule:</P>
<P>30 minutes, 3 times a week, until 10 sessions completed</P>
<P>Follow up: Not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:04:18 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS 0 to 10)</P>
<P>BASELINE Mean</P>
<P>G1 conventional TENS (n =19) 7.12</P>
<P>G2 AL-TENS (n = 18) 6.15</P>
<P>G3 Burst TENS (n = 19) 6.85</P>
<P>G4 Placebo TENS (n = 19) 7.56</P>
<P>Reported Results: no significant difference</P>
<P>SMD (G1 versus G4) -0.07 [95% CI Random: -0.71 to 0.56]</P>
<P>SMD (G1 versus G2) 0.20 [95% CI Random: -0.45 to 0.84]</P>
<P>SMD (G1 versus G3) 0.39 [95% CI Random: -0.25 to 1.03]</P>
<P>SIDE EFFECTS: not found<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:04:18 +0200" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:04:41 +0200" MODIFIED_BY="VEP  " STUDY_ID="STD-Smania-2003">
<CHAR_METHODS MODIFIED="2013-08-16 15:04:30 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients<BR/>examiner regarding treatment<BR/>therapist regarding clinical status</P>
<P>Analysed/Randomized: 18/18</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:13:26 +0200" MODIFIED_BY="VEP  ">
<P>Myofascial neck pain (trigger points at upper trapezius; duration not specified)</P>
<P>G1: N = 9<BR/>G2: N = 9</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:04:30 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Repetitive Magnetic Stimulation (rMS), Magstim Super Rapid Stimulator by Magstim company, intensity up to 400 mT (4000 G), 4000 pulses, administered in 5 sec trains at 20 Hz, separated by 25 sec pauses</P>
<P>G2: detuned ultrasound (Supersonic 1010, Italy)</P>
<P>Co-interventions: avoid any PT for 2 months, refrain from taking any analgesic drug for 15 days, no other treatment during study</P>
<P>Treatment schedule: 2 weeks, 10 sessions; duration: 20 minutes each<BR/>Follow up: 1 week and 1 month after treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:04:30 +0200" MODIFIED_BY="[Empty name]">
<P>NECK PAIN AND DISABILITY (NPDVAS 0-100)<BR/>Baseline Mean and other values: graphed</P>
<P>post-treatment; SMD: -0.89 (95% CI Random:- 1.87, 0.09)<BR/>follow-up 1 week after treatment; SMD: -1.39 (95% CI Random: -2.44, -0.33)<BR/>follow-up 1 month after treatment: SMD -1.08 (95% CI Random: -2.08, -0.07); NNT 3; treatment advantage 56%</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-16 15:04:41 +0200" MODIFIED_BY="[Empty name]">
<P>Amelioration from "after treatment" to 1-month follow-up reported.</P>
<P>Pilot study with small groups; see also Smania 2005, similar trial with 53 patients. Funding not reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:04:49 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smania-2005">
<CHAR_METHODS MODIFIED="2013-08-16 15:04:49 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients<BR/>examiner regarding treatment<BR/>therapist regarding clinical status</P>
<P>Analysed/Randomized: 53/53</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-16 15:04:49 +0200" MODIFIED_BY="VEP  ">
<P>Myofascial neck pain syndrome (trigger points at upper trapezius; duration not specified)</P>
<P>G1: N = 17<BR/>G2: N = 18<BR/>G3: N = 18</P>
<P>at 3 month follow-up:<BR/>G1: N = 15<BR/>G2: N = 16<BR/>G3: N = 15</P>
<P>32 patients excluded (from 85) before randomization (53)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:04:49 +0200" MODIFIED_BY="[Empty name]">
<P>G1: Repetitive Magnetic Stimulation (rMS), Magstim Super Rapid Stimulator by Magstim company, intensity up to 400 mT (4000 G), 4000 pulses, administered in 5 sec trains at 20 Hz, separated by 25 sec pauses; 20 minutes duration</P>
<P>G2: TENS (Phyacton 787; Uniphy, Netherlands) 100 Hz; 0,25 ms pulse width; asymmetrical rectangular biphasic wave form; intensity at comfort below muscular contraction; placement: negative electrode over most painful trigger point</P>
<P>G3: detuned ultrasound (Supersonic 1010, Italy)</P>
<P>Co-interventions: no PT for 2 months, no analgesic drug for 15 days, no other treatment during study</P>
<P>Treatment schedule: 2 weeks, 10 sessions; duration: 20 minutes each<BR/>Follow up: 1 week, 1 month and 3 months after treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:04:49 +0200" MODIFIED_BY="[Empty name]">
<P>NECK PAIN AND DISABILITY (NPDVAS 0-100)<BR/>Baseline Mean and other values: graphed</P>
<P>rMS versus Placebo US:<BR/>G1 versus G3: post-treatment; SMD: -0.77 (95% CI Random:- 1.46, -0.08)<BR/>G1 versus G3: follow-up 1 month after treatment; SMD-1.51 (95% CI Random: -2.27, -0.74); NNT 3; treatment advantage: 45.6%<BR/>G1 versus G3: follow-up 3 month after treatment: SMD -1.01 (95% CI Random: -1.77, -0.24)</P>
<P>TENS versus Placebo US:<BR/>G2 versus G3: post-treatment; SMD: -0.89 (95%CI Random: -1.76, -0.28)<BR/>G2 versus G3: follow-up 1 month after treatment; SMD -0.65 (95% CI Random: -1.32, -0.02)<BR/>G2 versus G3: follow-up 3 month after treatment: SMD -0.52 (95% CI Random: -1.24, -0.20)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-12-13 16:12:16 +0100" MODIFIED_BY="[Empty name]">
<P>See also Smania 2003, similar trial with 18 patients in total</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:04:56 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sutbeyaz--2006">
<CHAR_METHODS MODIFIED="2013-08-16 15:04:56 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 32/34</P>
<P>(27 patients excluded before randomizations)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:14:15 +0200" MODIFIED_BY="VEP  ">
<P>Cervical osteoarthritis</P>
<P>G1: N = 17<BR/>G2: N = 15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:04:56 +0200" MODIFIED_BY="[Empty name]">
<P>G1: PEMF System: Wave Ranger Professional (MRS 2000+ Home, FL-9492 Eschen); intensity 0,04 mT; frequency range 0.1- 64Hz, applied frequency not reported; application by whole body mat 1.8x0.6 m size</P>
<P>G2: same conditions as in G1, PEMF inactivated (sham control)</P>
<P>Co-interventions: NSAIDs if necessary, need recorded at end of study</P>
<P>Treatment schedule: 3 weeks, 2 times a day; duration 30 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:04:56 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS; 0 to 10 points)<BR/>after 3w treatment; SMD: -3.17(95% CI Random:- 4.25 to -2.09)</P>
<P>NECK PAIN AND DISABILITY SCORE (NPDS; 0 to 100 points)<BR/>after 3w treatment; SMD: -3.56 (95% CI Random:- 4.72 to -2.40)</P>
<P>Reported statistical analysis:<BR/>G1 pre/post: P&lt;0.001 for all items<BR/>G2 pre/post: not significant for all items<BR/>Baseline values differences: not significant for all items</P>
<P>GLOBAL PERCEIVED EFFECT (0 to 3, more is better)</P>
<P>after 3w treatment; SMD: -3.17(95% CI Random:-4.25 to -2.09)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-27 18:17:11 +0200" MODIFIED_BY="[Empty name]">
<P>The credibility of the results, strongly favouring PEMF and contrasting with no sham control effects, seems very low. Support e.g. by MRS 2000 company is neither reported, nor excluded, so funding bias has to be taken in account.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="VEP  " STUDY_ID="STD-Thuile-2002">
<CHAR_METHODS MODIFIED="2013-08-16 15:05:02 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: none</P>
<P>Analysed/Randomized: 92/92</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:14:34 +0200" MODIFIED_BY="VEP  ">
<P>Whiplash I and II (WAD) pain in neck and/or "in the back of the head" (duration not specified)</P>
<P>G1: N = 44<BR/>G2: N = 48</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:05:02 +0200" MODIFIED_BY="[Empty name]">
<P>G1: PEMF System, MRS 2000 plus MED (Vitalife Inc, Austria); intensity 0,01 to 0,03 mT, basic frequency 64Hz; duration: 16 minutes local magnetic cushion application, followed by 8 minutes whole body mat treatment ; medication: diclofenac, tizanidine</P>
<P>G2: Standard Therapy, diclofenac, tizanidine (no sham control)</P>
<P>Treatment schedule: 2 weeks, 2 times per day (G1)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:05:02 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS, 0-10)</P>
<P>Baseline Mean: G1 6.3, G2 5.3<BR/>End of Study Mean: G1 1.9, G2 4.6<BR/>Absolute Benefit: G1 4.4, G2 0.7</P>
<P>Reported Results: significant differences, P&lt;0.03 each</P>
<P>SMD (neck pain): -2.86 (95% CI Random: -2.79, -1.74)<BR/>SMD (headache): -2.27 (95% CI Random: -2.81, -1.75)</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Control group with standard medication only, no placebo magnetic field therapy; The credibility of the results appears to be very low. Support, e.g. by Vitalife Inc, Austria, is neither reported, nor excluded, so funding bias is possible.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-16 15:05:11 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trock-1994">
<CHAR_METHODS MODIFIED="2013-08-16 15:05:11 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Blinding: patients, observer</P>
<P>Analysed/randomized: 70/81</P>
<P>Intention-to-treat: not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-30 21:14:49 +0200" MODIFIED_BY="VEP  ">
<P>Chronic non-specific neck pain with radiologic findings of degenerative changes</P>
<P>G1: N = 42<BR/>G2: N = 39</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:05:11 +0200" MODIFIED_BY="[Empty name]">
<P>G1: PEMF therapy (5/10/12 Hz, rectangular; 10 minutes for each frequency)<BR/>G2: sham PEMF</P>
<P>Co-interventions: medication, physiotherapy</P>
<P>Treatment schedule: 18 sessions lasting 30 minutes each, over 4 to 6 weeks<BR/>Follow-up: 1 month after treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:05:11 +0200" MODIFIED_BY="[Empty name]">
<P>PAIN INTENSITY (VAS 100 mm):<BR/>Baseline Median: PEMF 72.02, placebo 62.30<BR/>End of Study Median: PEMF 46.16, placebo 47.64<BR/>Absolute Benefit: PEMF 25.88, placebo 14.66<BR/>at ST follow-up; SMD:-0.37 [95% CI Random:-0.85 to 0.10]</P>
<P>Reported Results: short term benefits, significant , P &lt; 0.04 at end of treatment; not significant, P = 0.1 at 1 month follow-up<BR/>Power: 41%</P>
<P>FUNCTION (Acivity of Daily Living; 0 to 24):<BR/>Baseline Mean: PEMF 11.94, placebo 11.5<BR/>End of Study: PEMF 8.16, placebo 9.36<BR/>Absolute Benefit: PEMF 3.78, placebo 2.14<BR/>at ST follow-up; SMD: -0.25 [95% CI Random:-0.72 to 0.23] Reported Results: not significant</P>
<P>GLOBAL RATING OF IMPROVEMENT (VAS 0 to 10 cm, more is better):<BR/>at ST follow-up; SMD 0.03 (95% CI Random: 0.03 (-0.44 to 0.50) Reported Results: not significant</P>
<P>SIDE EFFECTS: not reported<BR/>COST OF CARE: not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-27 18:47:30 +0200" MODIFIED_BY="[Empty name]">
<P>Funding bias may be present. Research support declared as Bio-Magnetic Systems, Inc. (Co-author Markoll was principle shareholder of Bio-Magnetic Sytems; Markoll and Trock were sentenced in 2001 for billing unapproved electro-magnetic therapy (see FDA report: http://www.fda.gov/ora/about/enf_story/archive/2001/ch6/oci6.htm).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>N = number of participants<BR/>DC = direct current<BR/>PT = physiotherapy<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ammer-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: multimodal treatment; the unique contribution of electrotherapy could not be determined</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:05:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chee--1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:05:51 +0200" MODIFIED_BY="[Empty name]">
<P>Design: quasi-RCT (drew cards and divided in two groups); extremely small sample size (7 versus 9 patients)<BR/>Outcome: palpatory evaluation of the presence of trigger point was no a pain or surrogate pain intensity measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:05:55 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:05:55 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Headache only, unable to split cervicogenic headache data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Coletta-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population: Unable to split data<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-13 18:07:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dusunceli-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-13 18:07:30 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison: Both comparison studies received the same TENS treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:05:59 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernadez_x002d_de_x002d_las-Penas2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:05:59 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Multimodal treatment for control group; no description of specific parameters for electrotherapy; unable to split data; no further data from authors available on request<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-13 18:07:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Forestier-2007a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-13 18:07:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: Thermal agent used (pulsed short wave, 200W)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-13 18:08:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Forestier-2007b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-13 18:08:07 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: Thermal agent used (pulsed short wave, 200W)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:02 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gabis-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:02 +0200" MODIFIED_BY="[Empty name]">
<P>Population: 20 patients, only three of them with cervicogenic headache</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:06 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gabis-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:06 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: trancranial electrical stimulation is not classical TENS</P>
<P>Population: chronic pain only 23 had cervical pain</P>
<P>Outcome: insufficient data on neck</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-13 18:08:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garrido_x002d_Elustondo-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-13 18:08:47 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome: Key parameter is only satisfaction of patients with all kinds of physiotherapy; TENS is only mentioned</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:11:26 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gemmell-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:11:26 +0200" MODIFIED_BY="[Empty name]">
<P>No neck pain; just stimulated trigger points</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-19 16:22:23 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzales_x002d_Iglesias-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-19 16:22:23 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Both comparison groups received TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-05-07 17:03:33 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hansson-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-05-07 17:03:33 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Not neck pain (oro-facial pain)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-05-07 17:03:36 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jahanshahi-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-05-07 17:03:36 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Not neck pain </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:37 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klaber_x002d_Moffett-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:37 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Multimodal treatment; unable to split data; less than 10% of patients received 6 different kinds of electrotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-13 18:09:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-13 18:09:30 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: Small group size (4groups with a total of 26 patients); multimodal treatment (combination of medium frequency AC+DC electrotherapy plus ultrasound)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:11:47 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Persson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:11:47 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Multimodal treatment; the unique contribution of electrotherapy could not be determined</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:11:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porzio-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:11:51 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Fewer than 80% of included patients had neck pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:11:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Provinciali-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:11:51 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Multimodal treatment; the unique contribution of electrotherapy could not be determined</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rigato-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Fewer than 80% of included patients had neck pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:44 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vas-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:44 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Placebo TENS, no active intervention of electrotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:46 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vikne-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:46 +0200" MODIFIED_BY="[Empty name]">
<P>Intervention: Electrotherapy mentioned, but no modality type or parameters mentioned</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vitiello-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>Design: Data were severely flawed in many points (recalculated and evaluated by a statistician). The communication with authors did not improve the credibility, neither of the data, nor of the results<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:11:57 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:11:57 +0200" MODIFIED_BY="[Empty name]">
<P>Population: 4 x 30 patients with pain of neck, shoulder, loin and legs, treated with four different kinds of electro-acupuncture (excluded in this review). Unable to split data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:49 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:49 +0200" MODIFIED_BY="[Empty name]">
<P>Population: Not neck pain (soft tissue injury as a result of inversion injury of the ankle)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-16 15:06:52 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yip-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-16 15:06:52 +0200" MODIFIED_BY="[Empty name]">
<P>Design: Quasi-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-12-20 17:50:54 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-08-21 23:28:04 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-08-20 21:59:27 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guayasam_x00ed_n-2013">
<CHAR_STUDY_NAME MODIFIED="2013-08-20 21:31:45 +0200" MODIFIED_BY="[Empty name]">
<P>Study of clinical documentation, controlled, double-blind, randomized, multicenter, designed to evaluate the effectiveness and tolerance of fixed combination of thiocolchicoside plus diclofenac potassium in reduction of acute painful muscle contracture</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-08-20 21:31:25 +0200" MODIFIED_BY="[Empty name]">
<P>Dr. Ivan Guayasamín, Medical Surgeon</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-20 21:35:06 +0200" MODIFIED_BY="[Empty name]">
<P>Acute painful striated muscle contracture,(cervical pain, backache, low back pain without sciatica, etc.); age 18 to 58; male/female</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-20 21:36:28 +0200" MODIFIED_BY="[Empty name]">
<P>Group I (experimental): 1 single tablet that contains in combination thiocolchicoside 4mg plus potassium diclofenac 50 mg every 12 hours by mouth to complete 10 doses, 5 days of treatment (TIO+DICLOK). Group II (Control): placebo, 1 tablet inactive every 12 hours orally to complete 10 doses, 5 days of treatment. Group I and Group II: Acetaminophen 500 mg as rescue medication PRN; <BR/>Sample size n=90</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-20 21:59:27 +0200" MODIFIED_BY="[Empty name]">
<P>Primary outcome(s): 1. Evaluation of efficacy 1.1 Muscular contracture degree by a visual inspection (Contracture visible muscle mass with fixed-antalgic attitude, Contracture visible muscle mass without fixed-antalgic attitude, No visual signs of muscle contracture). Measuring time: at baseline and after finished the treatment (Day 5). 1.2 Muscular contracture degree by palpation (Contracture severe with evoked pain during palpation, Contracture moderate with evoked pain during palpation, Contracture mild without evoked pain during palpation, Absence contracture). Measuring time: at baseline and after finished the treatment (Day 5). 1.3 Degree of overall pain intensity (Visual Analogue Scale (VAS) of 10 cm, ranging from no pain to worst pain imaginable very severe). Measuring time: at baseline and after finished the treatment (Day 5). 2. Evaluation of tolerability 2.1 Possible Adverse Reactions (AR). Measuring time: after finished the treatment (Day 5): - Occurrence of some AR in the subject (yes / no) - Nature of the AR (adverse event name) - Intensity of AR (Mild, moderate, severe) - Duration of AR (difference between the start date and the completion of the event) - Causation (causal categories described by the Uppsala Monitoring Centre (WHO): Definite, probable, possible, unlikely, conditional, not evaluable) - Treatment (medication withdrawal, other) - Severity of AR (Severe / serious; Not severe / not serious) Key secondary outcomes: 1. Efficacy 1.1 Efficacy of treatment by the patient (Very effective, Effective, Moderately Effective, Not effective (Ineffective). Measuring time: at the end of the treatment (Day 5) 1.2 Rescue medication (yes / no). Measuring time: at the end of the treatment (Day 5) 1.3 Total Tablets of rescue medication (Number of tablets). Measuring time: at the end of the treatment (Day 5) 1.4 Daily Tablets of rescue medication (Number of tablets). Measuring time: daily during the treatment 2. Tolerability 2.1 Tolerability of treatment by the patient (Very good, Good, Fair, Poor). Measuring time: at the end of the treatment (Day 5) 2.2 Degree of alertness - sleepiness (Visual Analogue Scale (VAS) of 10 cm, ranging from awake (alert) to severe sleepiness (sleeping)). Measuring time: at baseline and after finished the treatment (Day 5) 2.3 Psychomotor activity level (Tapping test (hitting the keyboard of a personal computer as soon as possible) for 30 seconds, record the number of hits). Measuring time: at baseline and after finished the treatment (Day 5) 2.4 Psychomotor activity level (Pauli Test for 3 minutes, recorded the number of successes achieved). Measuring time: at baseline and after finished the treatment (Day 5) 3. Efficacy and Tolerability 3.1 Overall rating of treatment by the investigator (Clinical Global Impression scale). Measuring time: at the end of the treatment (Day 5) 3.2 Overall treatment satisfaction by the investigator (Very Satisfied, Satisfied, Moderately satisfied, not satisfied (dissatisfied)). Measuring time: at the end of the treatment (Day 5) 3.3 Overall treatment satisfaction by the patient (Very Satisfied, Satisfied, Moderately satisfied, not satisfied (dissatisfied)). Measuring time: at the end of the treatment (Day 5)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-08-20 21:39:09 +0200" MODIFIED_BY="[Empty name]">
<P>Recruitment status: Complete Date of first enrollment: 2012/04/15</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-08-20 21:37:49 +0200" MODIFIED_BY="[Empty name]">
<P>First Name: Ana Middle Name: María Last Name: Fallas Quezada Affiliation: Gutis Ltda. Postal Address: Zona industrial de Pavas, 300 metros al oeste de las oficinas centrales de Pizza Hut City: San Jose País: Costa Rica Zip Code: Apdo. 5391-1000 Telephone: +(506) 2549 8300 Dirección de correo electrónico: <A HREF="mailto:a.fallas@gutis.com">a.fallas@gutis.com</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-08-20 21:32:15 +0200" MODIFIED_BY="[Empty name]">
<P>Ecuador</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-08-16 15:12:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taniguchi-2010">
<CHAR_STUDY_NAME MODIFIED="2013-08-16 15:12:04 +0200" MODIFIED_BY="[Empty name]">
<P>Effect of neck-type magnetotherapeutic device (magneloop) for neck and shoulder pain</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES MODIFIED="2013-01-17 17:15:04 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract of a congress presentation</P>
<P>Unpublished data only [14th Congress of Asia Pacific League of Associations for Rheumatology, APLAR 2010 Hong Kong Hong Kong. Conference Start: 20100711 Conference End: 20100715. Conference Publication: 230.; Taniguchi N, Kanai S. In: International Journal of Rheumatic Diseases. 2010</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-08-20 22:49:12 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Triano-2009">
<CHAR_STUDY_NAME MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]">
<P>InterX 5000 - A new treatment technique for people with chronic neck and shoulder pain</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-05-03 17:50:17 +0200" MODIFIED_BY="[Empty name]">
<P>a nerve stimulation device called the InterX 5000</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-16 15:12:12 +0200" MODIFIED_BY="[Empty name]">
<P>chronic neck and shoulder pain, &gt; 3 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-16 15:12:12 +0200" MODIFIED_BY="[Empty name]">
<P>InterX 5000 neurostimulator; 3 consecutive sessions, 3 times per week, 6 weeks, 20 minute sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-16 15:12:12 +0200" MODIFIED_BY="[Empty name]">
<P>Electromyography scan or an EMG, the Neck Walk Index (NWl), the Upper Limb Coordination During an Overhead Reach (ULCS) test, and the Task Limitation (Tl)/Functional lmpairment Test-Head and Neck, Shoulder, Arm (FlT-HaNSA)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-08-20 22:46:43 +0200" MODIFIED_BY="[Empty name]">
<P>2007 to June 2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-08-20 22:49:12 +0200" MODIFIED_BY="[Empty name]">
<P>Dr. John J. Triano, Canadian Memorial Chiropractic College</P>
<P>Dr Linda Woodhouse at the School of Rehabilitation Science at McMaster University, 905-525-9140 Ext.2259</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-01-10 19:37:10 +0100" MODIFIED_BY="[Empty name]">
<P>Industry Funder: Neuro Resource Group INC</P>
<P>Woodhouse L &amp; Triano J. Proposal to evaluate the efficacy of the InterX5000 in the treatment of chronic neck and shoulder pain. Neuro Group Inc, $100,000, 2007-06/2009-05.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-08-20 23:05:48 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weintraub-2007">
<CHAR_STUDY_NAME MODIFIED="2013-08-20 22:57:35 +0200" MODIFIED_BY="[Empty name]">
<P>Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain (SLEEP/MAG)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-08-20 22:58:55 +0200" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomized<BR/>Endpoint Classification: Efficacy Study<BR/>Intervention Model: Parallel Assignment<BR/>Masking: Double-Blind<BR/>Primary Purpose: Treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-20 23:02:00 +0200" MODIFIED_BY="[Empty name]">
<P>18 Years to 85 Years; male/female</P>
<P>Inclusion Criteria:</P>
<UL>
<LI>Female or male subjects age 18-80.</LI>
<LI>Capable of understanding and complying with study protocols.</LI>
<LI>Chronic cervical, thoracic or lumbar pain for at least six months.</LI>
<LI>Sleep difficulties and/or insomnia</LI>
</UL>
<P>Exclusion Criteria:</P>
<UL>
<LI>Unable to understand informed consent (mental retardation, psychosis, communicative impairment).</LI>
<LI>Cardiac pacemaker or other mechanical internal devices.</LI>
<LI>Tumor in the spine/history of malignancy.</LI>
<LI>Pregnancy.</LI>
<LI>Prior spine surgery</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-20 23:00:27 +0200" MODIFIED_BY="[Empty name]">
<P>Treated subjects will receive a permanent/static magnetic sleeping pad with a nominal strength of less than 1000 Gauss. Control subjects will receive physically identical sleeping pad with a nominal surface field strength of 0 Gauss (placebo). The magnets will be contained in a standard mattress pad and subjects will sleep on the pad.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-20 22:59:40 +0200" MODIFIED_BY="[Empty name]">
<P>Primary Outcome Measures: VAS Pain scores/Pittsburgh Sleep scores/Insomnia sleep scores/SF 15 pain descriptor scores/PGIC/<BR/>Secondary Outcome Measures: Autonomic Nerve Functions</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-08-20 23:05:48 +0200" MODIFIED_BY="[Empty name]">
<P>September 26, 2007</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-08-20 23:04:06 +0200" MODIFIED_BY="[Empty name]">
<P>Weintraub, Michael I., MD, FACP, FAAN; miwneuro@pol.net</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-08-20 23:05:29 +0200" MODIFIED_BY="[Empty name]">
<P>The recruitment status of this study is unknown because the information has not been verified recently.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-08-23 00:01:05 +0200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-08-22 23:55:14 +0200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:06:24 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-26 22:22:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>method of block randomisation is not clearly stated; it is not clear that complete blocks were done at each centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 17:48:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>describes a simple random scheme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 13:17:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:50:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>method not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 14:28:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>randomisation, not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 14:29:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>randomisation, not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:29 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 14:34:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>randomisation, method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-11 23:32:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 15:19:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>type of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:42 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 14:51:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>consecutive distribution to three groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:12:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:55:14 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:28 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:41 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:55 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:55:36 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>patients were assigned on a 1:1 ratio</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:15 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-08-22 23:55:32 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:06:33 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-16 15:01:42 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>envelopes were not numbered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-16 15:02:02 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>p 295 described as "patients were informed that they would be submitted to 1 of 2 possible treatments"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:19:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:50:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:51:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>the method is unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:52:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>this is unclear and poorly described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:40:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:37 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:24:50 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 15:36:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>unclear as described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:43 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:53:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not described </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:55:32 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 23:51:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:56:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:56 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:55:47 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:16 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-08-22 23:55:39 +0200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes - patients?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.03" NO="3">
<NAME>All outcomes - outcome assessors?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All outcomes - providers?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-28 13:08:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 17:20:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-02-28 17:20:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-28 13:10:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>not possible due to design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-01-05 18:01:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>not possible due to design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-01-05 18:01:46 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>not possible due to design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:06:54 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-11-08 17:58:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>2 treatment groups involved 2 different machines</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-11-08 17:59:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>not described in results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-28 17:21:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not described </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 13:17:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-02-28 17:21:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-28 17:50:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 13:25:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-02-28 17:51:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:15:02 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:15:04 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:15:05 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:15:16 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:15:17 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:15:18 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-11-13 19:42:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>due to difference in treatment method, not possible to blind the patient</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-11-13 19:43:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>only the treatment method was described but no report of who gave the treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-11-13 19:44:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>pain score rated by patient</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:15:38 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:15:39 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:15:40 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-05-10 16:25:07 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-05-10 16:25:44 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-05-10 16:26:23 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>VAS assessed by patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:16:26 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:16:27 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:16:28 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-05-10 16:42:13 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>not possible; differences in treatment methods</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-05-10 16:42:51 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-05-10 16:43:22 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>subjective rating of pain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-28 17:53:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 12:56:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-02-28 17:53:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:17:08 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:17:09 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-02-28 14:59:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-08-22 23:55:34 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-08-16 15:04:23 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>provider would likely know what settings are used on the TENS unit</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-08-22 23:55:39 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:17:29 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:17:30 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:17:31 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:17:43 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-27 21:17:44 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:17:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:17:57 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 16:17:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>primary outcome VAS assessed by patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:17:58 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-05-10 16:55:58 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2009-05-01 15:31:39 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>blinding of observer not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2012-05-10 16:56:49 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>pain score rated by patient</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-27 21:18:17 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-02-28 16:20:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-06-27 21:18:18 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" NO="11">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="GROUP" NO="12">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-08-23 00:01:05 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes - drop-outs?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>All outcomes - ITT analysis?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:06:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:06:38 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-16 15:01:42 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>see Figure 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-21 19:27:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>page 69 paragraph 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 18:07:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-11-08 18:01:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>no ITT analysis described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:07:06 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:07:08 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-28 17:51:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-28 17:51:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:15:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-28 17:51:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:15:19 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-28 17:52:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-05-03 18:51:01 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>Tables 1-3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-28 14:36:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 20:00:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-11-13 19:59:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 19:20:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>unclear, not described in results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-11-13 19:21:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:16:29 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:16:30 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:16:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-05-10 16:43:48 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-19 16:29:51 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>quick recovery of most cases within one week, while therapy was planned for 3 weeks (many dropouts)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:17:01 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-28 15:14:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-02-28 15:15:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-22 23:56:52 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-08-23 00:01:05 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:17:32 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:17:33 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-05-10 17:12:31 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>not described, but reported in fig. 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-05-10 17:13:54 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:17:59 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:18:00 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-28 16:18:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described in results, but in methods on page 64</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-05-10 16:58:29 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-27 21:18:19 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-06-27 21:18:20 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-08-22 23:58:59 +0200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 17:24:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>no steady protocol available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-16 15:01:42 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>no protocol provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 18:01:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 13:29:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-27 15:00:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported, no protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:08 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:21 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:14:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>No protocol was available or referenced</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 20:00:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:30:31 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>no protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 15:46:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>most data given as percentage change only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:44:06 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:53:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:16:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:58:59 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 23:53:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 17:14:08 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 23:19:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:58:46 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 17:47:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-07-24 16:21:34 +0200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2013-08-22 23:59:25 +0200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Similarity of baseline characteristics?</NAME>
<DESCRIPTION>
<P>Were the groups similar at baseline regarding the most important prognostic indicators?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:06:43 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-16 15:01:42 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>see Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:20:12 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:14:38 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-16 15:02:31 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>significant baseline group differences, especially G1 versus G3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:09 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:22 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-20 22:13:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>only post treatment measurements were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:51 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:22:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>table 1: seven groups are different in age</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 15:47:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>most data given as percentage change only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:52 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:53:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>strong deviations because of small group size</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:13 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:59:25 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:35 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:57:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>table 1 age: much different in the placebo group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:01 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:56 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-20 22:26:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>table 1 showed differences in age</P>
<P>table 2 showed differences in pain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2013-08-22 23:59:39 +0200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Co-interventions avoided or similar?</NAME>
<DESCRIPTION>
<P>Were co-intervention avoided or similar?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 17:36:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>unclear, not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-05 18:08:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 18:01:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 13:31:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 11:08:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>intention to avoid medication changes, but no details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 14:28:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>2-8 paracetamol tablets were allowed according to actual pain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:52:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>analgesics consumption (mefenamid acid) depending on pain</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-03 18:58:23 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>no information given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:59:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:22:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:31 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:44:31 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:54:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>self medication allowed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:16:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:59:39 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:54:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>no medication during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 16:00:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>no medication during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 16:27:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 16:59:31 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 16:27:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>instruction: not to change medication during trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2013-08-22 23:59:54 +0200" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Compliance acceptable?</NAME>
<DESCRIPTION>
<P>Was the compliance acceptable in all groups?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 17:43:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>not reported for exercise</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-15 16:13:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>exercise compliance not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 18:02:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 18:22:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:51:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:51:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:52:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 11:48:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>no information given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:58:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 19:22:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:35 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:46 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 12:57:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:16:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-22 23:59:54 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 15:55:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 17:15:19 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:06 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-10 17:00:12 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 16:31:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>unclear at least for medication (not controlled)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2013-08-23 00:00:01 +0200" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Timing outcome assessments similar?</NAME>
<DESCRIPTION>
<P>Was the timing of the outcome assessment similar in all groups?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:06:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chiu-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 13:11:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Escortell_x002d_Mayor-2011">
<DESCRIPTION>
<P>baseline one month and six months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:07:01 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farina-2004">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:14:39 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fialka-1989">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 13:37:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flynn-1987">
<DESCRIPTION>
<P>different treatment duration (2 weeks and 3 weeks)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:52:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1990">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 17:52:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Foley_x002d_Nolan-1992">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-03 19:02:41 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hendriks-1996">
<DESCRIPTION>
<P>P13Lp2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:15:45 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hong-1982">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:20 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hou-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hsueh-1997">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:16:47 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hurwitz-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 12:57:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nordemar-1981">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:14 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philipson-1983">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-23 00:00:01 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sahin-2011">
<DESCRIPTION>
<P>not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-28 16:01:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2003">
<DESCRIPTION>
<P>timing of final outcome is unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:17:50 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smania-2005">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sutbeyaz--2006">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:55 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Thuile-2002">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 21:18:23 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trock-1994">
<DESCRIPTION>
<P>reported in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-08-16 15:07:33 +0200" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-08-16 15:07:14 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-02-22 00:08:25 +0100" MODIFIED_BY="[Empty name]">Summary of findings: EMS</TITLE>
<TABLE COLS="4" ROWS="10">
<TR>
<TD COLSPAN="4">
<P>
<B>EMS + another treatment compared with that same treatment for neck pain</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>
<B>Patient or population: </B>Patients with subacute/chronic neck pain with or without radicular symptoms and cervicogenic headache</P>
<P>
<B>Settings: </B>Community USA</P>
<P>
<B>Intervention: </B>Electrical Muscle Stimulation (EMS) + another treatment<BR/>
</P>
<P>
<B>Comparison: </B>that same treatment</P>
</TD>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH VALIGN="TOP">
<P>Effect</P>
</TH>
<TH VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pain Intensity - intermediate-term follow-up (about 6 months)</B>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>One trial with factorial design (multiple treatment meta-analysis, I<SUP>2</SUP> = 0%) showed no difference in pain intensity</P>
<P>(pooled SMD 0.09, 95% CI Random -0.15 to 0.33)</P>
</TD>
<TD VALIGN="TOP">
<P>269 (1 study with factorial design of 4 independent comparisons)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
</P>
<P/>
<P>
<SUP>Design: 0</SUP>
</P>
<P>
<SUP>Limitations: 0</SUP>
</P>
<P>
<SUP>Inconsistency: 0</SUP>
</P>
<P>
<SUP>Indirectness: 0</SUP>
</P>
<P>
<SUP>Imprecision: -1 </SUP>
</P>
<P>
<SUP>Other: -1</SUP>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Function</B>
</P>
<P>
<B>intermediate-term follow-up</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>One trial with factorial design (multiple treatment meta-analysis, I<SUP>2</SUP> = 0%) showed no difference in pain intensity</P>
<P>(pooled SMD 0.09, 95% CI Random -0.15 to 0.33)</P>
</TD>
<TD VALIGN="TOP">
<P>269 (1 study with factorial design of 4 independent comparisons)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
</P>
<P/>
<P>
<SUP>Design: 0</SUP>
</P>
<P>
<SUP>Limitations: 0</SUP>
</P>
<P>
<SUP>Inconsistency: 0</SUP>
</P>
<P>
<SUP>Indirectness: 0</SUP>
</P>
<P>
<SUP>Imprecision: -1 </SUP>
</P>
<P>
<SUP>Other: -1</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Global Perceived Effect</B>
</P>
</TD>
<TD>
<P>Not measured</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Satisfaction</B>
</P>
<P>
<B>intermediate-term follow-up</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>One trial with factorial design (multiple treatment meta-analysis, I<SUP>2</SUP> = 0%) showed no difference in pain intensity</P>
<P>(pooled SMD 0.02, 95% CI Random -0.22 to 0.26)</P>
</TD>
<TD VALIGN="TOP">
<P>269 (1 study with factorial design of 4 independent comparisons)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
</P>
<P/>
<P>
<SUP>Design: 0</SUP>
</P>
<P>
<SUP>Limitations: 0</SUP>
</P>
<P>
<SUP>Inconsistency: 0</SUP>
</P>
<P>
<SUP>Indirectness: 0</SUP>
</P>
<P>
<SUP>Imprecision: -1 </SUP>
</P>
<P>
<SUP>Other: -1</SUP>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Quality of life</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Not measured</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Adverse effects</B>
</P>
</TD>
<TD>
<P>No known study related adverse events</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>
<B>Low quality:</B>
</P>
<P>1. Imprecision: Sparce EMS-related data (-1)</P>
<P>2. Other: 2x2x2 factorial design (8 groups; 3 of them with EMS plus another treatment; N= 336) No setting parameters for EMS; Treatment schedule unclear: " ...at least 1 treatment..." (manip / mob) No maximum, no average number of treatments reported (-1)</P>
<P>
<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2013-08-16 15:07:33 +0200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-08-16 15:07:21 +0200" MODIFIED_BY="[Empty name]">Summary of findings: static magnetic field (necklace)</TITLE>
<TABLE COLS="4" ROWS="10">
<TR>
<TD COLSPAN="4">
<P>
<B>Static magnetic field (necklace) compared with placebo for neck pain</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>
<B>Patient or population: </B>Patients with chronic non-specific neck pain</P>
<P>
<B>Settings: </B>Community USA - Rehabilitation Institute</P>
<P>
<B>Intervention: </B>Static magnetic field (necklace)<BR/>
</P>
<P>
<B>Comparison: </B>placebo</P>
</TD>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH VALIGN="TOP">
<P>Effect</P>
</TH>
<TH VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pain Intensity </B>
</P>
<P>
<B>immediate post-treatment (3 weeks)</B>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>One trial showed <B>no difference</B> in pain intensity</P>
<P>(SMD 0.27, 95% CI Random -0.27 to 0.82)</P>
</TD>
<TD VALIGN="TOP">
<P>52 (1 study)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
</P>
<P/>
<P>
<SUP>Design: 0</SUP>
</P>
<P>
<SUP>Limitations: 0</SUP>
</P>
<P>
<SUP>Inconsistency: 0</SUP>
</P>
<P>
<SUP>Indirectness: -1</SUP>
</P>
<P>
<SUP>Imprecision: -1 </SUP>
</P>
<P>
<SUP>Other: 0</SUP>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Function</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Not measured</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Global Perceived Effect</B>
</P>
<P>
<B>immediate post-treatment (3 weeks)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>One trial showed <B>no difference</B> in global perceived effect</P>
<P>(RR 0.85, 95% CI Random 0.48 to 1.50)</P>
</TD>
<TD VALIGN="TOP">
<P>52 (1 study)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
</P>
<P/>
<P>
<SUP>Design: 0</SUP>
</P>
<P>
<SUP>Limitations: 0</SUP>
</P>
<P>
<SUP>Inconsistency: 0</SUP>
</P>
<P>
<SUP>Indirectness: -1</SUP>
</P>
<P>
<SUP>Imprecision: -1 </SUP>
</P>
<P>
<SUP>Other: 0</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Satisfaction</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Not measured</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Quality of life</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Not measured</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Adverse effects</B>
</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="4">
<P>
<B>Low quality:</B>
</P>
<P>1. Imprecision: Sparce data (-1)</P>
<P>2. Directness: Single small trial (-1)<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2009-01-23 19:43:46 +0100" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-08-16 12:35:53 +0200" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-08-16 12:31:12 +0200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Modulated Galvanic current versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-24 09:21:35 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.186591836653186" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>Modulated Galvanic current</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours diad curr</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="13" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-07-24 09:21:35 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>at 5 days treatment</NAME>
<DICH_DATA CI_END="1.238384152715186" CI_START="0.3870284836716846" EFFECT_SIZE="0.6923076923076923" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.09285538581912764" LOG_CI_START="-0.4122570715541515" LOG_EFFECT_SIZE="-0.1597008428675119" ORDER="5" O_E="0.0" SE="0.29670555780805324" STUDY_ID="STD-Philipson-1983" TOTAL_1="20" TOTAL_2="20" VAR="0.08803418803418804" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-12-09 22:31:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.031625500634973" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>patient rated improvement at post treatment</NAME>
<GROUP_LABEL_1>Modulated Galvanic current</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours diad current</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="13" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>at 5 days treatment</NAME>
<DICH_DATA CI_END="1.3247608319304192" CI_START="0.4466587191207355" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" LOG_CI_END="0.12213747921741243" LOG_CI_START="-0.3500241838310859" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="6" O_E="0.0" SE="0.2773500981126145" STUDY_ID="STD-Philipson-1983" TOTAL_1="20" TOTAL_2="20" VAR="0.07692307692307691" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-08-16 12:31:34 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Iontophoresis versus no treatment</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-11 22:53:19 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.315696530104045" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>neck pain at post treatment</NAME>
<GROUP_LABEL_1>Iontophoresis</GROUP_LABEL_1>
<GROUP_LABEL_2>no treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Iontophor.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-06-18 20:43:59 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>at 5w treatment</NAME>
<DICH_DATA CI_END="1.7938216794284925" CI_START="0.5574690123706152" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.2537792684241523" LOG_CI_START="-0.2537792684241523" LOG_EFFECT_SIZE="0.0" ORDER="94" O_E="0.0" SE="0.29814239699997197" STUDY_ID="STD-Fialka-1989" TOTAL_1="15" TOTAL_2="15" VAR="0.08888888888888889" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-02-21 20:01:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.315696530104045" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>headache at post treatment</NAME>
<GROUP_LABEL_1>Iontophoresis</GROUP_LABEL_1>
<GROUP_LABEL_2>no treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Iontophor.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>at 5w treatment</NAME>
<DICH_DATA CI_END="1.574311978719904" CI_START="0.2794369046619412" EFFECT_SIZE="0.6632653061224489" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.19709079994849968" LOG_CI_START="-0.5537162380477784" LOG_EFFECT_SIZE="-0.1783127190496393" ORDER="3" O_E="0.0" SE="0.4410277706737916" STUDY_ID="STD-Fialka-1989" TOTAL_1="14" TOTAL_2="13" VAR="0.19450549450549454" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-08-16 12:31:53 +0200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Iontophoresis versus comparison</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-05-05 19:42:21 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>neck pain at post treatment</NAME>
<GROUP_LABEL_1>Iontophoresis </GROUP_LABEL_1>
<GROUP_LABEL_2>interferential current</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Iontophor.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="8" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-06-19 07:41:38 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>vs Interferential current - at 5w treatment</NAME>
<DICH_DATA CI_END="2.1088175104756295" CI_START="0.6001586167190669" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.3240389990744662" LOG_CI_START="-0.2217339541797036" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2008-06-18 20:44:58 +0200" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="0.3205897343611891" STUDY_ID="STD-Fialka-1989" TOTAL_1="15" TOTAL_2="15" VAR="0.10277777777777779" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="3" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-05-05 19:42:21 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>vs traction + therapeutic exercise + massage - at 5w treatment</NAME>
<DICH_DATA CI_END="8.951561337675422" CI_START="1.0054111970523745" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.9518987918743207" LOG_CI_START="0.002343717565004166" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="108" O_E="0.0" SE="0.5577733510227171" STUDY_ID="STD-Fialka-1989" TOTAL_1="15" TOTAL_2="15" VAR="0.3111111111111111" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-08-16 12:32:08 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>TENS versus placebo or sham</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2013-01-11 22:56:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.59645083531858" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="64" TOTAL_2="62" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.01" MODIFIED="2012-12-20 18:08:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>at 1 session</NAME>
<CONT_DATA CI_END="-1.7096098786141916" CI_START="-3.482175620417155" EFFECT_SIZE="-2.595892749515673" ESTIMABLE="YES" MEAN_1="-57.8" MEAN_2="-6.8" MODIFIED="2009-05-05 19:43:47 +0200" MODIFIED_BY="[Empty name]" ORDER="7" SD_1="24.8" SD_2="9.8" SE="0.45219344737575173" STUDY_ID="STD-Hsueh-1997" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.02" MODIFIED="2012-12-20 18:08:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>at 10 session over 2 weeks</NAME>
<CONT_DATA CI_END="-0.28200042975091477" CI_START="-1.6735551258046408" EFFECT_SIZE="-0.9777777777777777" ESTIMABLE="YES" MEAN_1="26.0" MEAN_2="39.0" ORDER="107" SD_1="13.0" SD_2="13.0" SE="0.35499496598665375" STUDY_ID="STD-Smania-2005" TOTAL_1="18" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.03" MODIFIED="2013-01-10 17:29:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>at 10 sessions over 3 weeks</NAME>
<CONT_DATA CI_END="0.5643873262102874" CI_START="-0.7078615398643073" EFFECT_SIZE="-0.07173710682700993" ESTIMABLE="YES" MEAN_1="6.85" MEAN_2="6.95" MODIFIED="2012-12-20 17:56:25 +0100" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="1.55" SD_2="1.15" SE="0.324559246014195" STUDY_ID="STD-Sahin-2011" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.04" MODIFIED="2012-12-20 18:08:38 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>at 8 session over 2 weeks</NAME>
<CONT_DATA CI_END="1.0537664650364358" CI_START="-1.041529991321014" EFFECT_SIZE="0.00611823685771086" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="2.31" MODIFIED="2008-07-09 20:15:03 +0200" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="1.51" SD_2="1.55" SE="0.5345242241400558" STUDY_ID="STD-Flynn-1987" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2008-12-02 23:45:01 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="16" TOTAL_2="15" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at ST follow-up</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.02.01" MODIFIED="2008-12-02 23:45:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>at 3 month follow-up</NAME>
<CONT_DATA CI_END="0.19845070058108427" CI_START="-1.2372912802912293" EFFECT_SIZE="-0.5194202898550725" ESTIMABLE="YES" MEAN_1="33.0" MEAN_2="41.0" ORDER="106" SD_1="15.0" SD_2="15.0" SE="0.3662674396563567" STUDY_ID="STD-Smania-2005" TOTAL_1="16" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2013-01-11 22:58:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.29637443085379" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="18" TOTAL_2="20" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pressure pain threshold at post treatment</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>at 1 session</NAME>
<CONT_DATA CI_END="-0.7090303022230283" CI_START="-2.152541558279662" EFFECT_SIZE="-1.430785930251345" ESTIMABLE="YES" MEAN_1="-0.19" MEAN_2="45.9" ORDER="8" SD_1="23.3" SD_2="37.4" SE="0.36824943403115207" STUDY_ID="STD-Hsueh-1997" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-08-16 12:32:29 +0200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>TENS + another intervention versus that same intervention</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2013-01-11 22:59:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.5088036692514395" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="86" TOTAL_2="95" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" MODIFIED="2008-06-19 07:20:10 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>at 1 session post treatment</NAME>
<CONT_DATA CI_END="-0.32907102466757776" CI_START="-2.015543379030541" EFFECT_SIZE="-1.1723072018490592" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="4.33" ORDER="12" SD_1="0.65" SD_2="1.82" SE="0.4302304449636936" STUDY_ID="STD-Hou-2002" TOTAL_1="9" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.02" MODIFIED="2008-06-19 08:05:17 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>at 1w treatment</NAME>
<CONT_DATA CI_END="0.3942388073627267" CI_START="-1.3924739221494402" EFFECT_SIZE="-0.4991175573933568" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="35.0" ORDER="112" SD_1="19.0" SD_2="45.0" SE="0.4558024391278434" STUDY_ID="STD-Nordemar-1981" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.03" MODIFIED="2008-06-19 08:05:17 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="64" WEIGHT="0.0" Z="0.0">
<NAME>at 6w treatment</NAME>
<CONT_DATA CI_END="0.2241025307910996" CI_START="-0.4616708787820402" EFFECT_SIZE="-0.11878417399547032" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.3" ORDER="102" SD_1="2.54" SD_2="2.48" SE="0.17494541098265912" STUDY_ID="STD-Chiu-2005" TOTAL_1="67" TOTAL_2="64" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2008-12-02 23:35:11 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="73" TOTAL_2="78" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at IT (6 month) follow-up</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.01" MODIFIED="2008-12-02 23:35:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>at 6w treatment + 6 month follow-up</NAME>
<CONT_DATA CI_END="0.0705490735397317" CI_START="-0.5703498221735003" EFFECT_SIZE="-0.2499003743168843" ESTIMABLE="YES" MEAN_1="-1.29" MEAN_2="-0.65" MODIFIED="2008-07-09 21:16:23 +0200" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="2.3" SD_2="2.76" SE="0.16349762056052067" STUDY_ID="STD-Chiu-2005" TOTAL_1="73" TOTAL_2="78" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-08-16 12:32:42 +0200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>TENS versus comparison</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2012-12-20 18:04:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="117" TOTAL_2="121" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TNS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparison</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.01" MODIFIED="2008-06-19 08:03:20 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>vs EMS - at 1 session</NAME>
<CONT_DATA CI_END="-0.6921612740820408" CI_START="-2.0510197279108016" EFFECT_SIZE="-1.371590500996421" ESTIMABLE="YES" MEAN_1="-57.8" MEAN_2="-15.8" MODIFIED="2008-06-19 08:03:20 +0200" MODIFIED_BY="[Empty name]" ORDER="111" SD_1="24.8" SD_2="34.1" SE="0.3466539345996311" STUDY_ID="STD-Hsueh-1997" TOTAL_1="20" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.02" MODIFIED="2008-06-19 08:10:33 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>vs Mobilization - at 1w treatment vs Mobilisation</NAME>
<CONT_DATA CI_END="0.8335147344709405" CI_START="-0.9197841985260139" EFFECT_SIZE="-0.0431347320275367" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="18.0" ORDER="113" SD_1="19.0" SD_2="25.0" SE="0.4472783548133416" STUDY_ID="STD-Nordemar-1981" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.03" MODIFIED="2008-12-02 23:43:43 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>vs US - at 2w treatment</NAME>
<CONT_DATA CI_END="1.0537664650364358" CI_START="-1.041529991321014" EFFECT_SIZE="0.00611823685771086" ESTIMABLE="YES" MEAN_1="2.32" MEAN_2="2.31" MODIFIED="2008-07-09 20:18:26 +0200" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="1.51" SD_2="1.55" SE="0.5345242241400558" STUDY_ID="STD-Flynn-1987" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.04" MODIFIED="2011-06-09 19:34:02 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment</NAME>
<CONT_DATA CI_END="0.5227478614749823" CI_START="-0.3188444800766697" EFFECT_SIZE="0.10195169069915629" ESTIMABLE="YES" MEAN_1="35.12" MEAN_2="33.0" MODIFIED="2011-06-09 19:34:02 +0200" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="22.3" SD_2="18.9" SE="0.2146958689521912" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.05" MODIFIED="2012-12-20 18:01:26 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>vs AL-TENS at 3W treatment</NAME>
<CONT_DATA CI_END="0.843643013854897" CI_START="-0.4491931100885961" EFFECT_SIZE="0.19722495188315048" ESTIMABLE="YES" MEAN_1="6.85" MEAN_2="6.55" MODIFIED="2012-12-20 18:01:26 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="1.55" SD_2="1.42" SE="0.32981119401714" STUDY_ID="STD-Sahin-2011" TOTAL_1="19" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.06" MODIFIED="2012-12-20 18:04:15 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>vs Burst TENS at 3W treatment</NAME>
<CONT_DATA CI_END="1.0344488584828468" CI_START="-0.2508837466817021" EFFECT_SIZE="0.3917825559005724" ESTIMABLE="YES" MEAN_1="6.85" MEAN_2="6.1" MODIFIED="2012-12-20 18:04:15 +0100" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="1.55" SD_2="2.15" SE="0.3278969958894879" STUDY_ID="STD-Sahin-2011" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2013-01-17 17:55:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.33810868310304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="35" TOTAL_2="36" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain at IT (5 month) follow-up</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.01" MODIFIED="2013-01-17 17:55:42 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment + 5 month follow-up</NAME>
<CONT_DATA CI_END="0.5800616611978326" CI_START="-0.351255734212265" EFFECT_SIZE="0.11440296349278384" ESTIMABLE="YES" MEAN_1="43.0" MEAN_2="40.06" MODIFIED="2011-06-09 19:37:28 +0200" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="26.8" SD_2="24.0" SE="0.2375853339031254" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2013-01-17 17:55:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.33810868310304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="42" TOTAL_2="45" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>function at post treatment</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.01" MODIFIED="2013-01-17 17:55:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment</NAME>
<CONT_DATA CI_END="0.539186028155299" CI_START="-0.302604049674123" EFFECT_SIZE="0.118290989240588" ESTIMABLE="YES" MEAN_1="23.9" MEAN_2="22.23" MODIFIED="2011-06-09 19:53:40 +0200" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="14.7" SD_2="13.3" SE="0.21474631280711143" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2013-01-17 17:55:51 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.552432908182226" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="35" TOTAL_2="36" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>function at IT (5 month) follow-up</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.04.01" MODIFIED="2013-01-17 17:55:51 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment + 6 month follow-up</NAME>
<CONT_DATA CI_END="0.3990135672221855" CI_START="-0.531769658894317" EFFECT_SIZE="-0.0663780458360658" ESTIMABLE="YES" MEAN_1="25.72" MEAN_2="26.67" MODIFIED="2011-06-09 19:57:06 +0200" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="13.9" SD_2="14.4" SE="0.2374490637221913" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.05" MODIFIED="2013-01-17 17:55:57 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.59645083531858" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="42" TOTAL_2="45" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>QoL at post treatment</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.05.01" MODIFIED="2013-01-17 17:55:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment</NAME>
<CONT_DATA CI_END="0.6145086924863045" CI_START="-0.22855763161263018" EFFECT_SIZE="0.19297553043683716" ESTIMABLE="YES" MEAN_1="-45.6" MEAN_2="-47.4" MODIFIED="2011-06-09 20:02:28 +0200" MODIFIED_BY="[Empty name]" ORDER="195" SD_1="9.7" SD_2="8.8" SE="0.21507189181763905" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="42" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.06" MODIFIED="2013-01-17 17:56:04 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.173376197852419" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="35" TOTAL_2="36" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>QoL at IT (5 month) follow-up</NAME>
<GROUP_LABEL_1>favour TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>favour comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.06.01" MODIFIED="2013-01-17 17:56:04 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>vs Manual Therapy - at 4w treatment + 6 month follow-up</NAME>
<CONT_DATA CI_END="0.6848753521371861" CI_START="-0.24856193792206926" EFFECT_SIZE="0.2181567071075584" ESTIMABLE="YES" MEAN_1="-45.4" MEAN_2="-47.54" MODIFIED="2011-06-09 20:16:23 +0200" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="10.1" SD_2="9.3" SE="0.23812613329175678" STUDY_ID="STD-Escortell_x002d_Mayor-2011" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-08-16 12:32:59 +0200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>EMS versus placebo</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2013-01-11 23:02:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.053620246695907" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="22" TOTAL_2="18" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>EMS</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours EMS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>at 1 session</NAME>
<CONT_DATA CI_END="0.26542564445149347" CI_START="-0.9916325017907668" EFFECT_SIZE="-0.3631034286696367" ESTIMABLE="YES" MEAN_1="-15.8" MEAN_2="-6.1" ORDER="24" SD_1="34.1" SD_2="9.8" SE="0.32068399117478036" STUDY_ID="STD-Hsueh-1997" TOTAL_1="22" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2008-12-09 22:30:13 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.008858689777396" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="18" TOTAL_2="22" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pressure pain threshold at post treatment</NAME>
<GROUP_LABEL_1>placebo</GROUP_LABEL_1>
<GROUP_LABEL_2>EMS</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours EMS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>at 1 session</NAME>
<CONT_DATA CI_END="0.1041303452166813" CI_START="-1.1655603711746672" EFFECT_SIZE="-0.5307150129789929" ESTIMABLE="YES" MEAN_1="-1.9" MEAN_2="13.6" ORDER="25" SD_1="23.3" SD_2="32.3" SE="0.32390664481758513" STUDY_ID="STD-Hsueh-1997" TOTAL_1="18" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2013-08-16 12:33:08 +0200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>EMS + another intervention versus that same intervention</NAME>
<CONT_OUTCOME CHI2="2.648464878283847" CI_END="0.3315322463028141" CI_START="-0.1482574113194316" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09163741749169126" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2013-02-21 20:11:21 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.44905636112846326" P_Q="0.44905636112846326" P_Z="0.4540461426659267" Q="2.648464878283847" RANDOM="YES" SCALE="4.34" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="100.0" Z="0.7486865757385102">
<NAME>pain intensity at IT (6month) follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5451630899715707" CI_START="-0.3990774702299358" DF="0" EFFECT_SIZE="0.07304280987081746" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.01" MODIFIED="2008-12-09 22:07:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.761714194289119" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.818824207346903" Z="0.3032305171170735">
<NAME>EMS + Manip vs Manip: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.5451630899715707" CI_START="-0.3990774702299358" EFFECT_SIZE="0.07304280987081746" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="2.66" ORDER="26" SD_1="2.41" SD_2="2.72" SE="0.2408821201944412" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.818824207346903"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3910464974120855" CI_START="-0.5532718497688851" DF="0" EFFECT_SIZE="-0.08111267617839978" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.02" MODIFIED="2008-12-09 22:07:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7363399818440468" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.814570799296423" Z="0.3367040881370418">
<NAME>EMS + Mobs vs Mobs: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.3910464974120855" CI_START="-0.5532718497688851" EFFECT_SIZE="-0.08111267617839978" ESTIMABLE="YES" MEAN_1="2.15" MEAN_2="2.31" ORDER="75" SD_1="1.93" SD_2="1.97" SE="0.24090196417628926" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.814570799296423"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4461413389233736" CI_START="-0.5358914733419043" DF="0" EFFECT_SIZE="-0.044875067209265394" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.03" MODIFIED="2008-12-09 22:07:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8578392297096843" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="34" WEIGHT="23.869854196841814" Z="0.17912541095463014">
<NAME>EMS + heat + manip vs Heat + manip: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.4461413389233736" CI_START="-0.5358914733419043" EFFECT_SIZE="-0.044875067209265394" ESTIMABLE="YES" MEAN_1="1.73" MEAN_2="1.82" ORDER="76" SD_1="2.15" SD_2="1.82" SE="0.25052317797965357" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="23.869854196841814"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9109907476727233" CI_START="-0.05839502168967731" DF="0" EFFECT_SIZE="0.42629786299152295" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.04" MODIFIED="2008-12-09 22:07:39 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.08473841686915706" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="24.496750796514863" Z="1.7238306658851248">
<NAME>EMS + heat + mobs vs Heat + mobs: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.9109907476727231" CI_START="-0.05839502168967725" EFFECT_SIZE="0.42629786299152295" ESTIMABLE="YES" MEAN_1="3.33" MEAN_2="2.18" ORDER="77" SD_1="2.89" SD_2="2.43" SE="0.24729683223997778" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="24.496750796514863"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2013-01-11 23:04:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.133101347707424" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>function at IT (6 months) follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.01" MODIFIED="2008-12-09 22:07:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0" Z="0.0">
<NAME>EMS + manip vs Manip: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.5540093261444436" CI_START="-0.3903164972507855" EFFECT_SIZE="0.08184641444682905" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="7.46" ORDER="30" SD_1="6.38" SD_2="6.66" SE="0.24090387140885003" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.02" MODIFIED="2008-12-09 22:07:55 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0" Z="0.0">
<NAME>EMS + mobs vs Mobs: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.3004661174759503" CI_START="-0.6452984888950639" EFFECT_SIZE="-0.17241618570955683" ESTIMABLE="YES" MEAN_1="5.85" MEAN_2="6.97" ORDER="78" SD_1="4.86" SD_2="7.64" SE="0.24127091462676986" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.03" MODIFIED="2008-12-09 22:08:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>EMS + heat + manip vs Heat + manip: at ?6w treatment</NAME>
<CONT_DATA CI_END="0.6586760955591835" CI_START="-0.3250366287830957" EFFECT_SIZE="0.16681973338804387" ESTIMABLE="YES" MEAN_1="6.4" MEAN_2="5.47" ORDER="79" SD_1="6.92" SD_2="3.86" SE="0.2509517348537217" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.04" MODIFIED="2008-12-09 22:05:28 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>EMS + heat + mobs vs Heat + mobs: ?6w treatment</NAME>
<CONT_DATA CI_END="0.7667056491425961" CI_START="-0.19634996170432323" EFFECT_SIZE="0.2851778437191364" ESTIMABLE="YES" MEAN_1="8.52" MEAN_2="6.44" ORDER="80" SD_1="8.08" SD_2="6.25" SE="0.24568196621044544" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.03" MODIFIED="2013-01-11 23:05:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.33810868310304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>patient satisfaction at post treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.01" MODIFIED="2008-12-09 22:08:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0" Z="0.0">
<NAME>EMS + manip vs Manip: at 4w treatment</NAME>
<CONT_DATA CI_END="0.34713683221225544" CI_START="-0.5977517523231493" EFFECT_SIZE="-0.1253074600554469" ESTIMABLE="YES" MEAN_1="38.0" MEAN_2="38.78" ORDER="34" SD_1="6.32" SD_2="5.99" SE="0.24104743556222594" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.02" MODIFIED="2008-12-09 22:08:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0" Z="0.0">
<NAME>EMS + mobs vs Mobs: at 4w treatment</NAME>
<CONT_DATA CI_END="0.353822819148584" CI_START="-0.5909630856770729" EFFECT_SIZE="-0.11857013326424444" ESTIMABLE="YES" MEAN_1="37.27" MEAN_2="38.08" ORDER="85" SD_1="7.36" SD_2="6.11" SE="0.24102124127739272" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.03" MODIFIED="2008-12-09 22:08:34 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>EMS + heat + manip vs Heat + manip: at 4w treatment</NAME>
<CONT_DATA CI_END="0.892472007087769" CI_START="-0.09961385090626429" EFFECT_SIZE="0.39642907809075234" ESTIMABLE="YES" MEAN_1="38.87" MEAN_2="36.49" ORDER="86" SD_1="5.25" SD_2="6.47" SE="0.2530877775865985" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.04" MODIFIED="2008-12-09 22:08:43 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>EMS + heat + mobs vs Heat + mobs: at 4w treatment</NAME>
<CONT_DATA CI_END="0.4312797852973797" CI_START="-0.5267626960930004" EFFECT_SIZE="-0.04774145539781035" ESTIMABLE="YES" MEAN_1="38.08" MEAN_2="38.38" ORDER="87" SD_1="6.01" SD_2="6.4" SE="0.2444030831554296" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.648464878283847" CI_END="0.3315322463028141" CI_START="-0.14825741131943157" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09163741749169124" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.04" MODIFIED="2013-07-04 22:00:37 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.44905636112846326" P_Q="1.0" P_Z="0.4540461426659267" Q="0.0" RANDOM="YES" SCALE="4.42" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="99.99999999999999" Z="0.7486865757385102">
<NAME>pain intensity at IT (6month) follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.648464878283847" CI_END="0.3315322463028141" CI_START="-0.14825741131943157" DF="3" EFFECT_SIZE="0.09163741749169124" ESTIMABLE="YES" I2="0.0" ID="CMP-008.04.01" MODIFIED="2009-05-29 14:19:11 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.44905636112846326" P_Z="0.4540461426659267" STUDIES="1" TAU2="0.0" TOTAL_1="131" TOTAL_2="138" WEIGHT="99.99999999999999" Z="0.7486865757385102">
<NAME>at 6w treatment</NAME>
<CONT_DATA CI_END="0.4461413389233736" CI_START="-0.5358914733419043" EFFECT_SIZE="-0.044875067209265394" ESTIMABLE="YES" MEAN_1="1.73" MEAN_2="1.82" MODIFIED="2009-05-29 08:26:18 +0200" MODIFIED_BY="[Empty name]" ORDER="60" SD_1="2.15" SD_2="1.82" SE="0.25052317797965357" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="23.86985419684181">
<FOOTNOTE>EMS + heat + manipulation vs Heat + manipulation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.5451630899715707" CI_START="-0.3990774702299358" EFFECT_SIZE="0.07304280987081746" ESTIMABLE="YES" MEAN_1="2.85" MEAN_2="2.66" MODIFIED="2009-05-29 08:27:07 +0200" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="2.41" SD_2="2.72" SE="0.2408821201944412" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.8188242073469">
<FOOTNOTE>EMS + Manipulation vs Manipulation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.3910464974120855" CI_START="-0.5532718497688851" EFFECT_SIZE="-0.08111267617839978" ESTIMABLE="YES" MEAN_1="2.15" MEAN_2="2.31" MODIFIED="2009-05-29 08:29:02 +0200" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="1.93" SD_2="1.97" SE="0.24090196417628926" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.81457079929642">
<FOOTNOTE>EMS + Mobs vs Mobs</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.9109907476727231" CI_START="-0.05839502168967725" EFFECT_SIZE="0.42629786299152295" ESTIMABLE="YES" MEAN_1="3.33" MEAN_2="2.18" MODIFIED="2009-05-29 14:02:38 +0200" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="2.89" SD_2="2.43" SE="0.24729683223997778" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="24.49675079651486">
<FOOTNOTE>EMS + heat + mobilization vs Heat + mobilization</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.908368946357423" CI_END="0.3267876978759491" CI_START="-0.15262317643597575" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08708226071998665" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.05" MODIFIED="2013-07-29 12:04:47 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5916413557746396" P_Q="1.0" P_Z="0.47644457084908576" Q="0.0" RANDOM="YES" SCALE="4.17" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="100.0" Z="0.7120326377596957">
<NAME>function at IT (6 months) follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.908368946357423" CI_END="0.3267876978759491" CI_START="-0.15262317643597575" DF="3" EFFECT_SIZE="0.08708226071998665" ESTIMABLE="YES" I2="0.0" ID="CMP-008.05.01" MODIFIED="2009-05-29 14:18:59 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5916413557746396" P_Z="0.47644457084908576" STUDIES="1" TAU2="0.0" TOTAL_1="131" TOTAL_2="138" WEIGHT="100.0" Z="0.7120326377596957">
<NAME>at 6w treatment</NAME>
<CONT_DATA CI_END="0.6586760955591835" CI_START="-0.3250366287830957" EFFECT_SIZE="0.16681973338804387" ESTIMABLE="YES" MEAN_1="6.4" MEAN_2="5.47" MODIFIED="2009-05-29 14:10:31 +0200" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="6.92" SD_2="3.86" SE="0.2509517348537217" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="23.750851454964245">
<FOOTNOTE>EMS + heat + manipulation vs Manipulation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.5540093261444436" CI_START="-0.3903164972507855" EFFECT_SIZE="0.08184641444682905" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="7.46" MODIFIED="2009-05-29 14:08:23 +0200" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="6.38" SD_2="6.66" SE="0.24090387140885003" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.773418724421038">
<FOOTNOTE>EMS + manipulation vs Manipulation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.7667056491425961" CI_START="-0.19634996170432323" EFFECT_SIZE="0.2851778437191364" ESTIMABLE="YES" MEAN_1="8.52" MEAN_2="6.44" MODIFIED="2009-05-29 14:10:41 +0200" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="8.08" SD_2="6.25" SE="0.24568196621044544" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="24.780669176662457">
<FOOTNOTE>EMS + heat + mobilization vs Mobilization</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.3004661174759503" CI_START="-0.6452984888950639" EFFECT_SIZE="-0.17241618570955683" ESTIMABLE="YES" MEAN_1="5.85" MEAN_2="6.97" MODIFIED="2009-05-29 14:10:21 +0200" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="4.86" SD_2="7.64" SE="0.24127091462676986" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.695060643952264">
<FOOTNOTE>EMS + mobilization vs Mobilization</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.982645102818476" CI_END="0.25769665875770953" CI_START="-0.2219940309439757" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.017851313906866912" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.06" MODIFIED="2013-07-04 22:20:29 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.39430889196525853" P_Q="1.0" P_Z="0.8840184460516916" Q="0.0" RANDOM="YES" SCALE="4.51" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="131" TOTAL_2="138" UNITS="" WEIGHT="100.0" Z="0.14587705404887802">
<NAME>patient satisfaction at post treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.982645102818476" CI_END="0.25769665875770953" CI_START="-0.2219940309439757" DF="3" EFFECT_SIZE="0.017851313906866912" ESTIMABLE="YES" I2="0.0" ID="CMP-008.06.01" MODIFIED="2009-05-29 14:18:50 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39430889196525853" P_Z="0.8840184460516916" STUDIES="1" TAU2="0.0" TOTAL_1="131" TOTAL_2="138" WEIGHT="100.0" Z="0.14587705404887802">
<NAME>at 6w treatment</NAME>
<CONT_DATA CI_END="0.353822819148584" CI_START="-0.5909630856770729" EFFECT_SIZE="-0.11857013326424444" ESTIMABLE="YES" MEAN_1="37.27" MEAN_2="38.08" MODIFIED="2009-05-29 14:17:09 +0200" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="7.36" SD_2="6.11" SE="0.24102124127739272" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.778388691407816">
<FOOTNOTE>EMS + mobilization vs Mobilization</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.34713683221225544" CI_START="-0.5977517523231493" EFFECT_SIZE="-0.1253074600554469" ESTIMABLE="YES" MEAN_1="38.0" MEAN_2="38.78" MODIFIED="2009-05-29 14:14:17 +0200" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="6.32" SD_2="5.99" SE="0.24104743556222594" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="34" TOTAL_2="35" WEIGHT="25.77278639354218">
<FOOTNOTE>EMS + manipulation vs Manipulation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.4312797852973797" CI_START="-0.5267626960930004" EFFECT_SIZE="-0.04774145539781035" ESTIMABLE="YES" MEAN_1="38.08" MEAN_2="38.38" MODIFIED="2009-05-29 14:17:19 +0200" MODIFIED_BY="[Empty name]" ORDER="74" SD_1="6.01" SD_2="6.4" SE="0.2444030831554296" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="33" TOTAL_2="34" WEIGHT="25.069925583547334">
<FOOTNOTE>EMS + heat + mobilization vs Heat + mobilization</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.892472007087769" CI_START="-0.09961385090626429" EFFECT_SIZE="0.39642907809075234" ESTIMABLE="YES" MEAN_1="38.87" MEAN_2="36.49" MODIFIED="2009-05-29 14:17:14 +0200" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="5.25" SD_2="6.47" SE="0.2530877775865985" STUDY_ID="STD-Hurwitz-2002" TOTAL_1="30" TOTAL_2="34" WEIGHT="23.378899331502666">
<FOOTNOTE>EMS + heat + manipulation vs Heat + manipulation</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2013-08-16 12:33:38 +0200" MODIFIED_BY="[Empty name]" NO="9">
<NAME>EMS (inferential current) versus no treatment</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-11 23:08:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.73403615012859" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>neck pain at post treatment</NAME>
<GROUP_LABEL_1>Interference</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours interference</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="9" I2="0.0" ID="CMP-009.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-12-09 21:56:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>at 5w treatment</NAME>
<DICH_DATA CI_END="3.240847726742291" CI_START="0.17911945119268866" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.5106586259136806" LOG_CI_START="-0.7468572500696697" LOG_EFFECT_SIZE="-0.11809931207799451" ORDER="39" O_E="0.0" SE="0.7386710503565985" STUDY_ID="STD-Fialka-1989" TOTAL_1="15" TOTAL_2="15" VAR="0.5456349206349206" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-12-09 21:56:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>headache at post treatment</NAME>
<GROUP_LABEL_1>Interference</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Interference</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="7" I2="0.0" ID="CMP-009.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-12-09 21:56:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>at 5w treatment</NAME>
<DICH_DATA CI_END="6.534537131925603" CI_START="0.28782701644490793" EFFECT_SIZE="1.3714285714285714" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.8152148301461019" LOG_CI_START="-0.5408684440954786" LOG_EFFECT_SIZE="0.13717319302531158" ORDER="40" O_E="0.0" SE="0.7965700280099732" STUDY_ID="STD-Fialka-1989" TOTAL_1="13" TOTAL_2="13" VAR="0.6345238095238095" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2013-08-16 12:33:57 +0200" MODIFIED_BY="[Empty name]" NO="10">
<NAME>PEMF (low frequency) versus sham</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.01" MODIFIED="2013-01-11 23:09:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.422698220684536" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="58" TOTAL_2="54" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PEMF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sham control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.01" MODIFIED="2008-12-24 11:17:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>30 sessions over 3 weeks treatment</NAME>
<CONT_DATA CI_END="-2.08916414283192" CI_START="-4.252819524508688" EFFECT_SIZE="-3.170991833670304" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="7.1" ORDER="41" SD_1="1.4" SD_2="1.43" SE="0.5519630459394675" STUDY_ID="STD-Sutbeyaz--2006" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.02" MODIFIED="2008-12-23 22:59:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks</NAME>
<CONT_DATA CI_END="0.002616632960808496" CI_START="-0.8853297621602482" EFFECT_SIZE="-0.44135656459971984" ESTIMABLE="YES" MEAN_1="-27.85" MEAN_2="-16.31" MODIFIED="2008-12-23 22:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="27.34" SD_2="24.28" SE="0.22652109990924948" STUDY_ID="STD-Trock-1994" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.02" MODIFIED="2013-01-11 23:10:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="3.9755440046649144" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="38" TOTAL_2="32" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at ST follow-up</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.02.01" MODIFIED="2008-12-23 23:00:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks treatment + 4 week follow-up</NAME>
<CONT_DATA CI_END="0.10304233206524738" CI_START="-0.8459538387130472" EFFECT_SIZE="-0.3714557533238999" ESTIMABLE="YES" MEAN_1="-25.87" MEAN_2="-14.66" MODIFIED="2008-12-23 23:00:29 +0100" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="30.22" SD_2="29.39" SE="0.24209530845052646" STUDY_ID="STD-Trock-1994" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.03" MODIFIED="2013-01-11 23:10:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.822486969999522" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="58" TOTAL_2="54" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>function at post treatment</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PEMF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sham control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.03.01" MODIFIED="2008-12-24 11:16:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>30 sessions over 3 weeks treatment</NAME>
<CONT_DATA CI_END="-2.3963867997950636" CI_START="-4.718811100599654" EFFECT_SIZE="-3.5575989501973586" ESTIMABLE="YES" MEAN_1="32.5" MEAN_2="65.6" ORDER="88" SD_1="7.6" SD_2="10.5" SE="0.592466065479666" STUDY_ID="STD-Sutbeyaz--2006" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.03.02" MODIFIED="2008-12-23 23:01:52 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks</NAME>
<CONT_DATA CI_END="0.32988641440971866" CI_START="-0.5475924327074521" EFFECT_SIZE="-0.10885300914886668" ESTIMABLE="YES" MEAN_1="-3.79" MEAN_2="-3.1" MODIFIED="2008-12-23 23:01:52 +0100" MODIFIED_BY="[Empty name]" ORDER="89" SD_1="6.7" SD_2="5.8" SE="0.22385075798295578" STUDY_ID="STD-Trock-1994" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.04" MODIFIED="2012-01-11 18:30:26 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.1562094371122935" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="38" TOTAL_2="32" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>function at ST follow-up</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.04.01" MODIFIED="2008-12-23 23:02:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks treatment + 4 week follow-up</NAME>
<CONT_DATA CI_END="0.2263203581123785" CI_START="-0.7179110070223764" EFFECT_SIZE="-0.24579532445499896" ESTIMABLE="YES" MEAN_1="-3.78" MEAN_2="-2.14" MODIFIED="2008-12-23 23:02:23 +0100" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="7.35" SD_2="5.57" SE="0.24087977447104422" STUDY_ID="STD-Trock-1994" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.05" MODIFIED="2013-01-11 23:11:27 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.685665950040361" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="58" TOTAL_2="54" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>global percieved effect at post treatment</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PEMF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sham control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.05.01" MODIFIED="2008-12-24 11:17:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>30 sessions over 3 weeks treatment</NAME>
<CONT_DATA CI_END="-2.08916414283192" CI_START="-4.252819524508688" EFFECT_SIZE="-3.170991833670304" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="7.1" ORDER="91" SD_1="1.4" SD_2="1.43" SE="0.5519630459394675" STUDY_ID="STD-Sutbeyaz--2006" TOTAL_1="17" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.05.02" MODIFIED="2008-12-23 23:03:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks</NAME>
<CONT_DATA CI_END="0.5405687773172947" CI_START="-0.3368253905713858" EFFECT_SIZE="0.10187169337295444" ESTIMABLE="YES" MEAN_1="-42.71" MEAN_2="-46.18" MODIFIED="2008-12-23 23:03:40 +0100" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="35.55" SD_2="31.71" SE="0.2238291557420069" STUDY_ID="STD-Trock-1994" TOTAL_1="41" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.06" MODIFIED="2009-01-23 20:16:34 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.51" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="38" TOTAL_2="32" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>global percieved effect at ST follow-up</NAME>
<GROUP_LABEL_1>PEMF</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.06.01" MODIFIED="2008-12-02 23:42:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0" Z="0.0">
<NAME>18 sessions over 4 to 6 weeks treatment + 4 week follow-up</NAME>
<CONT_DATA CI_END="0.5043273733292787" CI_START="-0.4362475572419001" EFFECT_SIZE="0.03403990804368927" ESTIMABLE="YES" MEAN_1="41.18" MEAN_2="40.0" ORDER="93" SD_1="35.88" SD_2="32.27" SE="0.23994699341169373" STUDY_ID="STD-Trock-1994" TOTAL_1="38" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2013-08-16 12:34:22 +0200" MODIFIED_BY="[Empty name]" NO="11">
<NAME>PEMF (low frequency) versus comparison</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.01" MODIFIED="2008-12-09 22:13:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="44" TOTAL_2="48" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>neck pain at post treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PEMF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.01.01" MODIFIED="2008-12-09 22:13:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>2w treatment</NAME>
<CONT_DATA CI_END="-2.2725938992238692" CI_START="-3.4487394998801078" EFFECT_SIZE="-2.8606666995519885" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="4.6" ORDER="52" SD_1="1.2" SD_2="0.6" SE="0.30004265637877137" STUDY_ID="STD-Thuile-2002" TOTAL_1="44" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2013-08-16 12:35:22 +0200" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Repetitive magnetic stimulation (rMS) versus placebo ultrasound</NAME>
<CONT_OUTCOME CHI2="0.04087458927921133" CI_END="-0.24411668113836227" CI_START="-1.3725905046610403" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.8083535928997012" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.01" MODIFIED="2012-01-11 18:30:36 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8397802931953352" P_Q="1.0" P_Z="0.004985936867331375" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="26" TOTAL_2="27" UNITS="" WEIGHT="100.0" Z="2.8079409479100397">
<NAME>pain/function at post treatment</NAME>
<GROUP_LABEL_1>rep. Magn. Stim.</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham US</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours rMS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sham US</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.04087458927921133" CI_END="-0.24411668113836227" CI_START="-1.3725905046610403" DF="1" EFFECT_SIZE="-0.8083535928997012" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.01" MODIFIED="2008-12-09 22:22:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8397802931953352" P_Z="0.004985936867331375" STUDIES="2" TAU2="0.0" TOTAL_1="26" TOTAL_2="27" WEIGHT="100.0" Z="2.8079409479100397">
<NAME>post 2w treatment</NAME>
<CONT_DATA CI_END="0.08976796622034211" CI_START="-1.8720047135112143" EFFECT_SIZE="-0.8911183736454361" ESTIMABLE="YES" MEAN_1="30.0" MEAN_2="45.0" ORDER="64" SD_1="17.0" SD_2="15.0" SE="0.5004614103130897" STUDY_ID="STD-Smania-2003" TOTAL_1="9" TOTAL_2="9" WEIGHT="33.08915027894829"/>
<CONT_DATA CI_END="-0.07764009609059608" CI_START="-1.4572084291383014" EFFECT_SIZE="-0.7674242626144487" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="39.0" ORDER="81" SD_1="15.0" SD_2="13.0" SE="0.351937164134026" STUDY_ID="STD-Smania-2005" TOTAL_1="17" TOTAL_2="18" WEIGHT="66.9108497210517"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.9177228332942242" CI_END="-0.741326138414562" CI_START="-1.692893934228504" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.217110036321533" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.02" MODIFIED="2009-08-04 23:31:54 +0200" MODIFIED_BY="VEP  " NO="2" P_CHI2="0.6320028563542177" P_Q="0.4905286104025258" P_Z="5.336164917568756E-7" Q="0.47536663126789247" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="41" TOTAL_2="42" UNITS="" WEIGHT="200.0" Z="5.01381372279831">
<NAME>pain/function at ST follow-up</NAME>
<GROUP_LABEL_1>rep. Magn. Stim.</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham US</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours rMS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sham US</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.4423562020263315" CI_END="-0.7426687349628585" CI_START="-1.9568412112312166" DF="1" EFFECT_SIZE="-1.3497549730970375" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.01" MODIFIED="2009-01-23 20:19:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5059874282393406" P_Z="1.314646254062156E-5" STUDIES="2" TAU2="0.0" TOTAL_1="26" TOTAL_2="27" WEIGHT="100.0" Z="4.35765294788204">
<NAME>follow-up 1 month after treatment</NAME>
<CONT_DATA CI_END="-0.07138431304430704" CI_START="-2.083607782000409" EFFECT_SIZE="-1.077496047522358" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="40.0" ORDER="92" SD_1="15.0" SD_2="20.0" SE="0.5133317461005059" STUDY_ID="STD-Smania-2003" TOTAL_1="9" TOTAL_2="9" WEIGHT="36.408966190264444"/>
<CONT_DATA CI_END="-0.7443424102242483" CI_START="-2.2669305447582966" EFFECT_SIZE="-1.5056364774912725" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="40.0" ORDER="93" SD_1="12.0" SD_2="15.0" SE="0.38842247779653843" STUDY_ID="STD-Smania-2005" TOTAL_1="17" TOTAL_2="18" WEIGHT="63.59103380973555"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.23991365433742784" CI_START="-1.7719381244172312" DF="0" EFFECT_SIZE="-1.0059258893773295" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.02" MODIFIED="2009-01-23 20:19:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.010058224331484207" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0" Z="2.573821179492373">
<NAME>follow-up 3 month after treatment</NAME>
<CONT_DATA CI_END="-0.23991365433742784" CI_START="-1.7719381244172312" EFFECT_SIZE="-1.0059258893773295" ESTIMABLE="YES" MEAN_1="26.0" MEAN_2="41.0" ORDER="94" SD_1="14.0" SD_2="15.0" SE="0.3908297504862887" STUDY_ID="STD-Smania-2005" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.03" MODIFIED="2012-01-11 18:31:12 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="44" TOTAL_2="48" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>headache at post treatment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PEMF</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.03.01" MODIFIED="2012-01-11 18:30:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>2w treatment</NAME>
<CONT_DATA CI_END="-1.7375513587531524" CI_START="-2.7946063388028337" EFFECT_SIZE="-2.266078848777993" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="3.5" MODIFIED="2012-01-11 18:30:32 +0100" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="0.5" SD_2="0.7" SE="0.2696618377652844" STUDY_ID="STD-Thuile-2002" TOTAL_1="44" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2013-08-16 12:35:53 +0200" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Static magnetic field (necklace) versus placebo</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.01" MODIFIED="2013-01-11 23:13:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.59645083531858" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="27" TOTAL_2="25" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>pain intensity at post treatment</NAME>
<GROUP_LABEL_1>magnetic necklace</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours mag necklace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>at 3w treatment</NAME>
<CONT_DATA CI_END="0.8191101262373963" CI_START="-0.27432471451380563" EFFECT_SIZE="0.27239270586179537" ESTIMABLE="YES" MEAN_1="2.74" MEAN_2="2.56" ORDER="70" SD_1="0.71" SD_2="0.58" SE="0.2789425850107646" STUDY_ID="STD-Hong-1982" TOTAL_1="27" TOTAL_2="25" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-013.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-12-09 22:27:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.186591836653186" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="25" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>global perceived effect at post treatment</NAME>
<GROUP_LABEL_1>placebo</GROUP_LABEL_1>
<GROUP_LABEL_2>magnetic necklace</GROUP_LABEL_2>
<GRAPH_LABEL_1>favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>favours mag necklace</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="14" I2="0.0" ID="CMP-013.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>at 3w treatment</NAME>
<DICH_DATA CI_END="1.504155141616967" CI_START="0.4787228720394333" EFFECT_SIZE="0.8485714285714285" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" LOG_CI_END="0.17729263258097908" LOG_CI_START="-0.3199158226471057" LOG_EFFECT_SIZE="-0.07131159503306331" ORDER="71" O_E="0.0" SE="0.29206270782252447" STUDY_ID="STD-Hong-1982" TOTAL_1="25" TOTAL_2="27" VAR="0.0853006253006253" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-08-23 00:01:06 +0200" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-08-20 23:07:14 +0200" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-08-23 00:01:06 +0200" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-08-16 12:37:06 +0200" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-004.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 TENS versus placebo or sham, outcome: 4.1 pain intensity at post-treatment.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-08-16 12:37:55 +0200" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-008.04" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 EMS + another intervention versus that same intervention, outcome: 8.4 pain intensity at IT (6-month) follow-up.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-08-16 12:38:27 +0200" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-008.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 EMS + another intervention versus that same intervention, outcome: 8.5 function at IT (6-month) follow-up.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2013-08-16 12:38:43 +0200" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-008.06" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 EMS + another intervention versus that same intervention, outcome: 8.6 patient satisfaction at post-treatment.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2013-08-16 12:39:30 +0200" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-012.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 12 Repetitive magnetic stimulation (rMS) versus placebo ultrasound, outcome: 12.2 pain and function at ST follow-up.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2013-08-16 12:40:01 +0200" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-013.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 13 Static magnetic field (necklace) versus placebo, outcome: 13.1 pain intensity at post-treatment.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-08-16 12:43:48 +0200" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2011-11-17 16:35:32 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-06-17 21:02:02 +0200" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2011-11-17 16:35:32 +0100" MODIFIED_BY="[Empty name]">
<P>Physical Medicine-COG_NeckPain_</P>
<P>July 11 2010</P>
<P>1. Neck Pain/</P>
<P>2. exp Brachial Plexus Neuropathies/</P>
<P>3. exp neck injuries/ or exp whiplash injuries/</P>
<P>4. cervical pain.mp.</P>
<P>5. neckache.mp.</P>
<P>6. whiplash.mp.</P>
<P>7. cervicodynia.mp.</P>
<P>8. cervicalgia.mp.</P>
<P>9. brachialgia.mp.</P>
<P>10. brachial neuritis.mp.</P>
<P>11. brachial neuralgia.mp.</P>
<P>12. neck pain.mp.</P>
<P>13. neck injur*.mp.</P>
<P>14. brachial plexus neuropath*.mp.</P>
<P>15. brachial plexus neuritis.mp.</P>
<P>16. thoracic outlet syndrome/ or cervical rib syndrome/</P>
<P>17. Torticollis/</P>
<P>18. exp brachial plexus neuropathies/ or exp brachial plexus neuritis/</P>
<P>19. cervico brachial neuralgia.ti,ab.</P>
<P>20. cervicobrachial neuralgia.ti,ab.</P>
<P>21. (monoradicul* or monoradicl*).tw.</P>
<P>22. or/1-21</P>
<P>23. exp headache/ and cervic*.tw.</P>
<P>24. exp genital diseases, female/</P>
<P>25. genital disease*.mp.</P>
<P>26. or/24-25</P>
<P>27. 23 not 26</P>
<P>28. 22 or 27</P>
<P>29. neck/</P>
<P>30. neck muscles/</P>
<P>31. exp cervical plexus/</P>
<P>32. exp cervical vertebrae/</P>
<P>33. atlanto-axial joint/</P>
<P>34. atlanto-occipital joint/</P>
<P>35. Cervical Atlas/</P>
<P>36. spinal nerve roots/</P>
<P>37. exp brachial plexus/</P>
<P>38. (odontoid* or cervical or occip* or atlant*).tw.</P>
<P>39. axis/ or odontoid process/</P>
<P>40. Thoracic Vertebrae/</P>
<P>41. cervical vertebrae.mp.</P>
<P>42. cervical plexus.mp.</P>
<P>43. cervical spine.mp.</P>
<P>44. (neck adj3 muscles).mp.</P>
<P>45. (brachial adj3 plexus).mp.</P>
<P>46. (thoracic adj3 vertebrae).mp.</P>
<P>47. neck.mp.</P>
<P>48. (thoracic adj3 spine).mp.</P>
<P>49. (thoracic adj3 outlet).mp.</P>
<P>50. trapezius.mp.</P>
<P>51. cervical.mp.</P>
<P>52. cervico*.mp.</P>
<P>53. 51 or 52</P>
<P>54. exp genital diseases, female/</P>
<P>55. genital disease*.mp.</P>
<P>56. exp *Uterus/</P>
<P>57. 54 or 55 or 56</P>
<P>58. 53 not 57</P>
<P>59. 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 58</P>
<P>60. exp pain/</P>
<P>61. exp injuries/</P>
<P>62. pain.mp.</P>
<P>63. ache.mp.</P>
<P>64. sore.mp.</P>
<P>65. stiff.mp.</P>
<P>66. discomfort.mp.</P>
<P>67. injur*.mp.</P>
<P>68. neuropath*.mp.</P>
<P>69. or/60-68</P>
<P>70. 59 and 69</P>
<P>71. Radiculopathy/</P>
<P>72. exp temporomandibular joint disorders/ or exp temporomandibular joint dysfunction syndrome/</P>
<P>73. myofascial pain syndromes/</P>
<P>74. exp "Sprains and Strains"/</P>
<P>75. exp Spinal Osteophytosis/</P>
<P>76. exp Neuritis/</P>
<P>77. Polyradiculopathy/</P>
<P>78. exp Arthritis/</P>
<P>79. Fibromyalgia/</P>
<P>80. spondylitis/ or discitis/</P>
<P>81. spondylosis/ or spondylolysis/ or spondylolisthesis/</P>
<P>82. radiculopathy.mp.</P>
<P>83. radiculitis.mp.</P>
<P>84. temporomandibular.mp.</P>
<P>85. myofascial pain syndrome*.mp.</P>
<P>86. thoracic outlet syndrome*.mp.</P>
<P>87. spinal osteophytosis.mp.</P>
<P>88. neuritis.mp.</P>
<P>89. spondylosis.mp.</P>
<P>90. spondylitis.mp.</P>
<P>91. spondylolisthesis.mp.</P>
<P>92. or/71-91</P>
<P>93. 59 and 92</P>
<P>94. exp neck/</P>
<P>95. exp cervical vertebrae/</P>
<P>96. Thoracic Vertebrae/</P>
<P>97. neck.mp.</P>
<P>98. (thoracic adj3 vertebrae).mp.</P>
<P>99. cervical.mp.</P>
<P>100. cervico*.mp.</P>
<P>101. 99 or 100</P>
<P>102. exp genital diseases, female/</P>
<P>103. genital disease*.mp.</P>
<P>104. exp *Uterus/</P>
<P>105. or/102-104</P>
<P>106. 101 not 105</P>
<P>107. (thoracic adj3 spine).mp.</P>
<P>108. cervical spine.mp.</P>
<P>109. 94 or 95 or 96 or 97 or 98 or 106 or 107 or 108</P>
<P>110. Intervertebral Disk/</P>
<P>111. (disc or discs).mp.</P>
<P>112. (disk or disks).mp.</P>
<P>113. 110 or 111 or 112</P>
<P>114. 109 and 113</P>
<P>115. herniat*.mp.</P>
<P>116. slipped.mp.</P>
<P>117. prolapse*.mp.</P>
<P>118. displace*.mp.</P>
<P>119. degenerat*.mp.</P>
<P>120. (bulge or bulged or bulging).mp.</P>
<P>121. 115 or 116 or 117 or 118 or 119 or 120</P>
<P>122. 114 and 121</P>
<P>123. intervertebral disk degeneration/ or intervertebral disk displacement/</P>
<P>124. intervertebral disk displacement.mp.</P>
<P>125. intervertebral disc displacement.mp.</P>
<P>126. intervertebral disk degeneration.mp.</P>
<P>127. intervertebral disc degeneration.mp.</P>
<P>128. 123 or 124 or 125 or 126 or 127</P>
<P>129. 109 and 128</P>
<P>130. 28 or 70 or 93 or 122 or 129</P>
<P>131. animals/ not (animals/ and humans/)</P>
<P>132. 130 not 131</P>
<P>133. exp *neoplasms/</P>
<P>134. exp *wounds, penetrating/</P>
<P>135. 133 or 134</P>
<P>136. 132 not 135</P>
<P>137. Neck Pain/rh [Rehabilitation]</P>
<P>138. exp Brachial Plexus Neuropathies/rh</P>
<P>139. exp neck injuries/rh or exp whiplash injuries/rh</P>
<P>140. thoracic outlet syndrome/rh or cervical rib syndrome/rh</P>
<P>141. Torticollis/rh</P>
<P>142. exp brachial plexus neuropathies/rh or exp brachial plexus neuritis/rh</P>
<P>143. 137 or 138 or 139 or 140 or 141 or 142</P>
<P>144. Radiculopathy/rh</P>
<P>145. exp temporomandibular joint disorders/rh or exp temporomandibular joint dysfunction syndrome/rh</P>
<P>146. myofascial pain syndromes/rh</P>
<P>147. exp "Sprains and Strains"/rh</P>
<P>148. exp Spinal Osteophytosis/rh</P>
<P>149. exp Neuritis/rh</P>
<P>150. Polyradiculopathy/rh</P>
<P>151. exp Arthritis/rh</P>
<P>152. Fibromyalgia/rh</P>
<P>153. spondylitis/rh or discitis/rh</P>
<P>154. spondylosis/rh or spondylolysis/rh or spondylolisthesis/rh</P>
<P>155. or/144-154</P>
<P>156. 59 and 155</P>
<P>157. exp Combined Modality Therapy/</P>
<P>158. Exercise/</P>
<P>159. Physical Exertion/</P>
<P>160. exp Exercise Therapy/</P>
<P>161. exp Rehabilitation/</P>
<P>162. exp Physical Therapy Modalities/</P>
<P>163. Hydrotherapy/</P>
<P>164. postur* correction.mp.</P>
<P>165. Feldenkrais.mp.</P>
<P>166. (alexander adj (technique or method)).tw.</P>
<P>167. Relaxation Therapy/</P>
<P>168. Biofeedback, Psychology/</P>
<P>169. or/157-168</P>
<P>170. 136 and 169</P>
<P>171. 143 or 156 or 170</P>
<P>172. animals/ not (animals/ and humans/)</P>
<P>173.  171 not 172</P>
<P>174.  exp randomized controlled trials as topic/</P>
<P>175.  randomized controlled trial.pt.</P>
<P>176.  controlled clinical trial.pt.</P>
<P>177.  (random* or sham or placebo*).tw.</P>
<P>178.  placebos/</P>
<P>179.  random allocation/</P>
<P>180.  single blind method/</P>
<P>181.  double blind method/</P>
<P>182.  ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or dumm* or mask*)).ti,ab.</P>
<P>183.  (rct or rcts).tw.</P>
<P>184.  (control* adj2 (study or studies or trial*)).tw.</P>
<P>185.  or/174- 184</P>
<P>186.  173 and 185</P>
<P>187.  limit 186 to yr="2006 -Current"</P>
<P>188.  limit 186 to yr="1902 - 2005"</P>
<P>189.  guidelines as topic/</P>
<P>200.  practice guidelines as topic/</P>
<P>201.  guideline.pt.</P>
<P>202.   practice guideline.pt.</P>
<P>203.  (guideline? or guidance or recommendations).ti.</P>
<P>204.   consensus.ti.</P>
<P>205.   or/189-204</P>
<P>206.   173 and 205</P>
<P>207.   136 and 205</P>
<P>208.   206 or 207</P>
<P>209.   limit 208 to yr="2006 -Current"</P>
<P>210.   limit 208 to yr="1902 - 2005"</P>
<P>211.   meta-analysis/</P>
<P>212.   exp meta-analysis as topic/</P>
<P>213.   (meta analy* or metaanaly* or met analy* or metanaly*).tw.</P>
<P>214.   review literature as topic/</P>
<P>215.   (collaborative research or collaborative review* or collaborative overview*).tw.</P>
<P>216.   (integrative research or integrative review* or intergrative overview*).tw.</P>
<P>217.   (quantitative adj3 (research or review* or overview*)).tw.</P>
<P>218.   (research integration or research overview*).tw.</P>
<P>219.   (systematic* adj3 (review* or overview*)).tw.</P>
<P>220.   (methodologic* adj3 (review* or overview*)).tw.</P>
<P>221.   exp technology assessment biomedical/</P>
<P>222.   (hta or thas or technology assessment*).tw.</P>
<P>223.   ((hand adj2 search*) or (manual* adj search*)).tw.</P>
<P>224.   ((electronic adj database*) or (bibliographic* adj database*)).tw.</P>
<P>225.   ((data adj2 abstract*) or (data adj2 extract*)).tw.</P>
<P>226.   (analys* adj3 (pool or pooled or pooling)).tw.</P>
<P>227.   mantel haenszel.tw.</P>
<P>228.   (cohrane or pubmed or pub med or medline or embase or psycinfo or psyclit or psychinfo or psychlit or cinahl or science citation indes).ab.</P>
<P>229.   or/211-228</P>
<P>230.   173 and 229</P>
<P>231.    limit 230 to yr="2006 -Current"</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-08-16 12:42:00 +0200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-02-01 19:17:09 +0100" MODIFIED_BY="[Empty name]">Criteria for assessing risk of bias for internal validity (Higgins 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-16 12:42:00 +0200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Random sequence generation (selection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Selection bias (biased allocation to interventions) due to inadequate generation of a randomized sequence</HEADING>
<P>There is a low risk of selection bias if the investigators describe a random component in the sequence generation process such as: referring to a random number table, using a computer random number generator, coin tossing, shuffling cards or envelopes, throwing dice, drawing of lots, minimisation (minimisation may be implemented without a random element, and this is considered to be equivalent to being random).</P>
<P>There is a high risk of selection bia<I>s</I> if the investigators describe a non-random component in the sequence generation process, such as: sequence generated by odd or even date of birth, date (or day) of admission, hospital or clinic record number; or allocation by judgement of the clinician, preference of the participant, results of a laboratory test or a series of tests, or availability of the intervention.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Allocation concealment (selection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</HEADING>
<P>There is a low risk of selection bias if the participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation); sequentially numbered drug containers of identical appearance; or sequentially numbered, opaque, sealed envelopes.</P>
<P>There is a high risk of bias if participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; or other explicitly unconcealed procedures.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of participants</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Performance bias due to knowledge of the allocated interventions by participants during the study</HEADING>
<P>There is a low risk of performance bias if blinding of participants was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of personnel/ care providers (performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Performance bias due to knowledge of the allocated interventions by personnel or care providers during the study</HEADING>
<P>There is a low risk of performance bias if blinding of personnel was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of outcome assessor (detection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Detection bias due to knowledge of the allocated interventions by outcome assessors</HEADING>
<P>There is low risk of detection bias if the blinding of the outcome assessment was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding, or:</P>
<UL>
<LI>for patient-reported outcomes in which the patient was the outcome assessor (e.g. pain, disability): there is a low risk of bias for outcome assessors if there is a low risk of bias for participant blinding (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>);</LI>
<LI>for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between patients and care providers (e.g. co-interventions, length of hospitalisation, treatment failure), in which the care provider is the outcome assessor: there is a low risk of bias for outcome assessors if there is a low risk of bias for care providers (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>);</LI>
<LI>for outcome criteria that are assessed from data from medical forms: there is a low risk of bias if the treatment or adverse effects of the treatment could not be noticed in the extracted data (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Incomplete outcome data (attrition bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Attrition bias due to amount, nature or handling of incomplete outcome data</HEADING>
<P>There is a low risk of attrition bias if there were no missing outcome data; reasons for missing outcome data were unlikely to be related to the true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data were balanced in numbers, with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, the plausible effect size (difference in means or standardised difference in means) among missing outcomes was not enough to have a clinically relevant impact on observed effect size, or missing data were imputed using appropriate methods (if drop-outs are very large, imputation using even "acceptable" methods may still suggest a high risk of bias) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>). The percentage of withdrawals and drop-outs should not exceed 20% for short-term follow-up and 30% for long-term follow-up and should not lead to substantial bias (these percentages are commonly used but arbitrary, not supported by literature) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Selective Reporting (reporting bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Reporting bias due to selective outcome reporting</HEADING>
<P>There is low risk of reporting bias if the study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way, or if the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).</P>
<P>There is a high risk of reporting bias<I> </I>if<I> </I>not all of the study's pre-specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Group similarity at baseline<SUP> </SUP>(selection bias)</HEADING>
<P>Bias due to dissimilarity at baseline for the most important prognostic indicators. </P>
<P>There is low risk of bia<I>s</I> if groups are similar at baseline for demographic factors, value of main outcome measure(s), and important prognostic factors (examples in the field of back and neck pain are duration and severity of complaints, vocational status, percentage of patients with neurological symptoms) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Co-interventions<SUP> </SUP>(performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias because co-interventions were different across groups</HEADING>
<P>There is low risk of bias if there were no co-interventions or they were similar between the index and control groups (van Tulder 2003).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Compliance<SUP> </SUP>(performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias due to inappropriate compliance with interventions across groups</HEADING>
<P>There is low risk of bias if compliance with the interventions was acceptable, based on the reported intensity/dosage, duration, number and frequency for both the index and control intervention(s). For single-session interventions (e.g. surgery), this item is irrelevant (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intention-to-treat-analysis</HEADING>
<P>There is low risk of bias if all randomized patients were reported/analysed in the group to which they were allocated by randomisation.  <I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Timing of outcome assessments (detection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias because important outcomes were not measured at the same time across groups</HEADING>
<P>There is low risk of bias if all important outcome assessments for all intervention groups were measured at the same time (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other bias</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias due to problems not covered elsewhere in the table</HEADING>
<P>There is a low risk of bias if the study appears to be free of other sources of bias not addressed elsewhere (e.g. study funding).</P>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-08-16 12:43:48 +0200" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2009-01-23 19:42:58 +0100" MODIFIED_BY="[Empty name]">Grading the quality of evidence - definition of domains</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-16 12:43:48 +0200" MODIFIED_BY="[Empty name]">
<P>
<B>
<U>Factors that might reduce the quality of the evidence</U>
</B>
</P>
<P>
<B>Study Design</B> refers to type of study (i.e. randomized, observational study)</P>
<P>
<B>Limitations within Study Design (Quality)</B> refers to the 12 risk of bias criteria noted in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>
<B>Consistency</B> (heterogeneity) refers to the similarity of results across studies. When all studies are included in the meta-analysis, &#8216;consistency&#8217; is defined as absence of statistical heterogeneity. In the case that not all studies are combined in a meta-analysis, &#8216;consistency&#8217; is defined when all studies for the specific outcome lead to the same decision or recommendation, and  &#8216;inconsistency&#8217; is present if the results of two or more studies lead to clinically different decisions or recommendations. Authors use their judgment to decide if there is inconsistency when only one study leads to clinically different decision or recommendation.</P>
<P>
<B>Directness (generalizability) </B>refers to the extent to which the people, interventions and outcome measures are similar to those of interest.</P>
<P>
<B>Precision </B>of the evidence relates to the number of studies, patients and events for each outcome. Imprecise data is defined as:</P>
<UL>
<LI>Only one study for an outcome, regardless of the sample size or the confidence interval.</LI>
<LI>Multiple studies combined in a meta-analysis: the confidence interval is sufficiently wide that the estimate is consistent with conflicting recommendations. For rare events one should consider the confidence interval around the risk difference rather than the confidence interval around the relative risk.</LI>
<LI>Multiple studies not combined in a meta-analysis: the total sample size is underpowered to detect a clinically significant difference between those who received the index intervention compared to those who received the control intervention. In this case, a post-hoc sample size calculation should be performed to determine the adequate sample size for each outcome.</LI>
</UL>
<P>
<B>Reporting (publication) bias </B>should only be considered present if there is actual evidence of reporting bias rather than only speculation about reporting bias. The Cochrane Reporting Bias Methods Group describes the following types of Reporting Bias and Definitions:</P>
<UL>
<LI>Publication Bias: the publication or non publication of research findings, depending on the nature and direction of the results.</LI>
<LI>Time Lag Bias: the rapid or delayed publication of research findings, depending on the nature and direction of the results.</LI>
<LI>Language Bias: the publication of research findings in a particular language, depending on the nature and direction of the results.</LI>
<LI>Funding Bias: the reporting of research findings, depending on how the results accord with the aspirations of the funding body.</LI>
<LI>Outcome Variable Selection Bias: the selective reporting of some outcomes but not others, depending on the nature and direction of the research findings.</LI>
<LI>Developed Country Biases: the non publication or non indication of findings, depending on whether the authors were based in developed or in developing countries.</LI>
</UL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 study included in quantitative synthesis (meta-analysis)&lt;/p&gt;&lt;ol&gt;&lt;li&gt;rMS vs placebo (n=2)&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="374">
<FLOWCHARTBOX TEXT="&lt;p&gt;20 studies (of 21 publications) included in qualitative synthesis:&lt;/p&gt;&lt;p&gt;Galvanic current&lt;/p&gt;&lt;ol&gt;&lt;li&gt;vs placebo (n=1)&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Iontophoresis&lt;/p&gt;&lt;ol&gt;&lt;li&gt;vs no treatment (n=1),&lt;/li&gt;&lt;li&gt;vs comparison (n=1)&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;TENS&lt;/p&gt;&lt;ol&gt;&lt;li&gt;vs placebo (n=3),&lt;/li&gt;&lt;li&gt;+ another treatment vs that same treatment (n=3),&lt;/li&gt;&lt;li&gt;vs comparison (n=3),&lt;/li&gt;&lt;li&gt;vs other dosage (n=1)&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;EMS&lt;/p&gt;&lt;ol&gt;&lt;li&gt;vs placebo (n=1),&lt;/li&gt;&lt;li&gt;vs no treatment (n=1),&lt;/li&gt;&lt;li&gt;+ another intervention vs that same intervention (n=1),&lt;/li&gt;&lt;li&gt;vs comparison (n=1)&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Magnetic field&lt;/p&gt;&lt;ol&gt;&lt;li&gt;static field vs placebo (n=1);&lt;/li&gt;&lt;li&gt;PEMF vs placebo (n=1); vs comparison (n=1)&lt;/li&gt;&lt;/ol&gt;" WIDTH="388">
<FLOWCHARTBOX TEXT="&lt;p&gt;45 of full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;149 of records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2218 of records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;2707 records identified through database searching for physical medicine methods&lt;br&gt;update 2002 n=139;&lt;br&gt;update 2004 n=223;&lt;br&gt;update 2006 n=174;&lt;br&gt;update 2010 n=2171;&lt;br&gt;update 2012 n=65&lt;/p&gt;" WIDTH="217"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 additional records identified through other sources&lt;/p&gt;&lt;p&gt;10 ClinicalTrials..gov&lt;/p&gt;&lt;p&gt;19 WHO ICTRP&lt;/p&gt;" WIDTH="206"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;6 record excluded (= ongoing study)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;n = 25 of full-text articles excluded (n = 7 in 2011), with reasons: intervention n = 9; design n = 5; population n = 9; comparison n = 1; outcome n = 1&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>